<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Dis Model Mech</journal-id>
<journal-id journal-id-type="iso-abbrev">Dis Model Mech</journal-id>
<journal-id journal-id-type="publisher-id">DMM</journal-id>
<journal-id journal-id-type="hwp">dmm</journal-id>
<journal-title-group>
<journal-title>Disease Models &amp; Mechanisms</journal-title>
</journal-title-group>
<issn pub-type="ppub">1754-8403</issn>
<issn pub-type="epub">1754-8411</issn>
<publisher>
<publisher-name>The Company of Biologists</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26542704</article-id>
<article-id pub-id-type="pmc">4728321</article-id>
<article-id pub-id-type="doi">10.1242/dmm.022103</article-id>
<article-id pub-id-type="publisher-id">DMM022103</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Non-muscle myosin II in disease: mechanisms and therapeutic opportunities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Newell-Litwa</surname>
<given-names>Karen A.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horwitz</surname>
<given-names>Rick</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lamers</surname>
<given-names>Marcelo L.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><addr-line>Department of Cell Biology</addr-line>, <institution>University of Virginia</institution>, <addr-line>Charlottesville, VA 22908</addr-line>, <country>USA</country></aff>
<aff id="af2"><label>2</label><addr-line>Department of Morphological Sciences</addr-line>, <institution>Institute of Basic Health Science, Federal University of Rio Grande do Sul</institution>, <addr-line>Porto Alegre, Rio Grande do Sul 90610-010</addr-line>, <country>Brazil</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label>Author for correspondence (<email>kal8m@virginia.edu</email>)</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>12</month>
<year>2015</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
<volume>8</volume>
<issue>12</issue>
<fpage>1495</fpage>
<lpage>1515</lpage>
<permissions>
<copyright-statement>© 2015. Published by The Company of Biologists Ltd</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="dmm-8-022103.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>The actin motor protein non-muscle myosin II (NMII) acts as a master regulator of cell morphology, with a role in several essential cellular processes, including cell migration and post-synaptic dendritic spine plasticity in neurons. NMII also generates forces that alter biochemical signaling, by driving changes in interactions between actin-associated proteins that can ultimately regulate gene transcription. In addition to its roles in normal cellular physiology, NMII has recently emerged as a critical regulator of diverse, genetically complex diseases, including neuronal disorders, cancers and vascular disease. In the context of these disorders, NMII regulatory pathways can be directly mutated or indirectly altered by disease-causing mutations. NMII regulatory pathway genes are also increasingly found in disease-associated copy-number variants, particularly in neuronal disorders such as autism and schizophrenia. Furthermore, manipulation of NMII-mediated contractility regulates stem cell pluripotency and differentiation, thus highlighting the key role of NMII-based pharmaceuticals in the clinical success of stem cell therapies. In this Review, we discuss the emerging role of NMII activity and its regulation by kinases and microRNAs in the pathogenesis and prognosis of a diverse range of diseases, including neuronal disorders, cancer and vascular disease. We also address promising clinical applications and limitations of NMII-based inhibitors in the treatment of these diseases and the development of stem-cell-based therapies.</p>
</abstract>
<abstract abstract-type="precis">
<p><bold>Summary:</bold> Non-muscle myosin II (NMII) contributes to diverse diseases, including neuronal disorders, cancer and vascular disease. We address the role of NMII in disease pathology and highlight promising clinical applications of NMII inhibitors for disease and stem-cell-based therapies.</p>
</abstract>
<kwd-group>
<title>KEY WORDS</title>
<kwd>Migration</kwd>
<kwd>Myosin</kwd>
<kwd>Stem cell</kwd>
<kwd>Synapse</kwd>
<kwd>NMII</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Non-muscle myosin II (NMII) is a major contributor to cellular organization, polarity and regulation, with altered NMII activity contributing to numerous disease pathologies. NMII crosslinks and slides actin filaments past each other, contracting them into actomyosin filament bundles (<xref ref-type="fig" rid="DMM022103F1">Fig. 1</xref>). Through interaction with adhesion complexes, these actomyosin filament bundles generate forces capable of deforming the cell membrane and associated substrate, and that have underlying functions in processes as diverse as cell migration and neuronal synaptogenesis (reviewed in <xref ref-type="bibr" rid="DMM022103C269">Vicente-Manzanares et al., 2009a</xref>,<xref ref-type="bibr" rid="DMM022103C270">b</xref>). These contractile forces not only shape the cell, they can also be converted into biochemical signals by altering the conformation, association and organization of actin-associated protein complexes, leading to downstream signaling changes such as altered gene expression (reviewed in <xref ref-type="bibr" rid="DMM022103C96">Humphrey et al., 2014</xref>). This process of converting mechanical stimuli into biochemical signals is known as mechanotransduction.</p>
<p>Given the crucial functions that it serves in a diverse range of tissues, it is not surprising that NMII also contributes to diverse disease pathologies, including neuronal disorders, cancer and cardiovascular diseases (reviewed in <xref ref-type="bibr" rid="DMM022103C147">Ma and Adelstein, 2014</xref>). It is also an attractive therapeutic target. For example, vasodilators that target myosin to regulate blood pressure are now being used to treat conditions that result from altered NMII activity. One such vasodilator, fasudil, which is used to increase blood flow following stroke, has also been successfully used to improve learning and working memory in Alzheimer's rodent models (<xref ref-type="bibr" rid="DMM022103C95">Huentelman et al., 2009</xref>; <xref ref-type="bibr" rid="DMM022103C239">Song et al., 2013</xref>), as well as neuron survival and motor function in amyotrophic lateral sclerosis (ALS) and Parkinson's disease rodent models (<xref ref-type="bibr" rid="DMM022103C255">Tönges et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C312">Zhao et al., 2015</xref>). Additionally, inhibitors of NMII support the efficient production of pluripotent stem cells and the directed differentiation of specific cell types <italic>in vitro</italic> (see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref> for a glossary of terms) (<xref ref-type="bibr" rid="DMM022103C27">Chen et al., 2010</xref>, <xref ref-type="bibr" rid="DMM022103C28">2014</xref>; <xref ref-type="bibr" rid="DMM022103C117">Kim et al., 2015</xref>; <xref ref-type="bibr" rid="DMM022103C273">Walker et al., 2010</xref>).
<boxed-text id="DMM022103B1" orientation="portrait" position="float"><caption><title>Box 1. Glossary</title></caption><p><bold>Adhesion-dependent cell migration:</bold> during this process, cells adhere to the extracellular matrix (ECM) through integrin-mediated focal adhesions. This attachment transmits forces to the cell interior, where they are balanced by NMII-mediated tension and result in signaling changes.</p><p><bold>Adhesion-independent cell migration:</bold> cells show weak or no interaction with the ECM; however, cortical actomyosin contractility propels cells through ECM fibers, resulting in a fast migratory process.</p><p><bold>Amoeboid-like cell migration:</bold> a fast migration process that relies on actin cytoskeleton and cell contractility; results in the formation of membrane blebs that allow cells to squeeze through confined spaces. Depending on extracellular cues, cells can switch between amoeboid and mesenchymal cell migration.</p><p><bold>Chromosomal passenger complex (CPC):</bold> the CPC consists of aurora B kinase, survivin, borealin and inner centromere protein (INCENP), and regulates mitotic events, including microtubule–kinetochore attachment and cytokinesis.</p><p><bold>Collective cell migration:</bold> two or more cells move as a group owing to the presence of cell–cell junctions, and the migratory output depends on coordinated cytoskeleton dynamics and cell signaling among all cells in the group.</p><p><bold>Copy number variants (CNVs):</bold> these are large deletions or duplications within the genome, of around ≥30 kb in size.</p><p><bold>Dendritic spines:</bold> post-synaptic protrusions that synapse with pre-synaptic axon terminals. They contain a post-synaptic density (PSD) that clusters neurotransmitter receptors and signaling scaffolds adjacent to the pre-synaptic terminal. In response to repeated excitatory stimulation, the size of the spine head and PSD increases, resulting in synaptic strengthening.</p><p><bold>Growth cones:</bold> dynamic actin-enriched structures at the tips of neurites, axons or dendrites that drive their motility toward a desired target. Chemoattractants and repellents steer growth cones.</p><p><bold>Mesenchymal-like cell migration:</bold> a multi-step process that involves the remodeling of the ECM, the formation of cell protrusions and of adhesions to the substrate, the contractility of the cell body, and the detachment of adhesions at the cell's rear. Depending on extracellular cues, cells can switch between mesenchymal and amoeboid cell migration.</p><p><bold>microRNA (miRNA):</bold> a type of small non-coding RNA that regulates gene expression by silencing complementary RNA targets. Typically, miRNAs consist of ∼22 nucleotides.</p><p><bold>Myosin regulatory light chain (MLC/RLC):</bold> the regulatory light chain for NMII, which is encoded by the <italic>MYL9</italic> gene. The phosphorylation of MLC on Ser19 and/or Thr18 increases myosin ATPase activity, resulting in actin bundling and contraction.</p><p><bold>Pluripotent stem cell:</bold> a cell with the potential to self-renew and to differentiate into any cell lineage of the three germinal layers: ectoderm, endoderm and mesoderm.</p><p><bold>Pre-synaptic terminals:</bold> the axonal compartment in contact with a post-synaptic spine. Pre-synaptic terminals contain synaptic vesicles, which release neurotransmitters into the synaptic cleft in response to action potentials.</p><p><bold>Protrusion:</bold> the broad membrane projection that cells extend during migration. They are characterized by nascent adhesions and fast actin polymerization, which pushes the membrane forward. NMII activity within protrusions results in actin retrograde flow and also leads to adhesion maturation.</p><p><bold>Single-cell migration:</bold> cells move individually and the migratory output relies mainly on the intrinsic properties of the migrating cell and the composition of the microenvironment, such as the presence of chemokines and ECM composition.</p><p><bold>Synaptic plasticity:</bold> stimuli-induced changes in neuronal spine morphology that underlie learning and memory formation.</p><p><bold>Synaptopathies:</bold> neuronal disorders that exhibit altered post-synaptic spine morphology and/or density, and include both neurodevelopmental disorders, such as autism, and neurodegenerative disorders, such as Alzheimer's disease.</p><p><bold>Transendothelial migration:</bold> the process by which cells pass through the endothelial barrier. It can occur through remodeling of cell–cell adhesions at the border of two endothelial cells (paracellular) or by passage of the extravasating cell through the endothelial cell body (transcellullar).</p></boxed-text></p>
<p>This Review focuses on how NMII and its regulatory pathways contribute to various disorders, while also exploring potential therapeutic benefits and limitations of NMII inhibitors in disease treatment and stem cell therapies. Given the multiple roles of NMII in diverse tissues, therapeutically targeting NMII presents challenges, although targeting upstream regulatory pathways can increase specificity for particular biological processes. We thus describe some of the known upstream regulatory pathways involved, highlighting how Rho GTPase and Ca<sup>2+</sup> signaling pathways activate kinases that regulate NMII in normal conditions and disease pathology. In addition, we discuss evidence for an emerging role of microRNAs (miRNAs; see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>) in the regulation of NMII activity in disease. Because both differential NMII expression and regulation can impact disease pathology, the following section discusses the structure of NMII, different NMII isoforms, and how phosphorylation mediates its association with and bundling of actin filaments, resulting in morphological and signaling changes.</p>
</sec>
<sec id="s2">
<title>NMII: structure, function and regulation</title>
<p>The multimeric, bipolar structure of NMII determines its ability to crosslink and contract actin filaments (<xref ref-type="bibr" rid="DMM022103C199">Pollard, 1982</xref>). There are three NMII isoforms (A, B and C; see <xref ref-type="boxed-text" rid="DMM022103B2">Box 2</xref>), which consist of different NMII heavy chains and shared essential and regulatory light chains (ELCs and RLCs; see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>) (<xref ref-type="bibr" rid="DMM022103C41">D'Apolito et al., 2002</xref>; <xref ref-type="bibr" rid="DMM022103C72">Golomb et al., 2004</xref>; <xref ref-type="bibr" rid="DMM022103C235">Simons et al., 1991</xref>). The heavy chain is comprised of a globular head domain, which binds both actin and adenosine triphosphate (ATP) (<xref ref-type="bibr" rid="DMM022103C209">Rayment et al., 1993a</xref>,<xref ref-type="bibr" rid="DMM022103C210">b</xref>); a neck region, which binds both the ELC and RLC (<xref ref-type="bibr" rid="DMM022103C286">Winkelmann et al., 1984</xref>); and a tail region, which homodimerizes in a helical fashion (<xref ref-type="bibr" rid="DMM022103C35">Côté et al., 1984</xref>) (<xref ref-type="fig" rid="DMM022103F1">Fig. 1</xref>). The non-helical end of the heavy chain tail exhibits the most sequence divergence between the three isoforms, and directs their differential subcellular distributions (<xref ref-type="bibr" rid="DMM022103C89">Hodge et al., 1992</xref>; <xref ref-type="bibr" rid="DMM022103C219">Ronen and Ravid, 2009</xref>; <xref ref-type="bibr" rid="DMM022103C228">Sandquist and Means, 2008</xref>), although recent evidence demonstrates that heterotypical complexes form between NMII isoforms particularly during initial cell spreading (<xref ref-type="bibr" rid="DMM022103C10">Beach et al., 2014</xref>). In addition to homodimerization, NMII filaments associate with each other in an anti-parallel fashion, allowing them to crosslink and contract actin filaments during ATP binding and hydrolysis (<xref ref-type="bibr" rid="DMM022103C215">Ricketson et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C259">Turbedsky et al., 2005</xref>). The phosphorylation of the RLC on Ser19 and/or Thr18 regulates the conformation and activity of NMII, with phosphorylation of both residues resulting in increased ATPase activity and a corresponding increase in actin association and bundling (<xref ref-type="bibr" rid="DMM022103C261">Umemoto et al., 1989</xref>; <xref ref-type="bibr" rid="DMM022103C266">Vicente-Manzanares and Horwitz, 2010</xref>; <xref ref-type="bibr" rid="DMM022103C268">Vicente-Manzanares et al., 2008</xref>; <xref ref-type="bibr" rid="DMM022103C305">Yuen et al., 2009</xref>). The resulting actomyosin filament bundles that are at the rear of the cell drive directional migration, and also the post-synaptic maturation of dendritic spines in neurons (<xref ref-type="bibr" rid="DMM022103C90">Hodges et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C268">Vicente-Manzanares et al., 2008</xref>, <xref ref-type="bibr" rid="DMM022103C271">2011</xref>) (see Box 1). Owing to the fundamental role of RLCs in regulating NMII activity, the upstream signaling pathways that mediate the phosphorylation and dephosphorylation of Ser19/Thr18, and the RLC kinases and phosphatases involved, are well studied and play important roles in NMII-mediated cellular processes and pathologies (reviewed in <xref ref-type="bibr" rid="DMM022103C238">Somlyo and Somlyo, 2003</xref>). In the following section, we discuss signaling pathways that mediate NMII activation, and focus on specific kinases that promote RLC phosphorylation leading to NMII activation.
<fig id="DMM022103F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p><bold>The structure of</bold>
<bold>NMII and its regulation by serine/threonine kinases.</bold> (A) NMII consists of a heavy chain, which includes a globular head domain that binds both actin and ATP; a neck region, which binds both the essential and regulatory light chains (ELC and RLC, respectively); and a tail region, which homodimerizes in a helical fashion, as well as a non-helical tail region that directs the subcellular localization of the NMII isoform. Serine/threonine kinases regulate NMII activity by phosphorylation of the myosin RLC on residues Thr18 and Ser19. These kinases function downstream of small Rho GTPases, as well as downstream of Ca<sup>2+</sup>/calmodulin signaling pathways. This figure also indicates pharmacological inhibitors of myosin regulatory kinases that can be used to modulate NMII activity. (B) NMII filaments associate with each other in an anti-parallel fashion, allowing them to crosslink and slide actin filaments past each other. RLC Ser19 phosphorylation increases NMII ATPase activity, leading to contraction of actin filament bundles, and phosphorylation of both Ser19 and Thr18 increases NMII ATPase activity, driving the association of multiple actin filaments into actomyosin filament bundles, often referred to as stress fibers. MLCK, myosin light chain kinase; MRCK, myotonic dystrophy kinase-related Cdc42-binding kinase; PAK, p21-associated kinase; ROCK, RhoA-associated kinase; MLCP, myosin light chain phosphatase.</p></caption><graphic xlink:href="dmm-8-022103-g1"></graphic></fig>
<boxed-text id="DMM022103B2" orientation="portrait" position="float"><caption><title>Box 2. NMII isoforms</title></caption><p><bold>Non-muscle myosin IIA (NMIIA):</bold> the myosin isoform consisting of non-muscle myosin heavy chain IIA (NMHCIIA), encoded by the <italic>MYH9</italic> gene, and regulatory and essential light chains that are shared with other NMII isoforms. In humans, mutations in <italic>MYH9</italic> result in <italic>MYH9</italic>-related disorders, including May-Hegglin anomaly, Fechtner syndrome and Sebastian syndrome (<xref ref-type="bibr" rid="DMM022103C86">Heath et al., 2001</xref>). In migrating cells, NMIIA preferentially localizes to protrusions and the central region of the cell, where it regulates adhesion maturation (<xref ref-type="bibr" rid="DMM022103C120">Kolega, 1998</xref>; <xref ref-type="bibr" rid="DMM022103C219">Ronen and Ravid, 2009</xref>; <xref ref-type="bibr" rid="DMM022103C228">Sandquist and Means, 2008</xref>; <xref ref-type="bibr" rid="DMM022103C268">Vicente-Manzanares et al., 2008</xref>).</p><p><bold>Non-muscle myosin IIB (NMIIB):</bold> the myosin isoform consisting of NMHCIIB, encoded by the <italic>MYH10</italic> gene, and regulatory and essential light chains that are shared with other NMII isoforms. In migratory cells, NMIIB preferentially localizes to the rear of the cell (<xref ref-type="bibr" rid="DMM022103C268">Vicente-Manzanares et al., 2008</xref>). It is also the primary NMII isoform found at synapses in neurons (<xref ref-type="bibr" rid="DMM022103C224">Ryu et al., 2006</xref>).</p><p><bold>Non-muscle myosin IIC (NMIIC):</bold> the most recently discovered non-muscle myosin isoform, consisting of NMHIIC, encoded by <italic>MYH14</italic>, and regulatory and essential light chains that are shared with other NMII isoforms (<xref ref-type="bibr" rid="DMM022103C72">Golomb et al., 2004</xref>). In neurons, NMIIC, along with NMIIB, drives neurite outgrowth (<xref ref-type="bibr" rid="DMM022103C291">Wylie and Chantler, 2008</xref>).</p></boxed-text></p>
<sec id="s2a">
<title>NMII: activity regulation</title>
<p>Serine/threonine kinases regulate NMII and function downstream of small Rho GTPases, such as Rac, RhoA and Cdc42, and Ca<sup>2+</sup>/calmodulin signaling pathways (reviewed in <xref ref-type="bibr" rid="DMM022103C238">Somlyo and Somlyo, 2003</xref>) (<xref ref-type="fig" rid="DMM022103F1">Fig. 1</xref>). In their GTP-bound state, Rho GTPases promote downstream signaling through kinases, such as p21-associated kinase (PAK), myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK), RhoA-associated kinase (ROCK) and citron kinase (<xref ref-type="bibr" rid="DMM022103C28a">Chew et al., 1998</xref>; <xref ref-type="bibr" rid="DMM022103C306a">Zeng et al., 2000</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C85">Heasman and Ridley, 2008</xref> and <xref ref-type="bibr" rid="DMM022103C270">Vicente-Manzanares et al., 2009b</xref>). Guanine nucleotide exchange factors (GEFs) activate Rho GTPases by loading GTP onto them, whereas GTPase-activating proteins (GAPs) stimulate GTP hydrolysis, to inactivate Rho GTPase signaling (reviewed in <xref ref-type="bibr" rid="DMM022103C85">Heasman and Ridley, 2008</xref>). Although able to activate NMII, Rac and Cdc42 signaling pathways generally promote actin polymerization, whereas RhoA, through its effector ROCK, activates NMII and drives the formation of actomyosin filament bundles, which are commonly referred to as ‘stress fibers’ (<xref ref-type="bibr" rid="DMM022103C31">Chrzanowska-Wodnicka and Burridge, 1996</xref>; <xref ref-type="bibr" rid="DMM022103C105">Jean et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C285">Wilkinson et al., 2005</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C85">Heasman and Ridley, 2008</xref>). As a result of its ability to dually regulate NMII activity through direct RLC phosphorylation and indirectly through inhibition of myosin light chain phosphatase (MLCP) (<xref ref-type="bibr" rid="DMM022103C4">Amano et al., 1996</xref>; <xref ref-type="bibr" rid="DMM022103C112">Katoh et al., 2001</xref>; <xref ref-type="bibr" rid="DMM022103C118">Kimura et al., 1996</xref>), ROCK serves as a master regulator of NMII activity. ROCK inhibitors are amongst the most promising therapeutics for NMII-related disorders (reviewed in <xref ref-type="bibr" rid="DMM022103C165">Mueller et al., 2005</xref> and <xref ref-type="bibr" rid="DMM022103C185">Pan et al., 2013</xref>). Ca<sup>2+</sup>/calmodulin-activated kinases, such as myosin light chain kinase (MLCK) and zipper-interacting protein kinase (ZIPK) (<xref ref-type="bibr" rid="DMM022103C71">Goeckeler and Wysolmerski, 1995</xref>; <xref ref-type="bibr" rid="DMM022103C168">Murata-Hori et al., 1999</xref>), also promote the phosphorylation of RLC on Ser19 and Thr18 (<xref ref-type="fig" rid="DMM022103F1">Fig. 1</xref>), and are increasingly promising therapeutic targets, especially for cancer treatment (<xref ref-type="bibr" rid="DMM022103C64">Fu et al., 2015</xref>; <xref ref-type="bibr" rid="DMM022103C77">Gu et al., 2006</xref>). NMII kinases can also cooperatively regulate actomyosin organization; for example, in fibroblasts, MLCK-mediated NMII activation forms cortical actin bundles, whereas activation by ROCK generates stress fibers (<xref ref-type="bibr" rid="DMM022103C257">Totsukawa et al., 2000</xref>). In addition to phosphoregulation of NMII activity, increasing evidence demonstrates that miRNAs regulate expression of NMII and its associated regulators. In each of the following sections, we will examine how specific kinases and miRNAs regulate NMII activity to contribute to disease pathology, beginning with an emerging role for NMII misregulation in complex neuronal disorders.</p>
</sec>
</sec>
<sec id="s3">
<title>The role of NMII in neuronal disorders</title>
<p>The presence of actomyosin-like proteins in the brain was first described in 1968 (<xref ref-type="bibr" rid="DMM022103C204">Puszkin et al., 1968</xref>), followed by biochemical and ultrastructural evidence for the presence of NMII at synapses (<xref ref-type="bibr" rid="DMM022103C13">Blitz and Fine, 1974</xref>; <xref ref-type="bibr" rid="DMM022103C122">Korobova and Svitkina, 2010</xref>; <xref ref-type="bibr" rid="DMM022103C164">Morales and Fifková, 1989</xref>). However, NMII has emerged only recently in the complex pathologies that contribute to a diverse range of neurological disorders (reviewed in <xref ref-type="bibr" rid="DMM022103C174">Nadif Kasri and Van Aelst, 2008</xref>). These include synaptic disorders, or synaptopathies (see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>), which manifest with altered post-synaptic spine morphology and/or density (reviewed in <xref ref-type="bibr" rid="DMM022103C194">Penzes et al., 2011</xref>). These disorders include: neurodevelopmental disorders, such as autism; neurodegenerative disorders, such as Alzheimer's disease; neuronal migration disorders, such as lissencephaly (<xref ref-type="bibr" rid="DMM022103C258">Tsai et al., 2007</xref>); and disorders of impaired process extension, such as axon regeneration following central nervous system (CNS) injuries (<xref ref-type="bibr" rid="DMM022103C98">Hur et al., 2011</xref>). In addition to a direct role in neuronal cell biology, NMII also regulates glia cell function (<xref ref-type="bibr" rid="DMM022103C11">Beadle et al., 2008</xref>; <xref ref-type="bibr" rid="DMM022103C223">Rusielewicz et al., 2014</xref>), integrity of the blood–brain barrier (as discussed later in this Review) (<xref ref-type="bibr" rid="DMM022103C12">Beard et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C241">Srivastava et al., 2013</xref>) and microglia activation in neuroinflammation (<xref ref-type="bibr" rid="DMM022103C104">Janßen et al., 2014</xref>). Here, we discuss the role of NMII in brain development and function, its contribution to diverse neuronal disorders, and the potential therapeutic applications of pharmacological inhibitors of NMII for nervous system disorders and injury.</p>
<sec id="s3a">
<title>NMII in synapse development and function</title>
<p>In neurons, NMII localizes to dynamic actin-enriched structures, including growth cones (see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>) and synapses (<xref ref-type="fig" rid="DMM022103F2">Fig. 2</xref>). Although neurons express all three NMII isoforms (A, B and C; see <xref ref-type="boxed-text" rid="DMM022103B2">Box 2</xref>), they are particularly enriched in the NMIIB isoform (<xref ref-type="bibr" rid="DMM022103C217">Rochlin et al., 1995</xref>). Whereas NMIIA, B and C localize to growth cones, where they regulate process extension (<xref ref-type="bibr" rid="DMM022103C217">Rochlin et al., 1995</xref>; <xref ref-type="bibr" rid="DMM022103C291">Wylie and Chantler, 2008</xref>; <xref ref-type="bibr" rid="DMM022103C292">Wylie et al., 1998</xref>), NMIIB is the predominant isoform present at synapses (<xref ref-type="bibr" rid="DMM022103C224">Ryu et al., 2006</xref>). NMIIB localizes both to pre-synaptic terminals (see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>), where it mediates synaptic vesicle recycling (<xref ref-type="bibr" rid="DMM022103C24">Chandrasekar et al., 2013</xref>), and post-synaptic dendritic spines (see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>), where it regulates the maturation of spines and the clustering of glutamate receptors in the post-synaptic density (PSD) in response to activation of the N-methyl-D-aspartate (NMDA) receptor (<xref ref-type="bibr" rid="DMM022103C90">Hodges et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C214">Rex et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C224">Ryu et al., 2006</xref>). Thus, NMII serves as an important regulator of stimuli-induced changes in spine morphology that underlie learning and memory formation (reviewed in <xref ref-type="bibr" rid="DMM022103C92">Hotulainen and Hoogenraad, 2010</xref>).
<fig id="DMM022103F2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p><bold>NMII regulates neuronal plasticity.</bold> (A) Confocal image of a GFP-expressing primary rat hippocampal neuron, highlighting the cell body, or soma, and processes, including post-synaptic dendrites, which form spines, and pre-synaptic axons, which form axon terminals containing synaptic vesicles. (B) NMII drives dynamic changes in neuronal morphology, including changes in dendritic spine formation and maturation, driven primarily by the isoform NMIIB. At the post-synaptic spine, NMII drives changes in actin organization that regulate spine and post-synaptic density (PSD) morphology and size, whereas, on the pre-synaptic side, NMII participates in synaptic vesicle recycling. The absence or inhibition of NMIIB activity results in dynamic ‘filopodia-like’ spine precursors and prevents spine maturation. In contrast, NMIIB activity drives spine and PSD maturation, although further NMIIB activity might result in spine and even dendrite retraction. (C) At the growth cone, all three NMII isoforms are present, and regulate substrate attachment and actin retrograde flow underlying neurite outgrowth. NGF, nerve growth factor; CSPGs, chondroitin sulfate proteoglycans; MAGs, myelin-associated glycoproteins.</p></caption><graphic xlink:href="dmm-8-022103-g2"></graphic></fig></p>
<p>During embryonic development, dendritic spines emerge as dynamic filopodia-like spine precursors (<xref ref-type="fig" rid="DMM022103F2">Fig. 2</xref>) (<xref ref-type="bibr" rid="DMM022103C39">Dailey and Smith, 1996</xref>; <xref ref-type="bibr" rid="DMM022103C203">Portera-Cailliau et al., 2003</xref>; <xref ref-type="bibr" rid="DMM022103C317">Ziv and Smith, 1996</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C306">Yuste and Bonhoeffer, 2004</xref>). These spine precursors stabilize upon contact with pre-synaptic terminals (<xref ref-type="bibr" rid="DMM022103C317">Ziv and Smith, 1996</xref>). This results in the formation of thin spines that have a distinct spine head and clustering of glutamate receptors into a signaling scaffold, known as the PSD, at the tip of the spine adjacent to the pre-synaptic terminal (<xref ref-type="bibr" rid="DMM022103C152">Marrs et al., 2001</xref>). In response to further excitatory stimulation, spines mature into a mushroom shape and have a larger PSD, further strengthening the synaptic connection (<xref ref-type="bibr" rid="DMM022103C60">Fortin et al., 2010</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C144">Lynch et al., 2007</xref>). In the absence of NMII, spines persist as filopodia-like spine precursors with small PSDs and have an impaired ability to respond to excitatory stimulation (<xref ref-type="bibr" rid="DMM022103C90">Hodges et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C214">Rex et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C224">Ryu et al., 2006</xref>). However, in response to excitatory stimulation, NMII is activated by RLC Ser19, Thr18 di-phosphorylation, resulting in a mature, mushroom-shaped spine and increased PSD size (<xref ref-type="bibr" rid="DMM022103C90">Hodges et al., 2011</xref>).</p>
<p>Serine/threonine kinases regulate myosin activation to drive these changes in spine morphology (<xref ref-type="fig" rid="DMM022103F2">Fig. 2</xref>). In particular, kinases associated with Rho GTPase signaling pathways are important regulators of synaptic development. For example, RhoA and its effector kinase ROCK promote synaptic strengthening in response to excitatory stimulation by RLC di-phosphorylation, leading to spine maturation (<xref ref-type="bibr" rid="DMM022103C90">Hodges et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C179">Newell-Litwa et al., 2015</xref>; <xref ref-type="bibr" rid="DMM022103C213">Rex et al., 2009</xref>). Likewise, the Rho GTPase Rac regulates the formation of dendritic spines and synapses through its effector kinase, PAK, and subsequent RLC phosphorylation (<xref ref-type="bibr" rid="DMM022103C308">Zhang et al., 2005</xref>). Finally, there is some evidence that Ca<sup>2+</sup>/calmodulin-activated MLCK regulates both pre-synaptic vesicle trafficking (<xref ref-type="bibr" rid="DMM022103C201">Polo-Parada et al., 2005</xref>; <xref ref-type="bibr" rid="DMM022103C253">Tokuoka and Goda, 2006</xref>; <xref ref-type="bibr" rid="DMM022103C304">Yue and Xu, 2014</xref>), as well as post-synaptic NMDA receptor currents (<xref ref-type="bibr" rid="DMM022103C130">Lei et al., 2001</xref>). Thus, myosin kinases are vitally important regulators of synaptic strengthening through changes in synapse morphology and molecular composition, which underlie excitatory neurotransmission. In the following section, we will examine how altered Rho GTPase signaling and kinase regulation of NMII contributes to both neuronal and glial disorders, and how therapeutically targeting these pathways alleviates disease symptoms in preclinical models.</p>
</sec>
<sec id="s3b">
<title>NMII in synaptic disorders</title>
<p>Consistent with the role of NMII and its associated regulatory pathways in synaptic formation and maturation, these pathways have recently emerged as major targets of multiple synaptopathies, including genetically complex neurodevelopmental disorders (<xref ref-type="bibr" rid="DMM022103C198">Pinto et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C311">Zhao et al., 2014</xref>). In particular, individuals with non-syndromic mental retardation (MR) exhibit mutations in proteins associated with Rho GTPase signaling pathways that regulate actomyosin activity, including the RhoA GAP, oligophrenin, the Rac GEF, PAK-interacting exchange factor Pix, and the myosin kinase, PAK (reviewed in <xref ref-type="bibr" rid="DMM022103C206">Ramakers, 2002</xref>). Individuals with non-syndromic MR have impaired cognitive ability, with intelligence quotients below 70 (a standard diagnostic marker for intellectual disability) (reviewed in <xref ref-type="bibr" rid="DMM022103C206">Ramakers, 2002</xref>). The majority of non-syndromic MR cases do not exhibit gross anatomical abnormalities, but manifest altered brain ultrastructure, including immature dendritic spines and decreased spine density in adolescence, although fragile X MR results in a persistent increase of immature dendritic spines reminiscent of early development (<xref ref-type="bibr" rid="DMM022103C101">Irwin et al., 2001</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C58">Fiala et al., 2002</xref> and <xref ref-type="bibr" rid="DMM022103C206">Ramakers, 2002</xref>). Similarly, schizophrenia is associated with decreased spine density and maturation (<xref ref-type="bibr" rid="DMM022103C194">Penzes et al., 2011</xref>), whereas autistic individuals frequently exhibit increased spine density (<xref ref-type="bibr" rid="DMM022103C99">Hutsler and Zhang, 2010</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C194">Penzes et al., 2011</xref>). A recent study of <italic>de novo</italic> mutations found in multiple neurodevelopmental disorders revealed that <italic>MYH9</italic> (<xref ref-type="boxed-text" rid="DMM022103B2">Box 2</xref>) is one of only three affected genes shared by autism, schizophrenia and intellectual disability, and <italic>de novo</italic> mutations for <italic>MYH10</italic> (<xref ref-type="boxed-text" rid="DMM022103B2">Box 2</xref>) are reported for both schizophrenia and autism (<xref ref-type="bibr" rid="DMM022103C133">Li et al., 2015b</xref>). Additionally, pathways that regulate NMII function, especially Rho GTPase signaling pathways, are disproportionately targeted by autism and schizophrenia copy number variants (CNVs; see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>) (<xref ref-type="bibr" rid="DMM022103C198">Pinto et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C311">Zhao et al., 2014</xref>). Whether these <italic>de novo</italic> mutations and CNVs in NMII and NMII regulatory pathways contribute to disease progression still needs to be established. However, recent evidence demonstrates that altered NMII regulation contributes to disease pathology in Timothy syndrome, which lies on the autism spectrum, through RhoA-mediated NMII activation leading to dendrite retraction (<xref ref-type="bibr" rid="DMM022103C124">Krey et al., 2013</xref>).</p>
<p>How might these copy number variations that are found in NMII signaling pathways contribute to synaptic abnormalities in neurodevelopmental disorders? Although the mechanism is unknown, altered expression of NMII regulatory proteins could lead to abnormal NMII activation, particularly at critical periods of brain development that involve synapse formation and synaptic pruning. For example, increased NMII activation might underlie the reduced synaptic density that features in schizophrenia by preventing the formation of spine precursors that occurs in the absence of NMII activity (<xref ref-type="bibr" rid="DMM022103C90">Hodges et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C224">Ryu et al., 2006</xref>) or by promoting spine retraction. Consistent with this hypothesis, increased levels of phosphorylated RLCs have been observed in the anterior cingulate cortex of brains from schizophrenics (<xref ref-type="bibr" rid="DMM022103C221">Rubio et al., 2012</xref>).</p>
<p>Although NMII inactivation promotes the formation of spine precursors (<xref ref-type="bibr" rid="DMM022103C90">Hodges et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C224">Ryu et al., 2006</xref>), subsequent NMII activation is necessary for spine maturation and stabilization (<xref ref-type="bibr" rid="DMM022103C90">Hodges et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C308">Zhang et al., 2005</xref>). Thus, decreased NMII activity could account for the decreased spine density observed in individuals with non-syndromic MR. Consistent with this hypothesis, inactivation of the non-syndromic MR-related NMII kinase PAK in rat hippocampal neurons resulted in decreased spine density, but this phenotype was rescued by myosin activation through the co-expression of a phosphomimetic RLC (<xref ref-type="bibr" rid="DMM022103C308">Zhang et al., 2005</xref>). Alternately, decreased spine density could arise from increased NMII contractility during spine formation or through elevated contractility leading to spine retraction and synapse pruning. In support of this hypothesis, the knockdown of the non-syndromic MR-related protein oligophrenin in rat hippocampal slices resulted in decreased spine density and/or length, which could be rescued by inhibition of myosin activity (<xref ref-type="bibr" rid="DMM022103C75">Govek et al., 2004</xref>; <xref ref-type="bibr" rid="DMM022103C175">Nadif Kasri et al., 2009</xref>). Thus, insights from known non-syndromic MR disease targets indicate that the mechanism that underlies similar synaptic deficits will likely depend on the affected molecule(s) and when/where they are active during brain development. Further studies are needed to elucidate how actomyosin pathways are regulated both temporally and spatially to determine spine morphology and density at distinct stages of brain development. Furthermore, in genetically complex disorders, such as autism and schizophrenia, studies are needed to elucidate the contribution of specific CNV-associated genes, which is now possible through the use of gene editing technologies in model organisms (<xref ref-type="bibr" rid="DMM022103C248">Swiech et al., 2014</xref>).</p>
<p>In addition to genetic alterations in the components of NMII-related signaling pathways, miRNAs have recently emerged as regulators of actomyosin signaling pathways that affect brain development and disease. For example, miR-137, which suppresses PAK signaling (<xref ref-type="bibr" rid="DMM022103C137">Liu et al., 2011</xref>), associates with schizophrenia (<xref ref-type="bibr" rid="DMM022103C216">Ripke et al., 2011</xref>). In autism, differentially expressed miRNAs disproportionately target actomyosin regulatory pathways (<xref ref-type="bibr" rid="DMM022103C167">Mundalil Vasu et al., 2014</xref>). In Down syndrome, miR-155 is upregulated, leading to synaptic dysfunction through downregulation of sorting nexin 27 (SNX27) (<xref ref-type="bibr" rid="DMM022103C143">Lu et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C278">Wang et al., 2013a</xref>), although miR-155 can also suppress NMII activation (<xref ref-type="bibr" rid="DMM022103C282">Weber et al., 2014</xref>), highlighting that miRNAs often regulate multiple targets that could function in disease pathology. Thus, although miRNAs could serve as clinical therapeutic targets for multiple neurological disorders, further investigation into their specificity for actomyosin pathways contributing to disease pathology is necessary.</p>
</sec>
<sec id="s3c">
<title>NMII regulators as therapeutic targets</title>
<p>NMII kinases are emerging as attractive therapeutic targets for the treatment of diverse synaptopathies (<xref ref-type="table" rid="DMM022103TB1">Table 1</xref>). For example, PAK inhibitors successfully reverse abnormal spine morphology in animal models of both fragile X MR (<xref ref-type="bibr" rid="DMM022103C47">Dolan et al., 2013</xref>) and schizophrenia (<xref ref-type="bibr" rid="DMM022103C83">Hayashi-Takagi et al., 2014</xref>). Likewise, ROCK inhibitors, which promote neurite outgrowth to restore neuronal connectivity, could be especially useful for the treatment of neurodegenerative disorders, such as Parkinson's disease and Alzheimer's disease, for which they are currently undergoing preclinical trials in animal models (<xref ref-type="bibr" rid="DMM022103C36">Couch et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C95">Huentelman et al., 2009</xref>; <xref ref-type="bibr" rid="DMM022103C251">Tatenhorst et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C254">Tönges et al., 2012</xref>; <xref ref-type="bibr" rid="DMM022103C312">Zhao et al., 2015</xref>). In addition to neurodegenerative disorders, ROCK inhibitors are being explored as a mechanism to treat altered synaptic connections and behavior that result from drug addiction (<xref ref-type="bibr" rid="DMM022103C45">DePoy et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C218">Roland et al., 2014</xref>). Thus, myosin regulatory kinases represent attractive therapeutic targets for diverse synaptic disorders. However, off-target effects of kinase inhibitors often prevent systemic application, thus necessitating mechanisms for localized delivery. For example, in addition to their effects on spine morphology, ROCK inhibitors affect blood pressure and permeability of the blood–brain barrier (<xref ref-type="bibr" rid="DMM022103C93">Huang et al., 2011</xref>). Moreover, the NMII inhibitor blebbistatin (<xref ref-type="fig" rid="DMM022103F1">Fig. 1</xref>) inhibits both muscle and non-muscle myosin II, and thus affects both skeletal and cardiac muscle contractions (<xref ref-type="bibr" rid="DMM022103C48">Dou et al., 2007</xref>; <xref ref-type="bibr" rid="DMM022103C242">Stewart et al., 2009</xref>). These examples highlight the need for more specific inhibitors and identification of alternate targets for perturbing NMII activity specifically within the desired tissue.
<table-wrap id="DMM022103TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p><bold>Targeting NMII kinases in the treatment of synaptopathies</bold></p></caption><graphic xlink:href="dmm-8-022103-i1"></graphic></table-wrap></p>
</sec>
<sec id="s3d">
<title>NMII in neuronal regeneration following CNS injury</title>
<p>Unlike synapses, where NMIIB is the predominant isoform, growth cones express all three NMII isoforms (<xref ref-type="bibr" rid="DMM022103C217">Rochlin et al., 1995</xref>; <xref ref-type="bibr" rid="DMM022103C291">Wylie and Chantler, 2008</xref>). In a neuroblastoma Neuro2A model of neurite extension, NMIIB and NMIIC promote neurite outgrowth, whereas NMIIA and NMIIC promote adhesion to the fibronectin substrate (<xref ref-type="bibr" rid="DMM022103C290">Wylie and Chantler, 2001</xref>, <xref ref-type="bibr" rid="DMM022103C291">2008</xref>; <xref ref-type="bibr" rid="DMM022103C292">Wylie et al., 1998</xref>) (<xref ref-type="fig" rid="DMM022103F2">Fig. 2</xref>). Whereas <italic>NMIIA</italic> expression remains constant before and during neurite growth, <italic>NMIIB</italic> mRNA levels increase during neurite outgrowth (<xref ref-type="bibr" rid="DMM022103C292">Wylie et al., 1998</xref>). During development, NMII-mediated actin remodeling drives axonal extension and retraction in response to attractants, such as nerve growth factor (NGF), or to repellents, such as netrin-1 and semaphorin-3A, to refine the innervation of the correct brain targets (<xref ref-type="bibr" rid="DMM022103C15">Brown and Bridgman, 2009</xref>; <xref ref-type="bibr" rid="DMM022103C16">Brown et al., 2009</xref>; <xref ref-type="bibr" rid="DMM022103C142">Loudon et al., 2006</xref>; <xref ref-type="bibr" rid="DMM022103C171">Murray et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C173">Myers et al., 2006</xref>).</p>
<p>Following CNS injury, some of the repellents that refine neural circuitry during development, such as myelin-associated glycoproteins (MAGs) and chondroitin sulfate proteoglycans (CSPGs), inhibit axon regeneration and re-innervation within the glia scar (<xref ref-type="fig" rid="DMM022103F2">Fig. 2</xref>) (reviewed in <xref ref-type="bibr" rid="DMM022103C17">Busch and Silver, 2007</xref>). The removal of these inhibitory factors has met with limited therapeutic success, suggesting that adult axons must overcome intrinsic factors that prevent their growth into an injury site (reviewed in <xref ref-type="bibr" rid="DMM022103C287">Wootla et al., 2012</xref>). RhoA/ROCK-mediated NMII activation functions downstream of inhibitory CSPGs, and the ROCK inhibitor Y-27632 partially rescued axon regrowth in an <italic>in vivo</italic> rat spinal cord injury model and <italic>in vitro</italic> in chick dorsal root and retinal ganglion cells as well as rat cerebellar granule neurons (<xref ref-type="bibr" rid="DMM022103C14">Borisoff et al., 2003</xref>; <xref ref-type="bibr" rid="DMM022103C125">Kubo et al., 2008</xref>; <xref ref-type="bibr" rid="DMM022103C162">Monnier et al., 2003</xref>). However, blebbistatin restored, and even surpassed, control axon growth on inhibitory substrates <italic>in vitro</italic> (<xref ref-type="bibr" rid="DMM022103C98">Hur et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C115">Kilinc et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C303">Yu et al., 2012</xref>). These pharmacological differences could be due in part to the observation that the ROCK inhibitor Y-27632 leads to increased CSPGs within the glia scar in a rat spinal cord injury model (<xref ref-type="bibr" rid="DMM022103C23">Chan et al., 2007</xref>). Thus, NMII is emerging as an attractive therapeutic target for axon regeneration in debilitating spinal cord injuries and CNS lesions.</p>
</sec>
<sec id="s3e">
<title>NMII in glia cell biology</title>
<p>Besides neurons, NMII is also involved in the biology of glia cells. Three glia cell types reside in the CNS: astrocytes, oligodendrocytes and microglia. Astrocytes are the predominant glial cell type in the brain, where they serve multiple functions, including the regulation of blood flow and glutamate uptake at synapses (reviewed in <xref ref-type="bibr" rid="DMM022103C220">Rossi, 2015</xref>). A branched, stellate morphology allows astrocytes to interact with these multiple targets, including the endothelium of the blood–brain barrier and synapses between neurons (reviewed in <xref ref-type="bibr" rid="DMM022103C220">Rossi, 2015</xref>). The inactivation of ROCK-mediated NMII activation is required for this branched morphology (<xref ref-type="bibr" rid="DMM022103C169">Murk et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C207">Ramakers and Moolenaar, 1998</xref>), and is also responsible for the reactive astroglial phenotype observed in response to interleukin (IL)-1β, the cytokine that mediates astrocyte scar formation following CNS injury (<xref ref-type="bibr" rid="DMM022103C109">John, 2004</xref>). However, because the directed migration of astrocytes toward the site of injury requires NMII (<xref ref-type="bibr" rid="DMM022103C193">Peng et al., 2013</xref>), ROCK inhibition could be used to prevent glia scar formation (<xref ref-type="bibr" rid="DMM022103C128">Lau et al., 2012</xref>). Thus, in addition to promoting axon regrowth into the injured site, NMII inhibition can also help prevent glial scar formation.</p>
<p>Astrocytes are also responsible for clearing glutamate from the synaptic cleft, a process mediated by the excitatory amino acid transporters (EAATs) (reviewed in <xref ref-type="bibr" rid="DMM022103C106">Jensen et al., 2015</xref>). ROCK-mediated myosin contractility regulates glutamate uptake by determining the astrocyte surface expression of EEAT1/2 (<xref ref-type="bibr" rid="DMM022103C127">Lau et al., 2011</xref>). Several neuronal disorders present with increased glutamate, resulting in cytotoxicity and/or abnormal neurotransmission (<xref ref-type="bibr" rid="DMM022103C176">Nakagawa and Kaneko, 2013</xref>). For example, increased glutamate lowers the seizure threshold in epilepsy, although ROCK inhibition protects neurons from the resulting cytotoxicity following a seizure (<xref ref-type="bibr" rid="DMM022103C107">Jeon et al., 2013</xref>). Thus, the myosin kinase ROCK is a promising therapeutic target for disorders associated with glutamate misregulation.</p>
<p>NMII also regulates myelination, which enables the rapid conductance of action potentials. In the CNS, oligodendrocytes branch to ensheath multiple axonal targets. During the process of oligodendrocyte differentiation and branching in rodent <italic>in vitro</italic> models, NMII is downregulated, with NMII activity preventing oligodendrocyte differentiation and NMII inhibition enhancing oligodendrocyte maturation and myelination (<xref ref-type="bibr" rid="DMM022103C274">Wang et al., 2008</xref>, <xref ref-type="bibr" rid="DMM022103C276">2012a</xref>). NMII inhibition promotes re-myelination following brain lesion in mice (<xref ref-type="bibr" rid="DMM022103C223">Rusielewicz et al., 2014</xref>). In contrast to oligodendrocytes, Schwann cells in the peripheral nervous system require NMII to elongate on and ensheath axons (<xref ref-type="bibr" rid="DMM022103C274">Wang et al., 2008</xref>), with robust ROCK-driven myosin phosphorylation characterizing the onset of myelination (<xref ref-type="bibr" rid="DMM022103C155">Melendez-Vasquez et al., 2004</xref>). Thus, pharmacological modulators of NMII activity could potentially be used to promote myelination in demyelinating disorders, such as multiple sclerosis.</p>
<p>Finally, NMII contributes to microglia function and to neuroinflammation resulting from microglia activation and release of inflammatory cytokines (reviewed in <xref ref-type="bibr" rid="DMM022103C230">Schwartz et al., 2013</xref>). In a mouse model of Parkinson's disease, ROCK inhibition prevents microglia activation and the phagocytosis of degenerating dopaminergic neurons (<xref ref-type="bibr" rid="DMM022103C8">Barcia et al., 2012</xref>). Similarly, ALS results in increased pro-inflammatory cytokine production, which is attenuated by ROCK inhibition, leading to increased mouse motoneuron survival <italic>in vivo</italic> (<xref ref-type="bibr" rid="DMM022103C46">Ding et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C186">Parisi et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C255">Tönges et al., 2014</xref>). As in synaptopathies, NMII-regulatory miRNAs might contribute to the pathology of neuroinflammatory disorders. In line with this, miRNAs associated with myosin regulation are upregulated in ALS (<xref ref-type="bibr" rid="DMM022103C186">Parisi et al., 2013</xref>). In multiple sclerosis, miR-155, which is known to regulate NMII activity (<xref ref-type="bibr" rid="DMM022103C282">Weber et al., 2014</xref>), promotes inflammation (<xref ref-type="bibr" rid="DMM022103C163">Moore et al., 2013</xref>). Thus, a detailed survey of myosin regulatory miRNAs in neuronal and glia function, particularly at discrete stages of development, would be greatly informative. In the following section we will address how NMII regulation, which shapes neuronal and glial functions, similarly drives morphological and signaling changes associated with cancer cell division and migration.</p>
</sec>
</sec>
<sec id="s4">
<title>NMII in cancer</title>
<p>Several cancers exhibit differential expression and/or activation of NMII isoforms and their associated regulators (<xref ref-type="table" rid="DMM022103TB2">Table 2</xref>), leading to changes in cell division and migration that underlie tumorigenesis and invasion. Both oncogenes and miRNAs regulate this differential NMII expression, although external factors within the tumor microenvironment, such as the extracellular matrix (ECM) and cytokines, also profoundly influence NMII activity. Understanding how intrinsic genetic factors and external factors within the tumor environment combine to regulate NMII expression/activity could allow for therapeutic intervention at distinct stages of cancer progression.
<table-wrap id="DMM022103TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p><bold>Altered NMII regulation in cancer</bold></p></caption><graphic xlink:href="dmm-8-022103-i2"></graphic></table-wrap></p>
<sec id="s4a">
<title>NMII and tumorigenesis</title>
<p>During tumorigenesis, mutations in oncogenes and/or in tumor suppressor genes result in uncontrolled cell division, decreased apoptosis, and changes in cell differentiation and motility. Several oncogenes activate NMII to promote these tumorigenic properties. For example, the oncogenes <italic>Ras</italic> and its downstream target <italic>BRAF</italic>, a serine-threonine kinase, which regulate cell survival and proliferation through a mitogen-activated protein kinase (MAPK) signaling cascade, also increase NMII activation, leading to tumor invasion <italic>in vitro</italic> and in a mouse melanoma model <italic>in vivo</italic> (<xref ref-type="bibr" rid="DMM022103C5">Arozarena et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C25">Chen et al., 2003</xref>; <xref ref-type="bibr" rid="DMM022103C87">Helfman and Pawlak, 2005</xref>; <xref ref-type="bibr" rid="DMM022103C313">Zhong et al., 1997</xref>). Conversely, some tumor suppressors downregulate NMII-mediated contractility <italic>in vitro</italic>. The tumor suppressor p53 decreases RhoA activation and also alters NMIIB expression, both resulting in impaired tumor invasion (<xref ref-type="bibr" rid="DMM022103C293">Xia and Land, 2007</xref>; <xref ref-type="bibr" rid="DMM022103C297">Yam et al., 2001</xref>). Interestingly, <xref ref-type="bibr" rid="DMM022103C229">Schramek et al. (2014)</xref> demonstrated that NMIIA acts as a tumor suppressor, with NMIIA downregulation resulting in impaired activation of p53 in keratinocytes both <italic>in vitro</italic> and <italic>in vivo</italic>. Additionally, non-coding miRNAs might directly and/or indirectly target NMII and its regulators, resulting in changes to tumor cell migration and proliferation (<xref ref-type="table" rid="DMM022103TB3">Table 3</xref>). Taken together, these findings suggest that diverse carcinogenic mutations act on the expression and activity of NMII at the onset of tumorigenesis and later on during invasion, implicating NMII regulation in the pathogenesis of multiple, different tumor types. Below, we will specifically examine how this altered NMII activity contributes to cancer progression through the regulation of cell division and cancer cell migration/metastasis.
<table-wrap id="DMM022103TB3" orientation="portrait" position="float"><label>Table 3.</label><caption><p><bold>miRNA regulators of NMII function</bold></p></caption><graphic xlink:href="dmm-8-022103-i3"></graphic></table-wrap></p>
</sec>
<sec id="s4b">
<title>NMII in cell division: propagating genetic abnormalities</title>
<p>During cytokinesis, actomyosin filaments organize into a contractile ring that separates dividing daughter cells (reviewed in <xref ref-type="bibr" rid="DMM022103C9">Barr and Gruneberg, 2007</xref>). The chromosomal passenger complex (CPC; see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>) positions RhoA activity within the cytokinetic ring, resulting in localized NMII forces that drive cell division (<xref ref-type="bibr" rid="DMM022103C44">DeBiasio et al., 1996</xref>; <xref ref-type="bibr" rid="DMM022103C184">Ou et al., 2010</xref>; Ya<xref ref-type="bibr" rid="DMM022103C180">ng et al., 2012</xref>). Even after failed cytokinesis, NMII-mediated traction forces resolve binucleate cells into euploid progeny in interphase (<xref ref-type="bibr" rid="DMM022103C30">Choudhary et al., 2013</xref>). However, in cancer cells, the altered localization and regulation of NMII activity can induce genetic abnormalities, such as aneuploidy (<xref ref-type="fig" rid="DMM022103F3">Fig. 3</xref>A). For example, in breast cancer cell lines, the downregulation of the tumor suppressor gene <italic>BRCA2 in vitro</italic> results in NMII mislocalization during mitosis, leading to chromosome instability and aneuploidy (<xref ref-type="bibr" rid="DMM022103C40">Daniels et al., 2004</xref>; <xref ref-type="bibr" rid="DMM022103C249">Takaoka et al., 2014</xref>). The NMIIC isoform is associated with delayed cytokinesis in lung tumor cells (<xref ref-type="bibr" rid="DMM022103C103">Jana et al., 2006</xref>), whereas several tumor cell lines exhibit decreased RLC phosphorylation and increased multinucleation, likely resulting from failed cytokinesis (<xref ref-type="bibr" rid="DMM022103C289">Wu et al., 2010</xref>). Thus, the correct regulation of NMII activity and its positioning within the cytokinetic ring preserves genome integrity. How genetic abnormalities arising from dysregulated NMII contribute to disease pathogenesis requires further investigation. However, NMII-mediated cell division can also coordinate tumor cell invasion by promoting cell detachment and facilitating the rupture of the epithelial basement membrane (<xref ref-type="bibr" rid="DMM022103C265">Vasiliev et al., 2004</xref>), thus serving as a master regulator of cancer progression.
<fig id="DMM022103F3" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p><bold>NMII drives cancer cell progression.</bold> (A) NMII in cell division. At the end of anaphase during mitosis, the chromosomal passenger complex (CPC) induces RhoA-mediated formation of an actin-NMII contractile ring (red), resulting in cytokinesis and division into two daughter cells (upper box; telophase). However, mislocalization of the contractile ring (lower box) can result in genetic abnormalities that are linked to cancer, such as aneuploidy or multinucleation. (B) NMII in cell migration and metastasis. During adhesion-dependent cell migration (see Box 1), cells polymerize actin at the cell front (unaligned yellow lines), while integrin-based adhesions (purple circles) mediate attachment to the extracellular matrix. NMIIA (blue) generates forces that alter actin organization at the cell front and initiate adhesion maturation (purple ellipses indicate adhesion elongation). NMIIB (blue) is involved in the formation of stress fibers (aligned yellow lines), nucleus translocation and in the detachment of adhesions at the cell rear. These mechanical forces induced by NMII can also influence other biochemical pathways (mechanotransduction) that are able to modify cell behavior. (C) NMII participates in various modes of cell migration. (i) Invasion of a single tumor cell is either mesenchymal (adhesion-dependent) or amoeboid (adhesion-independent). For mesenchymal-like, single-cell migration, myosin regulates the migration process as described in B; for amoeboid-like single-cell migration, increased NMII-mediated tension affects the cortical actin network (<xref ref-type="bibr" rid="DMM022103C222">Ruprecht et al., 2015</xref>), allowing for adhesion-independent migration through porous matrices. (ii) During collective cell migration, the leading cell generates NMII-mediated traction forces that are propagated to the follower cells through cell–cell adhesions (see <xref ref-type="fig" rid="DMM022103F4">Fig. 4</xref> for details).</p></caption><graphic xlink:href="dmm-8-022103-g3"></graphic></fig></p>
</sec>
<sec id="s4c">
<title>NMII in tumor invasion and metastasis</title>
<p>In addition to cell cycle regulation, NMII drives several key steps that are necessary for tumor invasion and metastasis (<xref ref-type="fig" rid="DMM022103F3">Fig. 3</xref>B,C), making it an attractive chemotherapeutic target. Cancer cells exhibit diverse migratory behaviors, depending on tumor type and localization (reviewed in <xref ref-type="bibr" rid="DMM022103C61">Friedl and Alexander, 2011</xref>). These include single versus collective cell migration (<xref ref-type="fig" rid="DMM022103F3">Fig. 3</xref>C), and adhesion-dependent versus -independent migration (see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>; also reviewed in <xref ref-type="bibr" rid="DMM022103C62">Friedl et al., 2012</xref>). In all cases, NMII is emerging as an important regulator of tumor metastasis. During adhesion-dependent, mesenchymal-like single-cell migration (see Box 1), the localized activity of distinct NMII isoforms determines the speed and persistence of migration <italic>in vitro</italic>. For example, NMIIA localizes to protrusions (see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>) at the front of the cell, where it regulates adhesion maturation, whereas NMIIB forms the contractile rear and drives adhesion maturation, nucleus dislocation and detachment from the substrate, thus propelling the cell in a forward direction (<xref ref-type="bibr" rid="DMM022103C73">Gomes et al., 2005</xref>; <xref ref-type="bibr" rid="DMM022103C267">Vicente-Manzanares et al., 2007</xref>). In adhesion-independent, amoeboid-like single-cell migration (see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>), NMII-mediated contractility allows normal cells (such as fibroblasts and zebrafish progenitor cells) or tumor cells (human melanoma and adenocarcinoma) to invade porous matrices <italic>in vitro</italic> without the need for ECM remodeling by generating forces that influence actin cortical flow to propel cells forward (<xref ref-type="bibr" rid="DMM022103C196">Petrie et al., 2012</xref>; <xref ref-type="bibr" rid="DMM022103C222">Ruprecht et al., 2015</xref>; <xref ref-type="bibr" rid="DMM022103C225">Sahai and Marshall, 2003</xref>). For example, gliomas use NMII-dependent contractility to squeeze through submicrometer pores within the brain<italic>,</italic> and inhibition of NMII activity by blebbistatin prevents glioma invasion <italic>in situ</italic> and <italic>in vitro</italic> in response to diverse pro-migratory signals (<xref ref-type="bibr" rid="DMM022103C11">Beadle et al., 2008</xref>; <xref ref-type="bibr" rid="DMM022103C226">Salhia et al., 2008</xref>). Experiments <italic>in vitro</italic> and <italic>in vivo</italic> demonstrate that, during collective tumor cell migration (see <xref ref-type="fig" rid="DMM022103F3">Fig. 3</xref>C), NMII promotes traction forces at the leading edge of cells, which drags the follower cells and generates a supra-cellular mechanical organization that contributes to the migration process (<xref ref-type="bibr" rid="DMM022103C18">Cai et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C65">Gaggioli et al., 2007</xref>; <xref ref-type="bibr" rid="DMM022103C180">Ng et al., 2012</xref>; <xref ref-type="bibr" rid="DMM022103C212">Reffay et al., 2014</xref>). NMII-mediated contractility also influences the transition between collective and single-cell migration that is observed during epithelial-to-mesenchymal transition underlying tumor invasion, by exerting forces that accelerate the turnover of cell–cell junctions (<xref ref-type="bibr" rid="DMM022103C191">Peglion et al., 2014</xref>). Because NMII plays a central role in diverse migratory behaviors, the pharmacological manipulation of NMII might be considered as a complementary therapeutic tool for improving the success of cancer therapies, especially in the treatment of highly metastatic tumors.</p>
<p>NMII activity also facilitates migration by enabling tumor cells to respond to both physical and biochemical cues within the microenvironment (<xref ref-type="bibr" rid="DMM022103C63">Friedland et al., 2009</xref>; <xref ref-type="bibr" rid="DMM022103C156">Meshel et al., 2005</xref>; <xref ref-type="bibr" rid="DMM022103C314">Zhong et al., 1998</xref>). The tumor microenvironment is a complex structure composed of ECM components, such as collagen, fibronectin and laminin, as well as multiple, abnormally expressed growth factors and chemokines that combine to regulate myosin activity (<xref ref-type="bibr" rid="DMM022103C6">Asokan et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C49">Dulyaninova et al., 2007</xref>; <xref ref-type="bibr" rid="DMM022103C82">Harrison et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C113">Kharait et al., 2006</xref>; <xref ref-type="bibr" rid="DMM022103C119">Klemke et al., 1997</xref>; <xref ref-type="bibr" rid="DMM022103C138">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C177">Nakashima et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C233">Shinto et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C243">Straussman et al., 2001</xref>; <xref ref-type="bibr" rid="DMM022103C315">Zhou et al., 2008</xref>). The physical stiffness of the tumor microenvironment positively correlates with NMII-mediated contractility, and increased contractility facilitates migration on stiffer substrates, as observed in bone metastasis (<xref ref-type="bibr" rid="DMM022103C136">Liu et al., 2009</xref>). Interestingly, cancer-associated fibroblasts exhibit increased NMII activity, resulting in ECM fiber realignment and facilitating tumor invasion of connective tissue (<xref ref-type="bibr" rid="DMM022103C19">Calvo et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C298">Yamaguchi et al., 2014</xref>). Furthermore, in mechanotransduction, physical forces generated by NMII alter the adhesion properties and downstream signaling pathways that regulate diverse cellular events, including cell proliferation, apoptosis and gene expression (reviewed in <xref ref-type="bibr" rid="DMM022103C96">Humphrey et al., 2014</xref>). For example, glioma cells exhibit increased proliferation and cell migration <italic>in vitro</italic> on stiffer substrates owing to changes in NMII-related signaling (<xref ref-type="bibr" rid="DMM022103C260">Ulrich et al., 2009</xref>). Thus, NMII not only serves as a mechanical regulator of cell migration, but also as a pivotal regulator of biochemical signaling that results from changes in adhesion composition and that influences several hallmarks of cancer (reviewed in <xref ref-type="bibr" rid="DMM022103C80">Hanahan and Weinberg, 2011</xref>).</p>
<p>In addition to the physical stiffness of the tumor microenvironment, soluble growth factors and cytokines can also influence NMII activity and thus the behavior of cancer cells. In prostate cancer, the activation of protein kinase C delta (PKCδ) by epidermal growth factor (EGF) increases the phosphorylation of NMIIB (<xref ref-type="bibr" rid="DMM022103C113">Kharait et al., 2006</xref>; <xref ref-type="bibr" rid="DMM022103C243">Straussman et al., 2001</xref>). Similarly, signaling by EGF results in the increased phosphorylation of NMIIA in both breast and pancreatic tumor cell lines <italic>in vitro</italic> (<xref ref-type="bibr" rid="DMM022103C49">Dulyaninova et al., 2007</xref>; <xref ref-type="bibr" rid="DMM022103C177">Nakashima et al., 2011</xref>). The association of hepatic growth factor (HGF) and EGF induces MLCK activation in breast cancer cells, resulting in increased proliferation and migration of the tumor cells (<xref ref-type="bibr" rid="DMM022103C82">Harrison et al., 2013</xref>). In gastric cancer, transforming growth factor β (TGFβ) induces RhoA activation and RLC phosphorylation, increasing tumor migration speed and invasiveness (<xref ref-type="bibr" rid="DMM022103C233">Shinto et al., 2010</xref>). In addition, there are reports of cross-talk between myosin regulatory proteins and mitogen-activated pathways (<xref ref-type="bibr" rid="DMM022103C119">Klemke et al., 1997</xref>; <xref ref-type="bibr" rid="DMM022103C315">Zhou et al., 2008</xref>). There is also <italic>in vitro</italic> evidence that interleukins and chemoattractants can modulate myosin activation under physiological conditions (<xref ref-type="bibr" rid="DMM022103C6">Asokan et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C138">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C205">Rah et al., 2007</xref>). The contribution of immune cells and inflammation to tumor cell behavior (reviewed in <xref ref-type="bibr" rid="DMM022103C80">Hanahan and Weinberg, 2011</xref>) warrants investigation into how abnormal IL expression affects NMII activity in cancer disease pathology. As discussed below, vascular biology might provide mechanistic insights into how inflammatory cytokines regulate tumor behavior, because pro-inflammatory cytokines can increase NMII activity in endothelial cells, leading to the rupture of adherens junctions (<xref ref-type="bibr" rid="DMM022103C97">Huppert et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C283">Weidert et al., 2014</xref>).</p>
<p>Conserved roles for NMII in cancer progression of diverse tumor types has led to the development of novel chemicals that regulate NMII activity, many of which show promising results <italic>in vitro</italic> (<xref ref-type="table" rid="DMM022103TB4">Table 4</xref>). Here, we have addressed how NMII promotes cancer by generating genetic abnormalities and driving cell migration, although NMII activity might also contribute to other stages of cancer, such as blood vessel recruitment (discussed below). These multiple roles in cancer progression make NMII an attractive chemotherapeutic target.
<table-wrap id="DMM022103TB4" orientation="portrait" position="float"><label>Table 4.</label><caption><p><bold>Potential NMII drugs for cancer therapy</bold></p></caption><graphic xlink:href="dmm-8-022103-i4"></graphic></table-wrap></p>
</sec>
</sec>
<sec id="s5">
<title>Myosin and vascular diseases</title>
<p>Myosin-related contractility plays an important role in the maintenance of blood vessel integrity. The vascular system consists of arteries, veins and capillaries. While capillaries are composed of an endothelial cell monolayer, which expresses NMII, arteries and veins consist of three cell layers: the intima layer, compromised of NMII-expressing endothelial cells; the muscular layer, containing both NMII and smooth muscle myosin; and the adventitial layer, which consists of connective tissue that contains fibroblasts expressing NMII. Endothelial cells throughout the vascular system are exposed to shear force fluctuations from blood flow. In response to these forces, NMII mediates changes in actomyosin organization and signaling that regulate endothelial cell–cell adhesions and the resulting vascular permeability (<xref ref-type="bibr" rid="DMM022103C34">Conway et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C256">Tornavaca et al., 2015</xref>). However, both chronic and acute vascular events, such as atherosclerosis and edema, compromise NMII activity in endothelial and smooth muscle cells, leading to drastic changes in blood vessel homeostasis and contributing to the development of vascular pathologies. In this section, we address the main roles of NMII in blood vessel integrity and how NMII expression/function is deregulated during the development of vascular diseases.</p>
<sec id="s5a">
<title>Myosin and vascular permeability</title>
<p>The permeability of the blood barrier regulates the flow of cells and molecules between intravascular and extravascular compartments (reviewed in <xref ref-type="bibr" rid="DMM022103C154">Mehta and Malik, 2006</xref>). This paracellular permeability relies on proper cell–cell adhesions, which are regulated by NMII (<xref ref-type="fig" rid="DMM022103F4">Fig. 4</xref>A). In endothelial cells, adherens junctions are mediated by vascular endothelial cadherin (VE-cadherin), a member of the cadherin family of transmembrane receptors, which interacts with the actin cytoskeleton network through adaptor proteins, including β-catenin and p120-catenin (reviewed in <xref ref-type="bibr" rid="DMM022103C70">Giannotta et al., 2013</xref>). NMIIA and NMIIB isoforms participate in the formation of actin bundles at the interdigitating filopodia-like structures that are observed during the formation of both VE-cadherin- and epithelial-cadherin (E-cadherin)-mediated intercellular bridges (<xref ref-type="bibr" rid="DMM022103C91">Hoelzle and Svitkina, 2012</xref>; <xref ref-type="bibr" rid="DMM022103C237">Smutny et al., 2010</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C302">Yonemura, 2011</xref>). However, whereas NMII normally stabilizes adherens junctions, increased NMII-mediated contractility can disrupt endothelial junctions, as observed during the transendothelial migration of leukocytes (see <xref ref-type="boxed-text" rid="DMM022103B1">Box 1</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C166">Muller, 2011</xref>). Inflammatory factors, such as interleukins, nitric oxide (NO) and oxidative stress, increase Ca<sup>2+</sup> influx and MLCK-mediated endothelial cell contractility, disrupting cell–cell adhesions and increasing the permeability of microvessels (<xref ref-type="bibr" rid="DMM022103C38">Cromer et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C67">Gandhirajan et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C134">Liao et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C160">Mishra et al., 2015</xref>; <xref ref-type="bibr" rid="DMM022103C211">Rees et al., 2012</xref>; <xref ref-type="bibr" rid="DMM022103C232">Shen et al., 2010</xref>). Thus, the tight regulation of NMII activity maintains vascular integrity, whereas its misregulation results in barrier dysfunction in acute vascular pathologies, such as the accumulation of interstitial liquid that occurs in edema, and in chronic diseases, such as inflammation and cancer (discussed below).
<fig id="DMM022103F4" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p><bold>NMII</bold>
<bold>regulates vascular biology and disease.</bold> (A) NMII remodels endothelial adherens junctions. VE-cadherin (orange ovals) mediates intercellular links between neighboring cells. Intracellularly, catenins (beige ovals) link VE-cadherin with the actin cytoskeleton (yellow lines). Myosin (blue) generates forces that stabilize intercellular bridges. However, enhanced NMII-mediated contractility can lead to the rupture of cell-cell adhesions. (B) NMII facilitates transendothelial migration. During rolling, leukocytes (green) interact with ICAM or VCAM receptors at the membrane of endothelial cells, resulting in an influx of Ca<sup>2</sup><sup>+</sup>. At the adherens junctions at the cell border, increased NMII activity mediated by MLCK results in the rupture of cell–cell adhesions. After leukocytes squeeze and pass by the border of the two endothelial cells (paracellular), there is a neo-formation of VE-cadherin. ICAM, intercellular adhesion molecule; VCAM, vascular cell adhesion molecule; MLCK, myosin light chain kinase.</p></caption><graphic xlink:href="dmm-8-022103-g4"></graphic></fig></p>
<p>NMII activity regulates endothelial cell–cell junctions, facilitating transendothelial leukocyte migration (<xref ref-type="fig" rid="DMM022103F4">Fig. 4</xref>B). During leukocyte rolling, the activation of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) on endothelial cells increases cytoplasmic Ca<sup>2+</sup> levels, resulting in MLCK-mediated contractility and a consequent rupture of cell–cell adhesions (<xref ref-type="bibr" rid="DMM022103C79">Haidari et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C141">Lorenzon et al., 1998</xref>; <xref ref-type="bibr" rid="DMM022103C263">van Buul et al., 2007</xref>, 2010; reviewed in <xref ref-type="bibr" rid="DMM022103C166">Muller, 2011</xref>) (<xref ref-type="fig" rid="DMM022103F4">Fig. 4</xref>B). Leukocytes also release inflammatory cytokines, such as IL-4, that increase endothelial RLC phosphorylation, disrupting cell junctions and allowing for transendothelial migration (<xref ref-type="bibr" rid="DMM022103C79">Haidari et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C141">Lorenzon et al., 1998</xref>; <xref ref-type="bibr" rid="DMM022103C263">van Buul et al., 2007</xref>, 2010; reviewed in <xref ref-type="bibr" rid="DMM022103C166">Muller, 2011</xref>). As previously discussed, NMII activity facilitates leukocyte nuclear compression, allowing cells to traverse through endothelial cell–cell junctions (<xref ref-type="bibr" rid="DMM022103C102">Jacobelli et al., 2013</xref>; <xref ref-type="bibr" rid="DMM022103C150">Manes and Pober, 2013</xref>; <xref ref-type="bibr" rid="DMM022103C245">Stroka et al., 2013</xref>). Interestingly, CD4+ T cells from elderly individuals exhibit decreased NMIIA expression and defective transendothelial migration (<xref ref-type="bibr" rid="DMM022103C20">Cane et al., 2012</xref>). Thus, NMII regulates immune response and inflammation by remodeling endothelial cell–cell adhesions, allowing for leukocyte invasion. Consistent with a role for NMII in inflammation, the NMII inhibitor blebbistatin decreases inflammation in the rat kidney <italic>in vivo</italic> by blocking leukocyte infiltration (<xref ref-type="bibr" rid="DMM022103C234">Si et al., 2010</xref>).</p>
<p>Changes in endothelial permeability and leukocyte migration might also contribute to atherosclerosis, in which chronic inflammation of the endothelial layer results in plaques containing lipids and minerals that obstruct arteries and perturb blood flow, and, when ruptured, can lead to blood vessel occlusion (reviewed in <xref ref-type="bibr" rid="DMM022103C66">Galkina and Ley, 2009</xref>). These plaques are commonly formed in regions of bifurcation of large and medium arteries, which are characterized by disturbances in blood flow (reviewed in <xref ref-type="bibr" rid="DMM022103C42">Davies et al., 2013</xref>). A possible explanation for this coincidence is that localized perturbations in fluid shear stress result in NMII-mediated mechanotransduction signals that modulate the behavior of, and patterns of gene expression in, endothelial cells (reviewed in <xref ref-type="bibr" rid="DMM022103C78">Hahn and Schwartz, 2009</xref>). Consistent with this hypothesis, NMIIB and its associated RLCs are increased in atherosclerotic plaques (<xref ref-type="bibr" rid="DMM022103C43">de la Cuesta et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C182">Nikol et al., 1997</xref>), and oxidized phospholipids associated with atherosclerosis increase RhoA-driven myosin activity (<xref ref-type="bibr" rid="DMM022103C55">Essler et al., 1999</xref>; <xref ref-type="bibr" rid="DMM022103C316">Zimman et al., 2010</xref>). The pharmacological inhibition of myosin kinases, either MLCK or ROCK, have been found to reduce the development and progression of atherosclerotic plaques in mouse models of atherosclerosis (<xref ref-type="bibr" rid="DMM022103C288">Wu et al., 2009</xref>). Chronic upregulation of myosin activity in atherosclerosis likely increases endothelial permeability as previously discussed, resulting in localized inflammation in the intima vascular layer as observed during the early development of atherosclerosis (<xref ref-type="bibr" rid="DMM022103C79">Haidari et al., 2011</xref>).</p>
<p>These differential effects of NMII activity on endothelial cell–cell junctions are also observed in cancer metastasis, where tumor cells increase endothelial NMII activity, disrupting adhesions and allowing for transcellular migration and tissue invasion (<xref ref-type="bibr" rid="DMM022103C114">Khuon et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C131">Li and Zhu, 2015</xref>; <xref ref-type="bibr" rid="DMM022103C132">Li et al., 2015a</xref>). For example, melanoma cells increase endothelial cell contractility <italic>in vitro</italic>, leading to the rupture of cell–cell adhesion by the simultaneous activation of VCAM and IL1β- and IL8-mediated signaling pathways (<xref ref-type="bibr" rid="DMM022103C283">Weidert et al., 2014</xref>). Interestingly, although better known for triggering microtubule destabilization, the anti-angiogenic drug combretastatin (<xref ref-type="table" rid="DMM022103TB4">Table 4</xref>) also regulates RLC phosphorylation in endothelial and T cells, disrupting T-cell translocation (<xref ref-type="bibr" rid="DMM022103C111">Kanthou and Tozer, 2002</xref>; <xref ref-type="bibr" rid="DMM022103C178">Nathan et al., 2012</xref>; <xref ref-type="bibr" rid="DMM022103C200">Pollock et al., 2014</xref>). Thus, NMII is a promising therapeutic target for conditions of exacerbated transendothelial migration, such as cancer and chronic inflammation, because of its dual roles in endothelial adhesion and migration of the invading cell.</p>
</sec>
<sec id="s5b">
<title>NMII in angiogenesis and disease therapy</title>
<p>During the process of angiogenesis, when new blood vessels form from existing vessels, NMII similarly regulates endothelial cell–cell junctions, while also directing cell–matrix interactions that promote endothelial cell migration. During initial vascular sprouting and vessel branching, the disruption of endothelial cell junctions increases cell interaction with the ECM, facilitating the migration of tip cells (<xref ref-type="fig" rid="DMM022103F5">Fig. 5</xref>). The subsequent proliferation and elongation of cells from behind the tip cell results in vessel stabilization and lumen formation, followed by lumen consolidation through fusion of the neovessel with the pre-existing vascular network (reviewed in <xref ref-type="bibr" rid="DMM022103C21">Carmeliet and Jain, 2011</xref>). NMII coordinates these stages of angiogenesis, and thus exhibits complex spatial and temporal regulation depending on the process. For instance, localized NMII inhibition <italic>in vitro</italic> promotes angiogenic sprouting (<xref ref-type="bibr" rid="DMM022103C59">Fischer et al., 2009</xref>) and initial vascular branching (<xref ref-type="bibr" rid="DMM022103C52">Elliott et al., 2015</xref>) in 3D angiogenic models by decreasing the tension on actin stress fibers, which disrupts VE-cadherin-mediated intercellular bridges and weakens cell–cell adhesions (<xref ref-type="bibr" rid="DMM022103C91">Hoelzle and Svitkina, 2012</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C302">Yonemura, 2011</xref>). Simultaneously, at the tip cell, NMIIA and NMIIB activity are necessary for endothelial cell migration (<xref ref-type="bibr" rid="DMM022103C121">Kolega, 2006</xref>). For the formation of the vascular lumen, NMII generates forces that stabilize VE-cadherin at cell–cell contacts (<xref ref-type="fig" rid="DMM022103F4">Fig. 4</xref>B), thus blocking further angiogenic sprouting (<xref ref-type="bibr" rid="DMM022103C1">Abraham et al., 2009</xref>; <xref ref-type="bibr" rid="DMM022103C244">Strilić et al., 2009</xref>). Interestingly, Nogo-A, a protein expressed by oligodendrocytes and neurons in the CNS, inhibits endothelial cell migration via a mechanism that involves RhoA–ROCK–NMII activation (<xref ref-type="bibr" rid="DMM022103C272">Wälchli et al., 2013</xref>). This negative modulation of angiogenesis in the CNS compromises the repair of brain injuries. As a result of the complex regulation of NMII at diverse stages of blood vessel development, the modulation of myosin activity could be a powerful, yet still unexplored, tool for both the repression and induction of angiogenesis in disorders such as cancer, stroke and diabetic chronic wounds.
<fig id="DMM022103F5" orientation="portrait" position="float"><label>Fig. 5.</label><caption><p><bold>Differential NMII activity defines distinct stages of angiogenesis.</bold> After the detection of stimuli (hypoxia or growth factors), NMII inhibition results in the loosening of endothelial adherens junctions, favoring the detachment of migrating endothelial cells (tip cell). The tip cell migrates into the connective tissue, in a mechanism that relies on NMII activation (see <xref ref-type="fig" rid="DMM022103F3">Fig. 3</xref>B). During collective cell migration (stalk elongation), NMII activation stabilizes the junctions of the follower endothelial cells, resulting in stalk elongation. During stalk elongation, the localized activation or inhibition of NMII results in the inhibition or induction of vascular branching, respectively.</p></caption><graphic xlink:href="dmm-8-022103-g5"></graphic></fig></p>
</sec>
</sec>
<sec id="s6">
<title>NMII in other diseases</title>
<sec id="s6a">
<title>MYH9-related diseases: NMII functions in development</title>
<p>Although this Review focuses primarily on emerging roles of NMII in genetically complex disorders, autosomal dominant mutations in NMHCIIA (<xref ref-type="boxed-text" rid="DMM022103B2">Box 2</xref>) have provided fundamental insights into how altered NMII activity contributes to disease. These autosomal dominant NMIIA mutations result in various <italic>MYH9</italic><italic>-</italic>related disorders (MYH9-RD), including May-Hegglin anomaly, Epstein syndrome, Fechtner syndrome and Sebastian syndrome; the hallmark features of which are fewer, but giant, platelets (referred to clinically as macrothrombocytopenia) and leukocyte inclusions. Individuals affected by a <italic>MYH9-</italic>related disorder often present with deafness, cataracts and nephropathy (<xref ref-type="bibr" rid="DMM022103C7">Balduini et al., 2011</xref>). In the process of platelet formation, megakaryocytes extend pro-platelet projections into the bloodstream, where fluid shear stress results in their release and fragmentation into platelets (reviewed in <xref ref-type="bibr" rid="DMM022103C252">Thon and Italiano, 2012</xref>). MYH9-RD megakaryocytes from affected humans and mouse models exhibit enlarged pro-platelet buds (<xref ref-type="bibr" rid="DMM022103C51">Eckly et al., 2009</xref>; <xref ref-type="bibr" rid="DMM022103C190">Pecci et al., 2009</xref>). Recent <italic>in vitro</italic> evidence demonstrates that fluid sheer stress locally activates cortical NMIIA, resulting in fragmentation of pro-platelets into platelets (<xref ref-type="bibr" rid="DMM022103C240">Spinler et al., 2015</xref>). Decreased platelet number in MYH9-RD could also result from reduced collagen adhesion and premature platelet release outside the bloodstream (<xref ref-type="bibr" rid="DMM022103C7">Balduini et al., 2011</xref>; <xref ref-type="bibr" rid="DMM022103C51">Eckly et al., 2009</xref>), highlighting the need for <italic>in vivo</italic> disease models that capture the role of NMII in diverse events leading to disease pathology. The following section addresses how NMII contributes to body and tissue patterning, and highlights isoform-specific roles for NMII that help to explain tissue-specific defects in MYH9-RD (<xref ref-type="bibr" rid="DMM022103C116">Kim et al., 2005</xref>).</p>
</sec>
<sec id="s6b">
<title>NMII in development and developmental disease</title>
<p>During development, NMII activity contributes to morphogenesis and tissue patterning. A recent study of individuals with congenital heart defects arising from incorrect left–right body patterning revealed that disease-associated CNVs commonly include an isoform of ROCK, ROCK2 (<xref ref-type="bibr" rid="DMM022103C56">Fakhro et al., 2011</xref>). Although CNVs do not necessarily contribute to disease pathology, animal models provide further evidence for a role of ROCK-mediated myosin contractility in body axis asymmetry, and demonstrate that ROCK negatively regulates TGFβ signaling through receptor internalization and degradation (<xref ref-type="bibr" rid="DMM022103C275">Wang et al., 2011</xref>, <xref ref-type="bibr" rid="DMM022103C277">2012b</xref>; <xref ref-type="bibr" rid="DMM022103C309">Zhang et al., 2009</xref>). This is of particular interest because TGFβ serves as a critical regulator of other NMII-dependent processes discussed in this Review, including the epithelial-to-mesenchymal transition that underlies cancer metastasis (<xref ref-type="bibr" rid="DMM022103C296">Xu et al., 2009</xref>) as well as stem cell renewal and differentiation (<xref ref-type="bibr" rid="DMM022103C280">Watabe and Miyazono, 2009</xref>).</p>
<p>At the tissue level, NMII functions downstream of non-canonical Wnt planar cell polarity (PCP) pathways to regulate polarity. In the auditory epithelium, PCP pathways polarize NMII-driven contractile forces to pattern hair cells, which regulate sound perception (<xref ref-type="bibr" rid="DMM022103C129">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="DMM022103C299">Yamamoto et al., 2009</xref>), providing a possible mechanism for the deafness associated with MYH9-RD. Similarly, in cardiac development, NMII activity functions downstream of PCP signaling in the polarized migration of the myocardium during the development of the heart's outflow tract, a process that relies primarily on NMIIB and possibly on NMIIC (<xref ref-type="bibr" rid="DMM022103C146">Ma and Adelstein, 2012</xref>; <xref ref-type="bibr" rid="DMM022103C151">Marigo et al., 2004</xref>; <xref ref-type="bibr" rid="DMM022103C197">Phillips et al., 2005</xref>). However, NMIIA directs convergence and extension tissue movements during the development of the kidney tubules (<xref ref-type="bibr" rid="DMM022103C135">Lienkamp et al., 2012</xref>), accounting for nephropathy in some MYH9-RD cases, characterized by altered NMIIA localization in renal structures and reduced NMIIA expression in podocytes (<xref ref-type="bibr" rid="DMM022103C69">Ghiggeri et al., 2003</xref>). Altered NMII expression has been reported for several glomerular diseases (<xref ref-type="bibr" rid="DMM022103C88">Hiroi et al., 1996</xref>; <xref ref-type="bibr" rid="DMM022103C161">Miura et al., 2013</xref>). In addition to regulating tissue patterning, PCP-mediated NMII activity might also contribute to cancer progression, with more aggressive ovarian cancers showing increased PCP signaling pathways corresponding with changes in actomyosin organization (<xref ref-type="bibr" rid="DMM022103C57">Feske et al., 2009</xref>). Thus, disrupted NMII activity results in developmental defects that provide insights into how NMII might contribute to the pathology of more genetically complex diseases, such as cancer.</p>
</sec>
</sec>
<sec id="s7">
<title>NMII in stem cell therapies</title>
<p>Given the increasing use of stem cells in research, it is imperative to understand the mechanisms that underlie the self-renewal of pluripotent stem cells and their directed differentiation to specific tissues in order to advance stem cell therapies. Recent findings demonstrate that NMII acts as an important regulator of both stem cell self-renewal and committed differentiation toward a specific cell type (<xref ref-type="bibr" rid="DMM022103C53">Engler et al., 2006</xref>; <xref ref-type="bibr" rid="DMM022103C281">Watanabe et al., 2007</xref>; <xref ref-type="bibr" rid="DMM022103C307">Zhang and Kilian, 2013</xref>). For example, NMII activity in response to substrate stiffness directs the differentiation of mesenchymal stem cells to muscle and bone on stiffer substrates and to neurons on softer substrates (<xref ref-type="bibr" rid="DMM022103C53">Engler et al., 2006</xref>). This suggests that altering the physiological stiffness of a stem cell's substrate and/or mimicking the activity of NMII to match that of a particular tissue might be sufficient to direct stem cells towards a particular fate (<xref ref-type="fig" rid="DMM022103F6">Fig. 6</xref>). In addition to discussing the mechanisms by which NMII differentially regulates stem cell self-renewal versus differentiation, we also discuss potential clinical applications of NMII inhibitors (<xref ref-type="bibr" rid="DMM022103C28">Chen et al., 2014</xref>).
<fig id="DMM022103F6" orientation="portrait" position="float"><label>Fig. 6.</label><caption><p><bold>NMII determines stem cell fate.</bold> Pluripotent stem cells are cultured in the presence of the ROCK inhibitor Y-27632 to prevent apoptosis (<xref ref-type="bibr" rid="DMM022103C27">Chen et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C281">Watanabe et al., 2007</xref>). NMII activity directs the differentiation of stem cells to specific tissue lineages: decreased NMII activity leads to neuronal fates, whereas increased NMII activity promotes the formation of stiffer tissues, such as muscle and bone (<xref ref-type="bibr" rid="DMM022103C53">Engler et al., 2006</xref>; <xref ref-type="bibr" rid="DMM022103C231">Seo et al., 2014</xref>; <xref ref-type="bibr" rid="DMM022103C279">Wang et al., 2013b</xref>).</p></caption><graphic xlink:href="dmm-8-022103-g6"></graphic></fig></p>
<sec id="s7a">
<title>NMII: a driver of differentiation</title>
<p>NMII regulates cell identity by several mechanisms, including signal mechanotransduction, transcriptional changes, ion-channel activation, and the regulation of cell–cell and cell–matrix interactions. When cells adhere to their ECM, external forces are transmitted through adhesion junctions to the inside of the cell, where NMII-dependent contractile forces balance them. Through mechanotransduction, these NMII-dependent contractile forces drive changes in signaling by regulating the composition of adhesion complexes. They also drive changes at the transcriptional level through mechanosensitive transcriptional coactivators, such as Yes-associated protein (YAP) (<xref ref-type="bibr" rid="DMM022103C50">Dupont et al., 2011</xref>).</p>
<p>In stem cells, the nuclear translocation of YAP acts as a transcriptional regulator of self-renewal or differentiation into specific cell types. In multipotent mesenchymal stem cells, integrin-β1 activation results in RhoA–ROCK-mediated myosin activation and in the nuclear translocation of YAP, favoring differentiation to bone rather than to adipose or cartilage (<xref ref-type="bibr" rid="DMM022103C250">Tang et al., 2013</xref>). Intriguingly, mesenchymal stem cells retain mechanical memory through YAP nuclear localization, such that culturing these cells on stiff substrates prior to their differentiation on soft substrates promotes osteogenesis rather than adipogenesis (<xref ref-type="bibr" rid="DMM022103C301">Yang et al., 2014</xref>). However, inhibiting YAP nuclear localization by culturing cells on soft matrices promotes the robust differentiation of stem cells into post-mitotic neurons, even in the absence of neurogenic factors (<xref ref-type="bibr" rid="DMM022103C172">Musah et al., 2014</xref>). This suggests that physical stiffness of the substrate is sufficient to drive the biochemical signaling events necessary for cells to differentiate into specific tissues (<xref ref-type="bibr" rid="DMM022103C53">Engler et al., 2006</xref>; <xref ref-type="bibr" rid="DMM022103C172">Musah et al., 2014</xref>). However, NMII-generated traction forces promote cortical neuron differentiation by activating the stretch-activated ion channel Piezo1, resulting in Ca<sup>2+</sup> influx and YAP nuclear localization (<xref ref-type="bibr" rid="DMM022103C189">Pathak et al., 2014</xref>). Thus, the specific function of YAP downstream of NMII activity likely results from cell-type-dependent mechanisms, such as specific transcription-factor interactions. This is illustrated in the intestinal epithelium, where YAP interaction with TEA domain (TEAD) transcription factors promotes stem cell self-renewal, whereas interaction with the transcription factor Kruppel-like factor 4 (Klf4) promotes differentiation into goblet cells (<xref ref-type="bibr" rid="DMM022103C100">Imajo et al., 2014</xref>).</p>
<p>In addition to directing stem cell fate through transcriptional regulation, NMII also negatively regulates stem cell survival through apoptosis. RhoA–ROCK-mediated NMII activity contributes to apoptosis through nuclear fragmentation, membrane blebbing and the subsequent release of damaging proteins (<xref ref-type="bibr" rid="DMM022103C37">Croft et al., 2005</xref>; <xref ref-type="bibr" rid="DMM022103C158">Mills, 1998</xref>; <xref ref-type="bibr" rid="DMM022103C284">Wickman et al., 2013</xref>). Because NMII-driven apoptosis limits stem cell viability, stem cell culture benefits from the use of either ROCK inhibitors, such as Y-267632, or NMII inhibitors, such as blebbistatin (<xref ref-type="bibr" rid="DMM022103C27">Chen et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C273">Walker et al., 2010</xref>; <xref ref-type="bibr" rid="DMM022103C281">Watanabe et al., 2007</xref>) (<xref ref-type="fig" rid="DMM022103F6">Fig. 6</xref>).</p>
</sec>
<sec id="s7b">
<title>Clinical applications of NMII inhibitors in stem cell therapies</title>
<p>Stem cell therapies hold promise for the treatment of numerous disorders, including cardiovascular disorders, spinal cord injuries and neurodegenerative diseases. However, several considerations limit the usefulness of stem cells in clinical settings, including the production of stem cells in sufficient quantities, the development of xeno-free culture systems, and their directed differentiation into the desired cell type. In each case, the manipulation of NMII activity is informing the development of technologies that advance research into stem cell therapies. For example, inhibition of ROCK-mediated NMII contractility allows for stem cell expansion on microcarriers in suspension, greatly enhancing stem cell production over traditional 2D culture methods (<xref ref-type="bibr" rid="DMM022103C28">Chen et al., 2014</xref>). ROCK inhibition also allows for stem cell growth under xeno-free culture conditions (<xref ref-type="bibr" rid="DMM022103C81">Harb et al., 2008</xref>). Finally, ROCK inhibition promotes neural differentiation of placental-derived multipotent cells to generate neural progenitor cells for the treatment of neurodegenerative disorders (<xref ref-type="bibr" rid="DMM022103C279">Wang et al., 2013b</xref>). Alternatively, increased NMII activation, via fabricated micropits, promotes osteogenic differentiation of mesenchymal cells (<xref ref-type="bibr" rid="DMM022103C231">Seo et al., 2014</xref>). Likewise, reducing substrate stiffness or inhibiting ROCK-mediated NMII activation promotes neural induction and the subsequent differentiation of neural stem cells to specific neuronal populations, such as motor neurons (<xref ref-type="bibr" rid="DMM022103C247">Sun et al., 2014</xref>). Thus, in addition to pharmacological inhibition, fine-tuning NMII activity through engineered scaffolds of a particular stiffness or substrate holds promise for both stem cell expansion and their directed differentiation (<xref ref-type="bibr" rid="DMM022103C172">Musah et al., 2014</xref>; reviewed in <xref ref-type="bibr" rid="DMM022103C170">Murphy et al., 2014</xref>).</p>
</sec>
</sec>
<sec id="s8">
<title>Perspectives on NMII in disease</title>
<sec id="s8a">
<title>Emerging regulators of NMII function as therapeutic targets</title>
<p>In this Review, we have sought to highlight the emerging roles for NMII in genetically complex disorders, such as cancer and neuronal diseases. In so doing, we have revealed that these diverse pathologies result from similar NMII-driven processes, including mechanical forces that drive dynamic cell movements and mechanotransduction that results in signaling changes that alter cell behavior. For example, NMII-mediated contractile forces drive both the cell migration that causes cancer metastasis and the synaptic plasticity that underlies cognitive function and that contributes to neurodevelopmental disorders (see Box 1). Similarly, biochemical signaling pathways downstream of NMII are shared across diverse disorders. In particular, recent evidence demonstrates that the mechanosensitive transcription factors YAP and transcriptional coactivator with PDZ-binding motif (TAZ; also known as WWTR1), which regulate both cancer cell progression and stem cell differentiation, also contribute to body axis patterning (<xref ref-type="bibr" rid="DMM022103C202">Porazinski et al., 2015</xref>) and angiogenesis (<xref ref-type="bibr" rid="DMM022103C29">Choi et al., 2015</xref>). Thus, understanding how altered NMII signaling contributes to a specific disease might provide insights into the mechanisms of other NMII-related disorders and ultimately help to identify novel therapeutic targets for the successful treatment of these disorders.</p>
<p>In an attempt to identify novel therapeutic targets for the treatment of NMII-related disorders, we have detailed common upstream regulatory mechanisms that govern NMII activity. These include diverse genetic mutations, as well as miRNAs, that converge either directly or indirectly on NMII regulation. Already, the miRNAs that regulate NMII activity in cancer and endothelial cell function (<xref ref-type="table" rid="DMM022103TB3">Table 3</xref>) have been implicated in stem cell pluripotency and differentiation (<xref ref-type="bibr" rid="DMM022103C153">Mathieu and Ruohola-Baker, 2013</xref>), and are poised to provide further insights into the roles of NMII in these processes. Thus, miRNAs that regulate NMII function could serve as additional targets for directed differentiation to desired therapeutic cell types. Furthermore, the pharmacological inhibition of shared myosin kinases (<xref ref-type="fig" rid="DMM022103F1">Fig. 1</xref>) shows promise for therapeutic intervention in numerous disorders, while creating scaffolds of a particular stiffness provides an alternate strategy for manipulating NMII activity. Furthering our understanding of the particular molecular mechanisms that govern the precise spatial and temporal activity of NMII in normal and disease states should also provide increasing specificity for these therapeutic strategies.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<title>Footnotes</title>
<fn fn-type="conflict">
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare no competing or financial interests.</p>
</fn>
<fn>
<p>
<bold>Author contributions</bold>
</p>
<p>M.L.L. and K.A.N.-L. conceived of and wrote the Review with significant input and editing from R.H.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>
<bold>Funding</bold>
</p>
<p>The laboratory of R.H. is supported by an NIGMS grant (GM23244) and K.A.N.-L. is supported by a Hartwell Foundation Fellowship. M.L.L. received support from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) #9748-13-0 and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) #443699/2014-3.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="DMM022103C1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>S.</given-names></name>, <name><surname>Yeo</surname><given-names>M.</given-names></name>, <name><surname>Montero-Balaguer</surname><given-names>M.</given-names></name>, <name><surname>Paterson</surname><given-names>H.</given-names></name>, <name><surname>Dejana</surname><given-names>E.</given-names></name>, <name><surname>Marshall</surname><given-names>C. J.</given-names></name> and <name><surname>Mavria</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>VE-cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation</article-title>. <source/><italic>Curr. Biol.</italic>
<volume>19</volume>, <fpage>668</fpage>-<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2009.02.057</pub-id><pub-id pub-id-type="pmid">19345098</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adyshev</surname><given-names>D. M.</given-names></name>, <name><surname>Moldobaeva</surname><given-names>N.</given-names></name>, <name><surname>Mapes</surname><given-names>B.</given-names></name>, <name><surname>Elangovan</surname><given-names>V.</given-names></name> and <name><surname>Garcia</surname><given-names>J. G. N.</given-names></name></person-group> (<year>2013</year>). <article-title>MicroRNA regulation of nonmuscle myosin light chain kinase expression in human lung endothelium</article-title>. <source/><italic>Am. J. Respir. Cell Mol. Biol.</italic>
<volume>49</volume>, <fpage>58</fpage>-<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2012-0397OC</pub-id><pub-id pub-id-type="pmid">23492194</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alon</surname><given-names>U.</given-names></name>, <name><surname>Barkai</surname><given-names>N.</given-names></name>, <name><surname>Notterman</surname><given-names>D. A.</given-names></name>, <name><surname>Gish</surname><given-names>K.</given-names></name>, <name><surname>Ybarra</surname><given-names>S.</given-names></name>, <name><surname>Mack</surname><given-names>D.</given-names></name> and <name><surname>Levine</surname><given-names>A. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>96</volume>, <fpage>6745</fpage>-<lpage>6750</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.12.6745</pub-id><pub-id pub-id-type="pmid">10359783</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amano</surname><given-names>M.</given-names></name>, <name><surname>Ito</surname><given-names>M.</given-names></name>, <name><surname>Kimura</surname><given-names>K.</given-names></name>, <name><surname>Fukata</surname><given-names>Y.</given-names></name>, <name><surname>Chihara</surname><given-names>K.</given-names></name>, <name><surname>Nakano</surname><given-names>T.</given-names></name>, <name><surname>Matsuura</surname><given-names>Y.</given-names></name> and <name><surname>Kaibuchi</surname><given-names>K.</given-names></name></person-group> (<year>1996</year>). <article-title>Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>271</volume>, <fpage>20246</fpage>-<lpage>20249</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.34.20246</pub-id><pub-id pub-id-type="pmid">8702756</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arozarena</surname><given-names>I.</given-names></name>, <name><surname>Sanchez-Laorden</surname><given-names>B.</given-names></name>, <name><surname>Packer</surname><given-names>L.</given-names></name>, <name><surname>Hidalgo-Carcedo</surname><given-names>C.</given-names></name>, <name><surname>Hayward</surname><given-names>R.</given-names></name>, <name><surname>Viros</surname><given-names>A.</given-names></name>, <name><surname>Sahai</surname><given-names>E.</given-names></name> and <name><surname>Marais</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A</article-title>. <source/><italic>Cancer Cell</italic>
<volume>19</volume>, <fpage>45</fpage>-<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2010.10.029</pub-id><pub-id pub-id-type="pmid">21215707</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asokan</surname><given-names>S. B.</given-names></name>, <name><surname>Johnson</surname><given-names>H. E.</given-names></name>, <name><surname>Rahman</surname><given-names>A.</given-names></name>, <name><surname>King</surname><given-names>S. J.</given-names></name>, <name><surname>Rotty</surname><given-names>J. D.</given-names></name>, <name><surname>Lebedeva</surname><given-names>I. P.</given-names></name>, <name><surname>Haugh</surname><given-names>J. M.</given-names></name> and <name><surname>Bear</surname><given-names>J. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Mesenchymal chemotaxis requires selective inactivation of myosin II at the leading edge via a noncanonical PLCγ/PKCα pathway</article-title>. <source/><italic>Dev. Cell</italic>
<volume>31</volume>, <fpage>747</fpage>-<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2014.10.024</pub-id><pub-id pub-id-type="pmid">25482883</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balduini</surname><given-names>C. L.</given-names></name>, <name><surname>Pecci</surname><given-names>A.</given-names></name> and <name><surname>Savoia</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias</article-title>. <source/><italic>Br. J. Haematol.</italic>
<volume>154</volume>, <fpage>161</fpage>-<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2141.2011.08716.x</pub-id><pub-id pub-id-type="pmid">21542825</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barcia</surname><given-names>C.</given-names></name>, <name><surname>Ros</surname><given-names>C. M.</given-names></name>, <name><surname>Annese</surname><given-names>V.</given-names></name>, <name><surname>Carrillo-de Sauvage</surname><given-names>M. A.</given-names></name>, <name><surname>Ros-Bernal</surname><given-names>F.</given-names></name>, <name><surname>Gómez</surname><given-names>A.</given-names></name>, <name><surname>Yuste</surname><given-names>J. E.</given-names></name>, <name><surname>Campuzano</surname><given-names>C. M.</given-names></name>, <name><surname>de Pablos</surname><given-names>V.</given-names></name>, <name><surname>Fernandez-Villalba</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo</article-title>. <source/><italic>Sci. Rep.</italic>
<volume>2</volume>, <fpage>809</fpage>
<pub-id pub-id-type="doi">10.1038/srep00809</pub-id><pub-id pub-id-type="pmid">23139861</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>F. A.</given-names></name> and <name><surname>Gruneberg</surname><given-names>U.</given-names></name></person-group> (<year>2007</year>). <article-title>Cytokinesis: placing and making the final cut</article-title>. <source/><italic>Cell</italic>
<volume>131</volume>, <fpage>847</fpage>-<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.11.011</pub-id><pub-id pub-id-type="pmid">18045532</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beach</surname><given-names>J. R.</given-names></name>, <name><surname>Shao</surname><given-names>L.</given-names></name>, <name><surname>Remmert</surname><given-names>K.</given-names></name>, <name><surname>Li</surname><given-names>D.</given-names></name>, <name><surname>Betzig</surname><given-names>E.</given-names></name> and <name><surname>Hammer</surname><given-names>J. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Nonmuscle myosin II isoforms coassemble in living cells</article-title>. <source/><italic>Curr. Biol.</italic>
<volume>24</volume>, <fpage>1160</fpage>-<lpage>1166</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2014.03.071</pub-id><pub-id pub-id-type="pmid">24814144</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beadle</surname><given-names>C.</given-names></name>, <name><surname>Assanah</surname><given-names>M. C.</given-names></name>, <name><surname>Monzo</surname><given-names>P.</given-names></name>, <name><surname>Vallee</surname><given-names>R.</given-names></name>, <name><surname>Rosenfeld</surname><given-names>S. S.</given-names></name> and <name><surname>Canoll</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>The role of myosin II in glioma invasion of the brain</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>19</volume>, <fpage>3357</fpage>-<lpage>3368</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E08-03-0319</pub-id><pub-id pub-id-type="pmid">18495866</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beard</surname><given-names>R. S.</given-names></name>, <name><surname>Haines</surname><given-names>R. J.</given-names></name>, <name><surname>Wu</surname><given-names>K. Y.</given-names></name>, <name><surname>Reynolds</surname><given-names>J. J.</given-names></name>, <name><surname>Davis</surname><given-names>S. M.</given-names></name>, <name><surname>Elliott</surname><given-names>J. E.</given-names></name>, <name><surname>Malinin</surname><given-names>N. L.</given-names></name>, <name><surname>Chatterjee</surname><given-names>V.</given-names></name>, <name><surname>Cha</surname><given-names>B. J.</given-names></name>, <name><surname>Wu</surname><given-names>M. H.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Non-muscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cells</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>127</volume>, <fpage>1840</fpage>-<lpage>1853</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.144550</pub-id><pub-id pub-id-type="pmid">24522189</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blitz</surname><given-names>A. L.</given-names></name> and <name><surname>Fine</surname><given-names>R. E.</given-names></name></person-group> (<year>1974</year>). <article-title>Muscle-like contractile proteins and tubulin in synaptosomes</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>71</volume>, <fpage>4472</fpage>-<lpage>4476</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.71.11.4472</pub-id><pub-id pub-id-type="pmid">4530997</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borisoff</surname><given-names>J. F.</given-names></name>, <name><surname>Chan</surname><given-names>C. C. M.</given-names></name>, <name><surname>Hiebert</surname><given-names>G. W.</given-names></name>, <name><surname>Oschipok</surname><given-names>L.</given-names></name>, <name><surname>Robertson</surname><given-names>G. S.</given-names></name>, <name><surname>Zamboni</surname><given-names>R.</given-names></name>, <name><surname>Steeves</surname><given-names>J. D.</given-names></name> and <name><surname>Tetzlaff</surname><given-names>W.</given-names></name></person-group> (<year>2003</year>). <article-title>Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates</article-title>. <source/><italic>Mol. Cell. Neurosci.</italic>
<volume>22</volume>, <fpage>405</fpage>-<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1016/S1044-7431(02)00032-5</pub-id><pub-id pub-id-type="pmid">12691741</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>J. A.</given-names></name> and <name><surname>Bridgman</surname><given-names>P. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Disruption of the cytoskeleton during Semaphorin 3A induced growth cone collapse correlates with differences in actin organization and associated binding proteins</article-title>. <source/><italic>Dev. Neurobiol.</italic>
<volume>69</volume>, <fpage>633</fpage>-<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20732</pub-id><pub-id pub-id-type="pmid">19513995</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>J. A.</given-names></name>, <name><surname>Wysolmerski</surname><given-names>R. B.</given-names></name> and <name><surname>Bridgman</surname><given-names>P. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Dorsal root ganglion neurons react to semaphorin 3A application through a biphasic response that requires multiple myosin II isoforms</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>20</volume>, <fpage>1167</fpage>-<lpage>1179</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E08-01-0065</pub-id><pub-id pub-id-type="pmid">19109430</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busch</surname><given-names>S. A.</given-names></name> and <name><surname>Silver</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>The role of extracellular matrix in CNS regeneration</article-title>. <source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>17</volume>, <fpage>120</fpage>-<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2006.09.004</pub-id><pub-id pub-id-type="pmid">17223033</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>D.</given-names></name>, <name><surname>Chen</surname><given-names>S.-C.</given-names></name>, <name><surname>Prasad</surname><given-names>M.</given-names></name>, <name><surname>He</surname><given-names>L.</given-names></name>, <name><surname>Wang</surname><given-names>X.</given-names></name>, <name><surname>Choesmel-Cadamuro</surname><given-names>V.</given-names></name>, <name><surname>Sawyer</surname><given-names>J. K.</given-names></name>, <name><surname>Danuser</surname><given-names>G.</given-names></name> and <name><surname>Montell</surname><given-names>D. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Mechanical feedback through E-cadherin promotes direction sensing during collective cell migration</article-title>. <source/><italic>Cell</italic>
<volume>157</volume>, <fpage>1146</fpage>-<lpage>1159</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.03.045</pub-id><pub-id pub-id-type="pmid">24855950</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvo</surname><given-names>F.</given-names></name>, <name><surname>Ege</surname><given-names>N.</given-names></name>, <name><surname>Grande-Garcia</surname><given-names>A.</given-names></name>, <name><surname>Hooper</surname><given-names>S.</given-names></name>, <name><surname>Jenkins</surname><given-names>R. P.</given-names></name>, <name><surname>Chaudhry</surname><given-names>S. I.</given-names></name>, <name><surname>Harrington</surname><given-names>K.</given-names></name>, <name><surname>Williamson</surname><given-names>P.</given-names></name>, <name><surname>Moeendarbary</surname><given-names>E.</given-names></name>, <name><surname>Charras</surname><given-names>G.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>15</volume>, <fpage>637</fpage>-<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2756</pub-id><pub-id pub-id-type="pmid">23708000</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>S.</given-names></name>, <name><surname>Ponnappan</surname><given-names>S.</given-names></name> and <name><surname>Ponnappan</surname><given-names>U.</given-names></name></person-group> (<year>2012</year>). <article-title>Impairment of non-muscle myosin IIA in human CD4+ T cells contributes to functional deficits in the elderly</article-title>. <source/><italic>Cell. Mol. Immunol.</italic>
<volume>9</volume>, <fpage>86</fpage>-<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1038/cmi.2011.41</pub-id><pub-id pub-id-type="pmid">21983869</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmeliet</surname><given-names>P.</given-names></name> and <name><surname>Jain</surname><given-names>R. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular mechanisms and clinical applications of angiogenesis</article-title>. <source/><italic>Nature</italic>
<volume>473</volume>, <fpage>298</fpage>-<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1038/nature10144</pub-id><pub-id pub-id-type="pmid">21593862</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castoreno</surname><given-names>A. B.</given-names></name>, <name><surname>Smurnyy</surname><given-names>Y.</given-names></name>, <name><surname>Torres</surname><given-names>A. D.</given-names></name>, <name><surname>Vokes</surname><given-names>M. S.</given-names></name>, <name><surname>Jones</surname><given-names>T. R.</given-names></name>, <name><surname>Carpenter</surname><given-names>A. E.</given-names></name> and <name><surname>Eggert</surname><given-names>U. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis</article-title>. <source/><italic>Nat. Chem. Biol.</italic>
<volume>6</volume>, <fpage>457</fpage>-<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.363</pub-id><pub-id pub-id-type="pmid">20436488</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>C. C. M.</given-names></name>, <name><surname>Wong</surname><given-names>A. K.</given-names></name>, <name><surname>Liu</surname><given-names>J.</given-names></name>, <name><surname>Steeves</surname><given-names>J. D.</given-names></name> and <name><surname>Tetzlaff</surname><given-names>W.</given-names></name></person-group> (<year>2007</year>). <article-title>ROCK inhibition with Y27632 activates astrocytes and increases their expression of neurite growth-inhibitory chondroitin sulfate proteoglycans</article-title>. <source/><italic>Glia</italic>
<volume>55</volume>, <fpage>369</fpage>-<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20466</pub-id><pub-id pub-id-type="pmid">17136770</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrasekar</surname><given-names>I.</given-names></name>, <name><surname>Huettner</surname><given-names>J. E.</given-names></name>, <name><surname>Turney</surname><given-names>S. G.</given-names></name> and <name><surname>Bridgman</surname><given-names>P. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Myosin II regulates activity dependent compensatory endocytosis at central synapses</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>33</volume>, <fpage>16131</fpage>-<lpage>16145</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2229-13.2013</pub-id><pub-id pub-id-type="pmid">24107946</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J. C.</given-names></name>, <name><surname>Zhuang</surname><given-names>S.</given-names></name>, <name><surname>Nguyen</surname><given-names>T. H.</given-names></name>, <name><surname>Boss</surname><given-names>G. R.</given-names></name> and <name><surname>Pilz</surname><given-names>R. B.</given-names></name></person-group> (<year>2003</year>). <article-title>Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>278</volume>, <fpage>2807</fpage>-<lpage>2818</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M207943200</pub-id><pub-id pub-id-type="pmid">12429740</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R.</given-names></name>, <name><surname>Yi</surname><given-names>E. C.</given-names></name>, <name><surname>Donohoe</surname><given-names>S.</given-names></name>, <name><surname>Pan</surname><given-names>S.</given-names></name>, <name><surname>Eng</surname><given-names>J.</given-names></name>, <name><surname>Cooke</surname><given-names>K.</given-names></name>, <name><surname>Crispin</surname><given-names>D. A.</given-names></name>, <name><surname>Lane</surname><given-names>Z.</given-names></name>, <name><surname>Goodlett</surname><given-names>D. R.</given-names></name>, <name><surname>Bronner</surname><given-names>M. P.</given-names></name><etal>et al.</etal></person-group> (<year>2005</year>). <article-title>Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape</article-title>. <source/><italic>Gastroenterology</italic>
<volume>129</volume>, <fpage>1187</fpage>-<lpage>1197</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2005.08.001</pub-id><pub-id pub-id-type="pmid">16230073</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G.</given-names></name>, <name><surname>Hou</surname><given-names>Z.</given-names></name>, <name><surname>Gulbranson</surname><given-names>D. R.</given-names></name> and <name><surname>Thomson</surname><given-names>J. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells</article-title>. <source/><italic>Cell Stem Cell</italic>
<volume>7</volume>, <fpage>240</fpage>-<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2010.06.017</pub-id><pub-id pub-id-type="pmid">20682449</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>A. K.-L.</given-names></name>, <name><surname>Chen</surname><given-names>X.</given-names></name>, <name><surname>Lim</surname><given-names>Y. M.</given-names></name>, <name><surname>Reuveny</surname><given-names>S.</given-names></name> and <name><surname>Oh</surname><given-names>S. K. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Inhibition of ROCK-myosin II signaling pathway enables culturing of human pluripotent stem cells on microcarriers without extracellular matrix coating</article-title>. <source/><italic>Tissue Eng. Part C. Methods</italic>
<volume>20</volume>, <fpage>227</fpage>-<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tec.2013.0191</pub-id><pub-id pub-id-type="pmid">23777438</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C28a">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>T. L.</given-names></name>, <name><surname>Masaracchia</surname><given-names>R. A.</given-names></name>, <name><surname>Goeckeler</surname><given-names>Z. M.</given-names></name> and <name><surname>Wysolmerski</surname><given-names>R. B.</given-names></name></person-group> (<year>1998</year>). <article-title>Phosphorylation of non-muscle myosin II regulatory light chain by p21-activated kinase (gamma-PAK)</article-title>. <source/><italic>J. Muscle Res. Cell Motil.</italic>
<volume>19</volume>, <fpage>839</fpage>-<lpage>854</lpage>. <pub-id pub-id-type="doi">10.1023/A:1005417926585</pub-id><pub-id pub-id-type="pmid">10047984</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H.-J.</given-names></name>, <name><surname>Zhang</surname><given-names>H.</given-names></name>, <name><surname>Park</surname><given-names>H.</given-names></name>, <name><surname>Choi</surname><given-names>K.-S.</given-names></name>, <name><surname>Lee</surname><given-names>H.-W.</given-names></name>, <name><surname>Agrawal</surname><given-names>V.</given-names></name>, <name><surname>Kim</surname><given-names>Y.-M.</given-names></name> and <name><surname>Kwon</surname><given-names>Y.-G.</given-names></name></person-group> (<year>2015</year>). <article-title>Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2</article-title>. <source/><italic>Nat. Commun.</italic>
<volume>6</volume>, <fpage>6943</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms7943</pub-id><pub-id pub-id-type="pmid">25962877</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhary</surname><given-names>A.</given-names></name>, <name><surname>Lera</surname><given-names>R. F.</given-names></name>, <name><surname>Martowicz</surname><given-names>M. L.</given-names></name>, <name><surname>Oxendine</surname><given-names>K.</given-names></name>, <name><surname>Laffin</surname><given-names>J. J.</given-names></name>, <name><surname>Weaver</surname><given-names>B. A.</given-names></name> and <name><surname>Burkard</surname><given-names>M. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Interphase cytofission maintains genomic integrity of human cells after failed cytokinesis</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>110</volume>, <fpage>13026</fpage>-<lpage>13031</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1308203110</pub-id><pub-id pub-id-type="pmid">23878225</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chrzanowska-Wodnicka</surname><given-names>M.</given-names></name> and <name><surname>Burridge</surname><given-names>K.</given-names></name></person-group> (<year>1996</year>). <article-title>Rho-stimulated contractility drives the formation of stress fibers and focal adhesions</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>133</volume>, <fpage>1403</fpage>-<lpage>1415</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.133.6.1403</pub-id><pub-id pub-id-type="pmid">8682874</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>C. C.</given-names></name>, <name><surname>Catera</surname><given-names>R.</given-names></name>, <name><surname>Hatzi</surname><given-names>K.</given-names></name>, <name><surname>Yan</surname><given-names>X.-J.</given-names></name>, <name><surname>Zhang</surname><given-names>L.</given-names></name>, <name><surname>Wang</surname><given-names>X. B.</given-names></name>, <name><surname>Fales</surname><given-names>H. M.</given-names></name>, <name><surname>Allen</surname><given-names>S. L.</given-names></name>, <name><surname>Kolitz</surname><given-names>J. E.</given-names></name>, <name><surname>Rai</surname><given-names>K. R.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA</article-title>. <source/><italic>Blood</italic>
<volume>112</volume>, <fpage>5122</fpage>-<lpage>5129</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-06-162024</pub-id><pub-id pub-id-type="pmid">18812466</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>C. C.</given-names></name>, <name><surname>Catera</surname><given-names>R.</given-names></name>, <name><surname>Zhang</surname><given-names>L.</given-names></name>, <name><surname>Didier</surname><given-names>S.</given-names></name>, <name><surname>Agagnina</surname><given-names>B. M.</given-names></name>, <name><surname>Damle</surname><given-names>R. N.</given-names></name>, <name><surname>Kaufman</surname><given-names>M. S.</given-names></name>, <name><surname>Kolitz</surname><given-names>J. E.</given-names></name>, <name><surname>Allen</surname><given-names>S. L.</given-names></name>, <name><surname>Rai</surname><given-names>K. R.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin</article-title>. <source/><italic>Blood</italic>
<volume>115</volume>, <fpage>3907</fpage>-<lpage>3915</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2009-09-244251</pub-id><pub-id pub-id-type="pmid">20110421</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname><given-names>D. E.</given-names></name>, <name><surname>Breckenridge</surname><given-names>M. T.</given-names></name>, <name><surname>Hinde</surname><given-names>E.</given-names></name>, <name><surname>Gratton</surname><given-names>E.</given-names></name>, <name><surname>Chen</surname><given-names>C. S.</given-names></name> and <name><surname>Schwartz</surname><given-names>M. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1</article-title>. <source/><italic>Curr. Biol.</italic>
<volume>23</volume>, <fpage>1024</fpage>-<lpage>1030</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2013.04.049</pub-id><pub-id pub-id-type="pmid">23684974</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Côté</surname><given-names>G. P.</given-names></name>, <name><surname>Robinson</surname><given-names>E. A.</given-names></name>, <name><surname>Appella</surname><given-names>E.</given-names></name> and <name><surname>Korn</surname><given-names>E. D.</given-names></name></person-group> (<year>1984</year>). <article-title>Amino acid sequence of a segment of the Acanthamoeba myosin II heavy chain containing all three regulatory phosphorylation sites</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>259</volume>, <fpage>12781</fpage>-<lpage>12787</lpage>.<pub-id pub-id-type="pmid">6149217</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couch</surname><given-names>B. A.</given-names></name>, <name><surname>DeMarco</surname><given-names>G. J.</given-names></name>, <name><surname>Gourley</surname><given-names>S. L.</given-names></name> and <name><surname>Koleske</surname><given-names>A. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Increased dendrite branching in AbetaPP/PS1 mice and elongation of dendrite arbors by fasudil administration</article-title>. <source/><italic>J. Alzheimers. Dis.</italic>
<volume>20</volume>, <fpage>1003</fpage>-<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-091114</pub-id><pub-id pub-id-type="pmid">20413901</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croft</surname><given-names>D. R.</given-names></name>, <name><surname>Coleman</surname><given-names>M. L.</given-names></name>, <name><surname>Li</surname><given-names>S.</given-names></name>, <name><surname>Robertson</surname><given-names>D.</given-names></name>, <name><surname>Sullivan</surname><given-names>T.</given-names></name>, <name><surname>Stewart</surname><given-names>C. L.</given-names></name> and <name><surname>Olson</surname><given-names>M. F.</given-names></name></person-group> (<year>2005</year>). <article-title>Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>168</volume>, <fpage>245</fpage>-<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200409049</pub-id><pub-id pub-id-type="pmid">15657395</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cromer</surname><given-names>W. E.</given-names></name>, <name><surname>Zawieja</surname><given-names>S. D.</given-names></name>, <name><surname>Tharakan</surname><given-names>B.</given-names></name>, <name><surname>Childs</surname><given-names>E. W.</given-names></name>, <name><surname>Newell</surname><given-names>M. K.</given-names></name> and <name><surname>Zawieja</surname><given-names>D. C.</given-names></name></person-group> (<year>2014</year>). <article-title>The effects of inflammatory cytokines on lymphatic endothelial barrier function</article-title>. <source/><italic>Angiogenesis</italic>
<volume>17</volume>, <fpage>395</fpage>-<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1007/s10456-013-9393-2</pub-id><pub-id pub-id-type="pmid">24141404</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dailey</surname><given-names>M. E.</given-names></name> and <name><surname>Smith</surname><given-names>S. J.</given-names></name></person-group> (<year>1996</year>). <article-title>The dynamics of dendritic structure in developing hippocampal slices</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>16</volume>, <fpage>2983</fpage>-<lpage>2994</lpage>.<pub-id pub-id-type="pmid">8622128</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname><given-names>M. J.</given-names></name>, <name><surname>Wang</surname><given-names>Y.</given-names></name>, <name><surname>Lee</surname><given-names>M.</given-names></name> and <name><surname>Venkitaraman</surname><given-names>A. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2</article-title>. <source/><italic>Science</italic>
<volume>306</volume>, <fpage>876</fpage>-<lpage>879</lpage>. <pub-id pub-id-type="doi">10.1126/science.1102574</pub-id><pub-id pub-id-type="pmid">15375219</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Apolito</surname><given-names>M.</given-names></name>, <name><surname>Guarnieri</surname><given-names>V.</given-names></name>, <name><surname>Boncristiano</surname><given-names>M.</given-names></name>, <name><surname>Zelante</surname><given-names>L.</given-names></name> and <name><surname>Savoia</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes</article-title>. <source/><italic>Gene</italic>
<volume>286</volume>, <fpage>215</fpage>-<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1119(02)00455-9</pub-id><pub-id pub-id-type="pmid">11943476</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>P. F.</given-names></name>, <name><surname>Civelek</surname><given-names>M.</given-names></name>, <name><surname>Fang</surname><given-names>Y.</given-names></name> and <name><surname>Fleming</surname><given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>The atherosusceptible endothelium: endothelial phenotypes in complex haemodynamic shear stress regions in vivo</article-title>. <source/><italic>Cardiovasc. Res.</italic>
<volume>99</volume>, <fpage>315</fpage>-<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvt101</pub-id><pub-id pub-id-type="pmid">23619421</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De la Cuesta</surname><given-names>F.</given-names></name>, <name><surname>Alvarez-Llamas</surname><given-names>G.</given-names></name>, <name><surname>Maroto</surname><given-names>A. S.</given-names></name>, <name><surname>Donado</surname><given-names>A.</given-names></name>, <name><surname>Zubiri</surname><given-names>I.</given-names></name>, <name><surname>Posada</surname><given-names>M.</given-names></name>, <name><surname>Padial</surname><given-names>L. R.</given-names></name>, <name><surname>Pinto</surname><given-names>A. G.</given-names></name>, <name><surname>Barderas</surname><given-names>M. G.</given-names></name> and <name><surname>Vivanco</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima</article-title>. <source/><italic>Mol. Cell. Proteomics</italic>
<volume>10</volume>, <fpage>M110.003517</fpage>
<pub-id pub-id-type="doi">10.1074/mcp.M110.003517</pub-id><pub-id pub-id-type="pmid">21248247</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeBiasio</surname><given-names>R. L.</given-names></name>, <name><surname>LaRocca</surname><given-names>G. M.</given-names></name>, <name><surname>Post</surname><given-names>P. L.</given-names></name> and <name><surname>Taylor</surname><given-names>D. L.</given-names></name></person-group> (<year>1996</year>). <article-title>Myosin II transport, organization, and phosphorylation: evidence for cortical flow/solation-contraction coupling during cytokinesis and cell locomotion</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>7</volume>, <fpage>1259</fpage>-<lpage>1282</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.7.8.1259</pub-id><pub-id pub-id-type="pmid">8856669</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DePoy</surname><given-names>L. M.</given-names></name>, <name><surname>Noble</surname><given-names>B.</given-names></name>, <name><surname>Allen</surname><given-names>A. G.</given-names></name> and <name><surname>Gourley</surname><given-names>S. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Developmentally divergent effects of Rho-kinase inhibition on cocaine- and BDNF-induced behavioral plasticity</article-title>. <source/><italic>Behav. Brain Res.</italic>
<volume>243</volume>, <fpage>171</fpage>-<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2013.01.004</pub-id><pub-id pub-id-type="pmid">23327740</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>J.</given-names></name>, <name><surname>Li</surname><given-names>Q.-Y.</given-names></name>, <name><surname>Wang</surname><given-names>X.</given-names></name>, <name><surname>Sun</surname><given-names>C.-H.</given-names></name>, <name><surname>Lu</surname><given-names>C.-Z.</given-names></name> and <name><surname>Xiao</surname><given-names>B.-G.</given-names></name></person-group> (<year>2010</year>). <article-title>Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice</article-title>. <source/><italic>J. Neurochem.</italic>
<volume>114</volume>, <fpage>1619</fpage>-<lpage>1629</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06876.x</pub-id><pub-id pub-id-type="pmid">20882700</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolan</surname><given-names>B. M.</given-names></name>, <name><surname>Duron</surname><given-names>S. G.</given-names></name>, <name><surname>Campbell</surname><given-names>D. A.</given-names></name>, <name><surname>Vollrath</surname><given-names>B.</given-names></name>, <name><surname>Shankaranarayana Rao</surname><given-names>B. S.</given-names></name>, <name><surname>Ko</surname><given-names>H.-Y.</given-names></name>, <name><surname>Lin</surname><given-names>G. G.</given-names></name>, <name><surname>Govindarajan</surname><given-names>A.</given-names></name>, <name><surname>Choi</surname><given-names>S.-Y.</given-names></name> and <name><surname>Tonegawa</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>110</volume>, <fpage>5671</fpage>-<lpage>5676</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1219383110</pub-id><pub-id pub-id-type="pmid">23509247</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>Y.</given-names></name>, <name><surname>Arlock</surname><given-names>P.</given-names></name> and <name><surname>Arner</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Blebbistatin specifically inhibits actin-myosin interaction in mouse cardiac muscle</article-title>. <source/><italic>Am. J. Physiol. Cell Physiol.</italic>
<volume>293</volume>, <fpage>C1148</fpage>-<lpage>C1153</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00551.2006</pub-id><pub-id pub-id-type="pmid">17615158</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dulyaninova</surname><given-names>N. G.</given-names></name>, <name><surname>House</surname><given-names>R. P.</given-names></name>, <name><surname>Betapudi</surname><given-names>V.</given-names></name> and <name><surname>Bresnick</surname><given-names>A. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>18</volume>, <fpage>3144</fpage>-<lpage>3155</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E06-11-1056</pub-id><pub-id pub-id-type="pmid">17567956</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname><given-names>S.</given-names></name>, <name><surname>Morsut</surname><given-names>L.</given-names></name>, <name><surname>Aragona</surname><given-names>M.</given-names></name>, <name><surname>Enzo</surname><given-names>E.</given-names></name>, <name><surname>Giulitti</surname><given-names>S.</given-names></name>, <name><surname>Cordenonsi</surname><given-names>M.</given-names></name>, <name><surname>Zanconato</surname><given-names>F.</given-names></name>, <name><surname>Le Digabel</surname><given-names>J.</given-names></name>, <name><surname>Forcato</surname><given-names>M.</given-names></name>, <name><surname>Bicciato</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Role of YAP/TAZ in mechanotransduction</article-title>. <source/><italic>Nature</italic>
<volume>474</volume>, <fpage>179</fpage>-<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1038/nature10137</pub-id><pub-id pub-id-type="pmid">21654799</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckly</surname><given-names>A.</given-names></name>, <name><surname>Strassel</surname><given-names>C.</given-names></name>, <name><surname>Freund</surname><given-names>M.</given-names></name>, <name><surname>Cazenave</surname><given-names>J.-P.</given-names></name>, <name><surname>Lanza</surname><given-names>F.</given-names></name>, <name><surname>Gachet</surname><given-names>C.</given-names></name> and <name><surname>Léon</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation</article-title>. <source/><italic>Blood</italic>
<volume>113</volume>, <fpage>3182</fpage>-<lpage>3189</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-06-164061</pub-id><pub-id pub-id-type="pmid">18984861</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>H.</given-names></name>, <name><surname>Fischer</surname><given-names>R. S.</given-names></name>, <name><surname>Myers</surname><given-names>K. A.</given-names></name>, <name><surname>Desai</surname><given-names>R. A.</given-names></name>, <name><surname>Gao</surname><given-names>L.</given-names></name>, <name><surname>Chen</surname><given-names>C. S.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name>, <name><surname>Waterman</surname><given-names>C. M.</given-names></name> and <name><surname>Danuser</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Myosin II controls cellular branching morphogenesis and migration in three dimensions by minimizing cell-surface curvature</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>17</volume>, <fpage>137</fpage>-<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3092</pub-id><pub-id pub-id-type="pmid">25621949</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engler</surname><given-names>A. J.</given-names></name>, <name><surname>Sen</surname><given-names>S.</given-names></name>, <name><surname>Sweeney</surname><given-names>H. L.</given-names></name> and <name><surname>Discher</surname><given-names>D. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Matrix elasticity directs stem cell lineage specification</article-title>. <source/><italic>Cell</italic>
<volume>126</volume>, <fpage>677</fpage>-<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.06.044</pub-id><pub-id pub-id-type="pmid">16923388</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>T.</given-names></name>, <name><surname>Hergenhahn</surname><given-names>M.</given-names></name>, <name><surname>Kenzelmann</surname><given-names>M.</given-names></name>, <name><surname>Cohen</surname><given-names>C. D.</given-names></name>, <name><surname>Bonrouhi</surname><given-names>M.</given-names></name>, <name><surname>Weninger</surname><given-names>A.</given-names></name>, <name><surname>Klären</surname><given-names>R.</given-names></name>, <name><surname>Gröne</surname><given-names>E. F.</given-names></name>, <name><surname>Wiesel</surname><given-names>M.</given-names></name>, <name><surname>Güdemann</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>). <article-title>Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue</article-title>. <source/><italic>Am. J. Pathol.</italic>
<volume>160</volume>, <fpage>2169</fpage>-<lpage>2180</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)61165-0</pub-id><pub-id pub-id-type="pmid">12057920</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essler</surname><given-names>M.</given-names></name>, <name><surname>Retzer</surname><given-names>M.</given-names></name>, <name><surname>Bauer</surname><given-names>M.</given-names></name>, <name><surname>Heemskerk</surname><given-names>J. W.</given-names></name>, <name><surname>Aepfelbacher</surname><given-names>M.</given-names></name> and <name><surname>Siess</surname><given-names>W.</given-names></name></person-group> (<year>1999</year>). <article-title>Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>274</volume>, <fpage>30361</fpage>-<lpage>30364</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.43.30361</pub-id><pub-id pub-id-type="pmid">10521411</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fakhro</surname><given-names>K. A.</given-names></name>, <name><surname>Choi</surname><given-names>M.</given-names></name>, <name><surname>Ware</surname><given-names>S. M.</given-names></name>, <name><surname>Belmont</surname><given-names>J. W.</given-names></name>, <name><surname>Towbin</surname><given-names>J. A.</given-names></name>, <name><surname>Lifton</surname><given-names>R. P.</given-names></name>, <name><surname>Khokha</surname><given-names>M. K.</given-names></name> and <name><surname>Brueckner</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>108</volume>, <fpage>2915</fpage>-<lpage>2920</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1019645108</pub-id><pub-id pub-id-type="pmid">21282601</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feske</surname><given-names>S. K.</given-names></name>, <name><surname>Sorond</surname><given-names>F. A.</given-names></name>, <name><surname>Henderson</surname><given-names>G. V.</given-names></name>, <name><surname>Seto</surname><given-names>M.</given-names></name>, <name><surname>Hitomi</surname><given-names>A.</given-names></name>, <name><surname>Kawasaki</surname><given-names>K.</given-names></name>, <name><surname>Sasaki</surname><given-names>Y.</given-names></name>, <name><surname>Asano</surname><given-names>T.</given-names></name> and <name><surname>Liao</surname><given-names>J. K.</given-names></name></person-group> (<year>2009</year>). <article-title>Increased leukocyte ROCK activity in patients after acute ischemic stroke</article-title>. <source/><italic>Brain Res.</italic>
<volume>1257</volume>, <fpage>89</fpage>-<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2008.12.045</pub-id><pub-id pub-id-type="pmid">19133241</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiala</surname><given-names>J. C.</given-names></name>, <name><surname>Spacek</surname><given-names>J.</given-names></name> and <name><surname>Harris</surname><given-names>K. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Dendritic spine pathology: cause or consequence of neurological disorders?</article-title>
<source/><italic>Brain Res. Rev.</italic>
<volume>39</volume>, <fpage>29</fpage>-<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-0173(02)00158-3</pub-id><pub-id pub-id-type="pmid">12086707</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>R. S.</given-names></name>, <name><surname>Gardel</surname><given-names>M.</given-names></name>, <name><surname>Ma</surname><given-names>X.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name> and <name><surname>Waterman</surname><given-names>C. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Local cortical tension by myosin II guides 3D endothelial cell branching</article-title>. <source/><italic>Curr. Biol.</italic>
<volume>19</volume>, <fpage>260</fpage>-<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2008.12.045</pub-id><pub-id pub-id-type="pmid">19185493</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortin</surname><given-names>D. A.</given-names></name>, <name><surname>Davare</surname><given-names>M. A.</given-names></name>, <name><surname>Srivastava</surname><given-names>T.</given-names></name>, <name><surname>Brady</surname><given-names>J. D.</given-names></name>, <name><surname>Nygaard</surname><given-names>S.</given-names></name>, <name><surname>Derkach</surname><given-names>V. A.</given-names></name> and <name><surname>Soderling</surname><given-names>T. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Long-term potentiation-dependent spine enlargement requires synaptic Ca2+-permeable AMPA receptors recruited by CaM-kinase I</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>30</volume>, <fpage>11565</fpage>-<lpage>11575</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1746-10.2010</pub-id><pub-id pub-id-type="pmid">20810878</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedl</surname><given-names>P.</given-names></name> and <name><surname>Alexander</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Cancer invasion and the microenvironment: plasticity and reciprocity</article-title>. <source/><italic>Cell</italic>
<volume>147</volume>, <fpage>992</fpage>-<lpage>1009</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.11.016</pub-id><pub-id pub-id-type="pmid">22118458</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedl</surname><given-names>P.</given-names></name>, <name><surname>Locker</surname><given-names>J.</given-names></name>, <name><surname>Sahai</surname><given-names>E.</given-names></name> and <name><surname>Segall</surname><given-names>J. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Classifying collective cancer cell invasion</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>14</volume>, <fpage>777</fpage>-<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2548</pub-id><pub-id pub-id-type="pmid">22854810</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedland</surname><given-names>J. C.</given-names></name>, <name><surname>Lee</surname><given-names>M. H.</given-names></name> and <name><surname>Boettiger</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Mechanically activated integrin switch controls alpha5beta1 function</article-title>. <source/><italic>Science</italic>
<volume>323</volume>, <fpage>642</fpage>-<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1126/science.1168441</pub-id><pub-id pub-id-type="pmid">19179533</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>L.</given-names></name>, <name><surname>Zhang</surname><given-names>S.</given-names></name>, <name><surname>Zhang</surname><given-names>L.</given-names></name>, <name><surname>Tong</surname><given-names>X.</given-names></name>, <name><surname>Zhang</surname><given-names>J.</given-names></name>, <name><surname>Zhang</surname><given-names>Y.</given-names></name>, <name><surname>Ouyang</surname><given-names>L.</given-names></name>, <name><surname>Liu</surname><given-names>B.</given-names></name> and <name><surname>Huang</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Systems biology network-based discovery of a small molecule activator BL-AD008 targeting AMPK/ZIPK and inducing apoptosis in cervical cancer</article-title>. <source/><italic>Oncotarget</italic>
<volume>6</volume>, <fpage>8071</fpage>-<lpage>8088</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.3513</pub-id><pub-id pub-id-type="pmid">25797270</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaggioli</surname><given-names>C.</given-names></name>, <name><surname>Hooper</surname><given-names>S.</given-names></name>, <name><surname>Hidalgo-Carcedo</surname><given-names>C.</given-names></name>, <name><surname>Grosse</surname><given-names>R.</given-names></name>, <name><surname>Marshall</surname><given-names>J. F.</given-names></name>, <name><surname>Harrington</surname><given-names>K.</given-names></name> and <name><surname>Sahai</surname><given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>9</volume>, <fpage>1392</fpage>-<lpage>1400</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1658</pub-id><pub-id pub-id-type="pmid">18037882</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galkina</surname><given-names>E.</given-names></name> and <name><surname>Ley</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Immune and inflammatory mechanisms of atherosclerosis (*)</article-title>. <source/><italic>Annu. Rev. Immunol.</italic>
<volume>27</volume>, <fpage>165</fpage>-<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132620</pub-id><pub-id pub-id-type="pmid">19302038</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandhirajan</surname><given-names>R. K.</given-names></name>, <name><surname>Meng</surname><given-names>S.</given-names></name>, <name><surname>Chandramoorthy</surname><given-names>H. C.</given-names></name>, <name><surname>Mallilankaraman</surname><given-names>K.</given-names></name>, <name><surname>Mancarella</surname><given-names>S.</given-names></name>, <name><surname>Gao</surname><given-names>H.</given-names></name>, <name><surname>Razmpour</surname><given-names>R.</given-names></name>, <name><surname>Yang</surname><given-names>X.-F.</given-names></name>, <name><surname>Houser</surname><given-names>S. R.</given-names></name>, <name><surname>Chen</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation</article-title>. <source/><italic>J. Clin. Invest.</italic>
<volume>123</volume>, <fpage>887</fpage>-<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1172/jci65647</pub-id><pub-id pub-id-type="pmid">23348743</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname><given-names>T.</given-names></name>, <name><surname>Cox</surname><given-names>J.</given-names></name>, <name><surname>Ostasiewicz</surname><given-names>P.</given-names></name>, <name><surname>Wisniewski</surname><given-names>J. R.</given-names></name> and <name><surname>Mann</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Super-SILAC mix for quantitative proteomics of human tumor tissue</article-title>. <source/><italic>Nat. Methods</italic>
<volume>7</volume>, <fpage>383</fpage>-<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1446</pub-id><pub-id pub-id-type="pmid">20364148</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghiggeri</surname><given-names>G. M.</given-names></name>, <name><surname>Caridi</surname><given-names>G.</given-names></name>, <name><surname>Magrini</surname><given-names>U.</given-names></name>, <name><surname>Sessa</surname><given-names>A.</given-names></name>, <name><surname>Savoia</surname><given-names>A.</given-names></name>, <name><surname>Seri</surname><given-names>M.</given-names></name>, <name><surname>Pecci</surname><given-names>A.</given-names></name>, <name><surname>Romagnoli</surname><given-names>R.</given-names></name>, <name><surname>Gangarossa</surname><given-names>S.</given-names></name>, <name><surname>Noris</surname><given-names>P.</given-names></name><etal>et al.</etal></person-group> (<year>2003</year>). <article-title>Genetics, clinical and pathological features of glomerulonephrites associated with mutations of nonmuscle myosin IIA (Fechtner syndrome)</article-title>. <source/><italic>Am. J. Kidney Dis.</italic>
<volume>41</volume>, <fpage>95</fpage>-<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1053/ajkd.2003.50028</pub-id><pub-id pub-id-type="pmid">12500226</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannotta</surname><given-names>M.</given-names></name>, <name><surname>Trani</surname><given-names>M.</given-names></name> and <name><surname>Dejana</surname><given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity</article-title>. <source/><italic>Dev. Cell</italic>
<volume>26</volume>, <fpage>441</fpage>-<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2013.08.020</pub-id><pub-id pub-id-type="pmid">24044891</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goeckeler</surname><given-names>Z. M.</given-names></name> and <name><surname>Wysolmerski</surname><given-names>R. B.</given-names></name></person-group> (<year>1995</year>). <article-title>Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>130</volume>, <fpage>613</fpage>-<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.130.3.613</pub-id><pub-id pub-id-type="pmid">7622562</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golomb</surname><given-names>E.</given-names></name>, <name><surname>Ma</surname><given-names>X.</given-names></name>, <name><surname>Jana</surname><given-names>S. S.</given-names></name>, <name><surname>Preston</surname><given-names>Y. A.</given-names></name>, <name><surname>Kawamoto</surname><given-names>S.</given-names></name>, <name><surname>Shoham</surname><given-names>N. G.</given-names></name>, <name><surname>Goldin</surname><given-names>E.</given-names></name>, <name><surname>Conti</surname><given-names>M. A.</given-names></name>, <name><surname>Sellers</surname><given-names>J. R.</given-names></name> and <name><surname>Adelstein</surname><given-names>R. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>, <fpage>2800</fpage>-<lpage>2808</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M309981200</pub-id><pub-id pub-id-type="pmid">14594953</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>E. R.</given-names></name>, <name><surname>Jani</surname><given-names>S.</given-names></name> and <name><surname>Gundersen</surname><given-names>G. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Nuclear movement regulated by Cdc42, MRCK, myosin, and actin flow establishes MTOC polarization in migrating cells</article-title>. <source/><italic>Cell</italic>
<volume>121</volume>, <fpage>451</fpage>-<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.02.022</pub-id><pub-id pub-id-type="pmid">15882626</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goudarzi</surname><given-names>M.</given-names></name>, <name><surname>Banisch</surname><given-names>T. U.</given-names></name>, <name><surname>Mobin</surname><given-names>M. B.</given-names></name>, <name><surname>Maghelli</surname><given-names>N.</given-names></name>, <name><surname>Tarbashevich</surname><given-names>K.</given-names></name>, <name><surname>Strate</surname><given-names>I.</given-names></name>, <name><surname>van den Berg</surname><given-names>J.</given-names></name>, <name><surname>Blaser</surname><given-names>H.</given-names></name>, <name><surname>Bandemer</surname><given-names>S.</given-names></name>, <name><surname>Paluch</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Identification and regulation of a molecular module for Bleb-based cell motility</article-title>. <source/><italic>Dev. Cell</italic>
<volume>23</volume>, <fpage>210</fpage>-<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2012.05.007</pub-id><pub-id pub-id-type="pmid">22705393</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govek</surname><given-names>E.-E.</given-names></name>, <name><surname>Newey</surname><given-names>S. E.</given-names></name>, <name><surname>Akerman</surname><given-names>C. J.</given-names></name>, <name><surname>Cross</surname><given-names>J. R.</given-names></name>, <name><surname>Van der Veken</surname><given-names>L.</given-names></name> and <name><surname>Van Aelst</surname><given-names>L.</given-names></name></person-group> (<year>2004</year>). <article-title>The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis</article-title>. <source/><italic>Nat. Neurosci.</italic>
<volume>7</volume>, <fpage>364</fpage>-<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1038/nn1210</pub-id><pub-id pub-id-type="pmid">15034583</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grindrod</surname><given-names>S.</given-names></name>, <name><surname>Suy</surname><given-names>S.</given-names></name>, <name><surname>Fallen</surname><given-names>S.</given-names></name>, <name><surname>Eto</surname><given-names>M.</given-names></name>, <name><surname>Toretsky</surname><given-names>J.</given-names></name> and <name><surname>Brown</surname><given-names>M. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells</article-title>. <source/><italic>Front. Oncol.</italic>
<volume>1</volume>, <fpage>27</fpage>
<pub-id pub-id-type="doi">10.3389/fonc.2011.00027</pub-id><pub-id pub-id-type="pmid">22655237</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>L.-Z.</given-names></name>, <name><surname>Hu</surname><given-names>W.-Y.</given-names></name>, <name><surname>Antic</surname><given-names>N.</given-names></name>, <name><surname>Mehta</surname><given-names>R.</given-names></name>, <name><surname>Turner</surname><given-names>J. R.</given-names></name> and <name><surname>de Lanerolle</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells</article-title>. <source/><italic>Eur. J. Cancer</italic>
<volume>42</volume>, <fpage>948</fpage>-<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejca.2005.12.017</pub-id><pub-id pub-id-type="pmid">16574402</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>C.</given-names></name> and <name><surname>Schwartz</surname><given-names>M. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Mechanotransduction in vascular physiology and atherogenesis</article-title>. <source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>10</volume>, <fpage>53</fpage>-<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2596</pub-id><pub-id pub-id-type="pmid">19197332</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haidari</surname><given-names>M.</given-names></name>, <name><surname>Zhang</surname><given-names>W.</given-names></name>, <name><surname>Chen</surname><given-names>Z.</given-names></name>, <name><surname>Ganjehei</surname><given-names>L.</given-names></name>, <name><surname>Warier</surname><given-names>N.</given-names></name>, <name><surname>Vanderslice</surname><given-names>P.</given-names></name> and <name><surname>Dixon</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Myosin light chain phosphorylation facilitates monocyte transendothelial migration by dissociating endothelial adherens junctions</article-title>. <source/><italic>Cardiovasc. Res.</italic>
<volume>92</volume>, <fpage>456</fpage>-<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvr240</pub-id><pub-id pub-id-type="pmid">21908648</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name> and <name><surname>Weinberg</surname><given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Hallmarks of cancer: the next generation</article-title>. <source/><italic>Cell</italic>
<volume>144</volume>, <fpage>646</fpage>-<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harb</surname><given-names>N.</given-names></name>, <name><surname>Archer</surname><given-names>T. K.</given-names></name> and <name><surname>Sato</surname><given-names>N.</given-names></name></person-group> (<year>2008</year>). <article-title>The Rho-Rock-Myosin signaling axis determines cell-cell integrity of self-renewing pluripotent stem cells</article-title>. <source/><italic>PLoS ONE</italic>
<volume>3</volume>, <fpage>e3001</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0003001</pub-id><pub-id pub-id-type="pmid">18714354</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>S. M. W.</given-names></name>, <name><surname>Knifley</surname><given-names>T.</given-names></name>, <name><surname>Chen</surname><given-names>M.</given-names></name> and <name><surname>O'Connor</surname><given-names>K. L.</given-names></name></person-group> (<year>2013</year>). <article-title>LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells</article-title>. <source/><italic>BMC Cancer</italic>
<volume>13</volume>, <fpage>501</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2407-13-501</pub-id><pub-id pub-id-type="pmid">24160245</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi-Takagi</surname><given-names>A.</given-names></name>, <name><surname>Araki</surname><given-names>Y.</given-names></name>, <name><surname>Nakamura</surname><given-names>M.</given-names></name>, <name><surname>Vollrath</surname><given-names>B.</given-names></name>, <name><surname>Duron</surname><given-names>S. G.</given-names></name>, <name><surname>Yan</surname><given-names>Z.</given-names></name>, <name><surname>Kasai</surname><given-names>H.</given-names></name>, <name><surname>Huganir</surname><given-names>R. L.</given-names></name>, <name><surname>Campbell</surname><given-names>D. A.</given-names></name> and <name><surname>Sawa</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>111</volume>, <fpage>6461</fpage>-<lpage>6466</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1321109111</pub-id><pub-id pub-id-type="pmid">24706880</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q.-Y.</given-names></name>, <name><surname>Chen</surname><given-names>J.</given-names></name>, <name><surname>Kung</surname><given-names>H.-F.</given-names></name>, <name><surname>Yuen</surname><given-names>A. P.-W.</given-names></name> and <name><surname>Chiu</surname><given-names>J.-F.</given-names></name></person-group> (<year>2004</year>). <article-title>Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics</article-title>. <source/><italic>Proteomics</italic>
<volume>4</volume>, <fpage>271</fpage>-<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200300550</pub-id><pub-id pub-id-type="pmid">14730689</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heasman</surname><given-names>S. J.</given-names></name> and <name><surname>Ridley</surname><given-names>A. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Mammalian Rho GTPases: new insights into their functions from in vivo studies</article-title>. <source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>9</volume>, <fpage>690</fpage>-<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2476</pub-id><pub-id pub-id-type="pmid">18719708</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>K. E.</given-names></name>, <name><surname>Campos-Barros</surname><given-names>A.</given-names></name>, <name><surname>Toren</surname><given-names>A.</given-names></name>, <name><surname>Rozenfeld-Granot</surname><given-names>G.</given-names></name>, <name><surname>Carlsson</surname><given-names>L. E.</given-names></name>, <name><surname>Savige</surname><given-names>J.</given-names></name>, <name><surname>Denison</surname><given-names>J. C.</given-names></name>, <name><surname>Gregory</surname><given-names>M. C.</given-names></name>, <name><surname>White</surname><given-names>J. G.</given-names></name>, <name><surname>Barker</surname><given-names>D. F.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>). <article-title>Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes</article-title>. <source/><italic>Am. J. Hum. Genet.</italic>
<volume>69</volume>, <fpage>1033</fpage>-<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1086/324267</pub-id><pub-id pub-id-type="pmid">11590545</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helfman</surname><given-names>D. M.</given-names></name> and <name><surname>Pawlak</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>Myosin light chain kinase and acto-myosin contractility modulate activation of the ERK cascade downstream of oncogenic Ras</article-title>. <source/><italic>J. Cell. Biochem.</italic>
<volume>95</volume>, <fpage>1069</fpage>-<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.20498</pub-id><pub-id pub-id-type="pmid">15962288</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiroi</surname><given-names>J.</given-names></name>, <name><surname>Kimura</surname><given-names>K.</given-names></name>, <name><surname>Aikawa</surname><given-names>M.</given-names></name>, <name><surname>Tojo</surname><given-names>A.</given-names></name>, <name><surname>Suzuki</surname><given-names>Y.</given-names></name>, <name><surname>Nagamatsu</surname><given-names>T.</given-names></name>, <name><surname>Omata</surname><given-names>M.</given-names></name>, <name><surname>Yazaki</surname><given-names>Y.</given-names></name> and <name><surname>Nagai</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Expression of a nonmuscle myosin heavy chain in glomerular cells differentiates various types of glomerular disease in rats</article-title>. <source/><italic>Kidney Int.</italic>
<volume>49</volume>, <fpage>1231</fpage>-<lpage>1241</lpage>. <pub-id pub-id-type="doi">10.1038/ki.1996.177</pub-id><pub-id pub-id-type="pmid">8731086</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodge</surname><given-names>T. P.</given-names></name>, <name><surname>Cross</surname><given-names>R.</given-names></name> and <name><surname>Kendrick-Jones</surname><given-names>J.</given-names></name></person-group> (<year>1992</year>). <article-title>Role of the COOH-terminal nonhelical tailpiece in the assembly of a vertebrate nonmuscle myosin rod</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>118</volume>, <fpage>1085</fpage>-<lpage>1095</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.118.5.1085</pub-id><pub-id pub-id-type="pmid">1512291</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodges</surname><given-names>J. L.</given-names></name>, <name><surname>Newell-Litwa</surname><given-names>K.</given-names></name>, <name><surname>Asmussen</surname><given-names>H.</given-names></name>, <name><surname>Vicente-Manzanares</surname><given-names>M.</given-names></name> and <name><surname>Horwitz</surname><given-names>A. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Myosin IIB activity and phosphorylation status determines dendritic spine and post-synaptic density morphology</article-title>. <source/><italic>PLoS ONE</italic>
<volume>6</volume>, <fpage>e24149</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0024149</pub-id><pub-id pub-id-type="pmid">21887379</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoelzle</surname><given-names>M. K.</given-names></name> and <name><surname>Svitkina</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>The cytoskeletal mechanisms of cell-cell junction formation in endothelial cells</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>23</volume>, <fpage>310</fpage>-<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E11-08-0719</pub-id><pub-id pub-id-type="pmid">22090347</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotulainen</surname><given-names>P.</given-names></name> and <name><surname>Hoogenraad</surname><given-names>C. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Actin in dendritic spines: connecting dynamics to function</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>189</volume>, <fpage>619</fpage>-<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201003008</pub-id><pub-id pub-id-type="pmid">20457765</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X. N.</given-names></name>, <name><surname>Fu</surname><given-names>J.</given-names></name> and <name><surname>Wang</surname><given-names>W. Z.</given-names></name></person-group> (<year>2011</year>). <article-title>The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis</article-title>. <source/><italic>J. Neuroimmunol.</italic>
<volume>239</volume>, <fpage>61</fpage>-<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2011.08.015</pub-id><pub-id pub-id-type="pmid">21978848</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.-Q.</given-names></name>, <name><surname>Han</surname><given-names>Z.-D.</given-names></name>, <name><surname>Liang</surname><given-names>Y.-X.</given-names></name>, <name><surname>Lin</surname><given-names>Z.-Y.</given-names></name>, <name><surname>Ling</surname><given-names>X.-H.</given-names></name>, <name><surname>Fu</surname><given-names>X.</given-names></name>, <name><surname>Cai</surname><given-names>C.</given-names></name>, <name><surname>Bi</surname><given-names>X.-C.</given-names></name>, <name><surname>Dai</surname><given-names>Q.-S.</given-names></name>, <name><surname>Chen</surname><given-names>J.-H.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer</article-title>. <source/><italic>Med. Oncol.</italic>
<volume>31</volume>, <fpage>820</fpage>
<pub-id pub-id-type="doi">10.1007/s12032-013-0820-4</pub-id><pub-id pub-id-type="pmid">24338276</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huentelman</surname><given-names>M. J.</given-names></name>, <name><surname>Stephan</surname><given-names>D. A.</given-names></name>, <name><surname>Talboom</surname><given-names>J.</given-names></name>, <name><surname>Corneveaux</surname><given-names>J. J.</given-names></name>, <name><surname>Reiman</surname><given-names>D. M.</given-names></name>, <name><surname>Gerber</surname><given-names>J. D.</given-names></name>, <name><surname>Barnes</surname><given-names>C. A.</given-names></name>, <name><surname>Alexander</surname><given-names>G. E.</given-names></name>, <name><surname>Reiman</surname><given-names>E. M.</given-names></name> and <name><surname>Bimonte-Nelson</surname><given-names>H. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Peripheral delivery of a ROCK inhibitor improves learning and working memory</article-title>. <source/><italic>Behav. Neurosci.</italic>
<volume>123</volume>, <fpage>218</fpage>-<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1037/a0014260</pub-id><pub-id pub-id-type="pmid">19170447</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphrey</surname><given-names>J. D.</given-names></name>, <name><surname>Dufresne</surname><given-names>E. R.</given-names></name> and <name><surname>Schwartz</surname><given-names>M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Mechanotransduction and extracellular matrix homeostasis</article-title>. <source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>15</volume>, <fpage>802</fpage>-<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3896</pub-id><pub-id pub-id-type="pmid">25355505</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huppert</surname><given-names>J.</given-names></name>, <name><surname>Closhen</surname><given-names>D.</given-names></name>, <name><surname>Croxford</surname><given-names>A.</given-names></name>, <name><surname>White</surname><given-names>R.</given-names></name>, <name><surname>Kulig</surname><given-names>P.</given-names></name>, <name><surname>Pietrowski</surname><given-names>E.</given-names></name>, <name><surname>Bechmann</surname><given-names>I.</given-names></name>, <name><surname>Becher</surname><given-names>B.</given-names></name>, <name><surname>Luhmann</surname><given-names>H. J.</given-names></name>, <name><surname>Waisman</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Cellular mechanisms of IL-17-induced blood-brain barrier disruption</article-title>. <source/><italic>FASEB J.</italic>
<volume>24</volume>, <fpage>1023</fpage>-<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1096/fj.09-141978</pub-id><pub-id pub-id-type="pmid">19940258</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>E.-M.</given-names></name>, <name><surname>Yang</surname><given-names>I. H.</given-names></name>, <name><surname>Kim</surname><given-names>D.-H.</given-names></name>, <name><surname>Byun</surname><given-names>J.</given-names></name>, <name><surname>Saijilafu</surname><given-names>J.</given-names></name>, <name><surname>Xu</surname><given-names>W.-L.</given-names></name>, <name><surname>Nicovich</surname><given-names>P. R.</given-names></name>, <name><surname>Cheong</surname><given-names>R.</given-names></name>, <name><surname>Levchenko</surname><given-names>A.</given-names></name>, <name><surname>Thakor</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Engineering neuronal growth cones to promote axon regeneration over inhibitory molecules</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>108</volume>, <fpage>5057</fpage>-<lpage>5062</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1011258108</pub-id><pub-id pub-id-type="pmid">21383151</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutsler</surname><given-names>J. J.</given-names></name> and <name><surname>Zhang</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders</article-title>. <source/><italic>Brain Res.</italic>
<volume>1309</volume>, <fpage>83</fpage>-<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.09.120</pub-id><pub-id pub-id-type="pmid">19896929</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imajo</surname><given-names>M.</given-names></name>, <name><surname>Ebisuya</surname><given-names>M.</given-names></name> and <name><surname>Nishida</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Dual role of YAP and TAZ in renewal of the intestinal epithelium</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>17</volume>, <fpage>7</fpage>-<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3084</pub-id><pub-id pub-id-type="pmid">25531778</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>S. A.</given-names></name>, <name><surname>Patel</surname><given-names>B.</given-names></name>, <name><surname>Idupulapati</surname><given-names>M.</given-names></name>, <name><surname>Harris</surname><given-names>J. B.</given-names></name>, <name><surname>Crisostomo</surname><given-names>R. A.</given-names></name>, <name><surname>Larsen</surname><given-names>B. P.</given-names></name>, <name><surname>Kooy</surname><given-names>F.</given-names></name>, <name><surname>Willems</surname><given-names>P. J.</given-names></name>, <name><surname>Cras</surname><given-names>P.</given-names></name>, <name><surname>Kozlowski</surname><given-names>P. B.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>). <article-title>Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination</article-title>. <source/><italic>Am. J. Med. Genet.</italic>
<volume>98</volume>, <fpage>161</fpage>-<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1002/1096-8628(20010115)98:2&lt;161::AID-AJMG1025&gt;3.0.CO;2-B</pub-id><pub-id pub-id-type="pmid">11223852</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobelli</surname><given-names>J.</given-names></name>, <name><surname>Estin Matthews</surname><given-names>M.</given-names></name>, <name><surname>Chen</surname><given-names>S.</given-names></name> and <name><surname>Krummel</surname><given-names>M. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Activated T cell trans-endothelial migration relies on myosin-IIA contractility for squeezing the cell nucleus through endothelial cell barriers</article-title>. <source/><italic>PLoS ONE</italic>
<volume>8</volume>, <fpage>e75151</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0075151</pub-id><pub-id pub-id-type="pmid">24069389</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jana</surname><given-names>S. S.</given-names></name>, <name><surname>Kawamoto</surname><given-names>S.</given-names></name> and <name><surname>Adelstein</surname><given-names>R. S.</given-names></name></person-group> (<year>2006</year>). <article-title>A specific isoform of nonmuscle myosin II-C is required for cytokinesis in a tumor cell line</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>281</volume>, <fpage>24662</fpage>-<lpage>24670</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M604606200</pub-id><pub-id pub-id-type="pmid">16790446</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janßen</surname><given-names>S.</given-names></name>, <name><surname>Gudi</surname><given-names>V.</given-names></name>, <name><surname>Prajeeth</surname><given-names>C. K.</given-names></name>, <name><surname>Singh</surname><given-names>V.</given-names></name>, <name><surname>Stahl</surname><given-names>K.</given-names></name>, <name><surname>Heckers</surname><given-names>S.</given-names></name>, <name><surname>Skripuletz</surname><given-names>T.</given-names></name>, <name><surname>Pul</surname><given-names>R.</given-names></name>, <name><surname>Trebst</surname><given-names>C.</given-names></name>, <name><surname>Tsiavaliaris</surname><given-names>G.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>A pivotal role of nonmuscle myosin II during microglial activation</article-title>. <source/><italic>Exp. Neurol.</italic>
<volume>261</volume>, <fpage>666</fpage>-<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2014.08.010</pub-id><pub-id pub-id-type="pmid">25150163</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>L.</given-names></name>, <name><surname>Majumdar</surname><given-names>D.</given-names></name>, <name><surname>Shi</surname><given-names>M.</given-names></name>, <name><surname>Hinkle</surname><given-names>L. E.</given-names></name>, <name><surname>Diggins</surname><given-names>N. L.</given-names></name>, <name><surname>Ao</surname><given-names>M.</given-names></name>, <name><surname>Broussard</surname><given-names>J. A.</given-names></name>, <name><surname>Evans</surname><given-names>J. C.</given-names></name>, <name><surname>Choma</surname><given-names>D. P.</given-names></name> and <name><surname>Webb</surname><given-names>D. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Activation of Rac by Asef2 promotes myosin II-dependent contractility to inhibit cell migration on type I collagen</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>126</volume>, <fpage>5585</fpage>-<lpage>5597</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.131060</pub-id><pub-id pub-id-type="pmid">24144700</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>A. A.</given-names></name>, <name><surname>Fahlke</surname><given-names>C.</given-names></name>, <name><surname>Bjørn-Yoshimoto</surname><given-names>W. E.</given-names></name> and <name><surname>Bunch</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities</article-title>. <source/><italic>Curr. Opin. Pharmacol.</italic>
<volume>20</volume>, <fpage>116</fpage>-<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2014.10.008</pub-id><pub-id pub-id-type="pmid">25466154</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>B. T.</given-names></name>, <name><surname>Jeong</surname><given-names>E. A.</given-names></name>, <name><surname>Park</surname><given-names>S.-Y.</given-names></name>, <name><surname>Son</surname><given-names>H.</given-names></name>, <name><surname>Shin</surname><given-names>H. J.</given-names></name>, <name><surname>Lee</surname><given-names>D. H.</given-names></name>, <name><surname>Kim</surname><given-names>H. J.</given-names></name>, <name><surname>Kang</surname><given-names>S. S.</given-names></name>, <name><surname>Cho</surname><given-names>G. J.</given-names></name>, <name><surname>Choi</surname><given-names>W. S.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>The Rho-kinase (ROCK) inhibitor Y-27632 protects against excitotoxicity-induced neuronal death in vivo and in vitro</article-title>. <source/><italic>Neurotox. Res.</italic>
<volume>23</volume>, <fpage>238</fpage>-<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-012-9339-2</pub-id><pub-id pub-id-type="pmid">22810835</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johann</surname><given-names>D. J.</given-names></name>, <name><surname>Rodriguez-Canales</surname><given-names>J.</given-names></name>, <name><surname>Mukherjee</surname><given-names>S.</given-names></name>, <name><surname>Prieto</surname><given-names>D. A.</given-names></name>, <name><surname>Hanson</surname><given-names>J. C.</given-names></name>, <name><surname>Emmert-Buck</surname><given-names>M.</given-names></name> and <name><surname>Blonder</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry</article-title>. <source/><italic>J. Proteome Res.</italic>
<volume>8</volume>, <fpage>2310</fpage>-<lpage>2318</lpage>. <pub-id pub-id-type="doi">10.1021/pr8009403</pub-id><pub-id pub-id-type="pmid">19284784</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>G. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Interleukin-1β induces a reactive astroglial phenotype via deactivation of the Rho GTPase-rock axis</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>24</volume>, <fpage>2837</fpage>-<lpage>2845</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4789-03.2004</pub-id><pub-id pub-id-type="pmid">15028778</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurmeister</surname><given-names>S.</given-names></name>, <name><surname>Baumann</surname><given-names>M.</given-names></name>, <name><surname>Balwierz</surname><given-names>A.</given-names></name>, <name><surname>Keklikoglou</surname><given-names>I.</given-names></name>, <name><surname>Ward</surname><given-names>A.</given-names></name>, <name><surname>Uhlmann</surname><given-names>S.</given-names></name>, <name><surname>Zhang</surname><given-names>J. D.</given-names></name>, <name><surname>Wiemann</surname><given-names>S.</given-names></name> and <name><surname>Sahin</surname><given-names>Ö.</given-names></name></person-group> (<year>2012</year>). <article-title>MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F</article-title>. <source/><italic>Mol. Cell. Biol.</italic>
<volume>32</volume>, <fpage>633</fpage>-<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.06212-11</pub-id><pub-id pub-id-type="pmid">22144583</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanthou</surname><given-names>C.</given-names></name> and <name><surname>Tozer</surname><given-names>G. M.</given-names></name></person-group> (<year>2002</year>). <article-title>The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells</article-title>. <source/><italic>Blood</italic>
<volume>99</volume>, <fpage>2060</fpage>-<lpage>2069</lpage>. <pub-id pub-id-type="doi">10.1182/blood.V99.6.2060</pub-id><pub-id pub-id-type="pmid">11877280</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>K.</given-names></name>, <name><surname>Kano</surname><given-names>Y.</given-names></name>, <name><surname>Amano</surname><given-names>M.</given-names></name>, <name><surname>Onishi</surname><given-names>H.</given-names></name>, <name><surname>Kaibuchi</surname><given-names>K.</given-names></name> and <name><surname>Fujiwara</surname><given-names>K.</given-names></name></person-group> (<year>2001</year>). <article-title>Rho-kinase-mediated contraction of isolated stress fibers</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>153</volume>, <fpage>569</fpage>-<lpage>584</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.153.3.569</pub-id><pub-id pub-id-type="pmid">11331307</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kharait</surname><given-names>S.</given-names></name>, <name><surname>Dhir</surname><given-names>R.</given-names></name>, <name><surname>Lauffenburger</surname><given-names>D.</given-names></name> and <name><surname>Wells</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells</article-title>. <source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>343</volume>, <fpage>848</fpage>-<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.03.044</pub-id><pub-id pub-id-type="pmid">16564022</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuon</surname><given-names>S.</given-names></name>, <name><surname>Liang</surname><given-names>L.</given-names></name>, <name><surname>Dettman</surname><given-names>R. W.</given-names></name>, <name><surname>Sporn</surname><given-names>P. H. S.</given-names></name>, <name><surname>Wysolmerski</surname><given-names>R. B.</given-names></name> and <name><surname>Chew</surname><given-names>T.-L.</given-names></name></person-group> (<year>2010</year>). <article-title>Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>123</volume>, <fpage>431</fpage>-<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.053793</pub-id><pub-id pub-id-type="pmid">20067998</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilinc</surname><given-names>D.</given-names></name>, <name><surname>Blasiak</surname><given-names>A.</given-names></name>, <name><surname>O'Mahony</surname><given-names>J. J.</given-names></name> and <name><surname>Lee</surname><given-names>G. U.</given-names></name></person-group> (<year>2014</year>). <article-title>Low piconewton towing of CNS axons against diffusing and surface-bound repellents requires the inhibition of motor protein-associated pathways</article-title>. <source/><italic>Sci. Rep.</italic>
<volume>4</volume>, <fpage>7128</fpage>
<pub-id pub-id-type="doi">10.1038/srep07128</pub-id><pub-id pub-id-type="pmid">25417891</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.-Y.</given-names></name>, <name><surname>Kovács</surname><given-names>M.</given-names></name>, <name><surname>Kawamoto</surname><given-names>S.</given-names></name>, <name><surname>Sellers</surname><given-names>J. R.</given-names></name> and <name><surname>Adelstein</surname><given-names>R. S.</given-names></name></person-group> (<year>2005</year>). <article-title>Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>280</volume>, <fpage>22769</fpage>-<lpage>22775</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M503488200</pub-id><pub-id pub-id-type="pmid">15845534</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.</given-names></name>, <name><surname>Ossipova</surname><given-names>O.</given-names></name> and <name><surname>Sokol</surname><given-names>S. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Neural crest specification by inhibition of the ROCK/Myosin II pathway</article-title>. <source/><italic>Stem Cells</italic>. <volume>33</volume>, <fpage>674</fpage>-<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1002/stem.1877</pub-id><pub-id pub-id-type="pmid">25346532</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>K.</given-names></name>, <name><surname>Ito</surname><given-names>M.</given-names></name>, <name><surname>Amano</surname><given-names>M.</given-names></name>, <name><surname>Chihara</surname><given-names>K.</given-names></name>, <name><surname>Fukata</surname><given-names>Y.</given-names></name>, <name><surname>Nakafuku</surname><given-names>M.</given-names></name>, <name><surname>Yamamori</surname><given-names>B.</given-names></name>, <name><surname>Feng</surname><given-names>J.</given-names></name>, <name><surname>Nakano</surname><given-names>T.</given-names></name>, <name><surname>Okawa</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>1996</year>). <article-title>Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-Kinase)</article-title>. <source/><italic>Science</italic>
<volume>273</volume>, <fpage>245</fpage>-<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1126/science.273.5272.245</pub-id><pub-id pub-id-type="pmid">8662509</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klemke</surname><given-names>R. L.</given-names></name>, <name><surname>Cai</surname><given-names>S.</given-names></name>, <name><surname>Giannini</surname><given-names>A. L.</given-names></name>, <name><surname>Gallagher</surname><given-names>P. J.</given-names></name>, <name><surname>de Lanerolle</surname><given-names>P.</given-names></name> and <name><surname>Cheresh</surname><given-names>D. A.</given-names></name></person-group> (<year>1997</year>). <article-title>Regulation of cell motility by mitogen-activated protein kinase</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>137</volume>, <fpage>481</fpage>-<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.137.2.481</pub-id><pub-id pub-id-type="pmid">9128257</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolega</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>Cytoplasmic dynamics of myosin IIA and IIB: spatial “sorting” of isoforms in locomoting cells</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>111</volume>, <fpage>2085</fpage>-<lpage>2095</lpage>.<pub-id pub-id-type="pmid">9664030</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolega</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>The role of myosin II motor activity in distributing myosin asymmetrically and coupling protrusive activity to cell translocation</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>17</volume>, <fpage>4435</fpage>-<lpage>4445</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E06-05-0431</pub-id><pub-id pub-id-type="pmid">16855019</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korobova</surname><given-names>F.</given-names></name> and <name><surname>Svitkina</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Molecular architecture of synaptic actin cytoskeleton in hippocampal neurons reveals a mechanism of dendritic spine morphogenesis</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>21</volume>, <fpage>165</fpage>-<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E09-07-0596</pub-id><pub-id pub-id-type="pmid">19889835</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kretschy</surname><given-names>N.</given-names></name>, <name><surname>Teichmann</surname><given-names>M.</given-names></name>, <name><surname>Kopf</surname><given-names>S.</given-names></name>, <name><surname>Atanasov</surname><given-names>A. G.</given-names></name>, <name><surname>Saiko</surname><given-names>P.</given-names></name>, <name><surname>Vonach</surname><given-names>C.</given-names></name>, <name><surname>Viola</surname><given-names>K.</given-names></name>, <name><surname>Giessrigl</surname><given-names>B.</given-names></name>, <name><surname>Huttary</surname><given-names>N.</given-names></name>, <name><surname>Raab</surname><given-names>I.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen</article-title>. <source/><italic>Br. J. Cancer</italic>
<volume>108</volume>, <fpage>570</fpage>-<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1038/bjc.2012.580</pub-id><pub-id pub-id-type="pmid">23299527</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krey</surname><given-names>J. F.</given-names></name>, <name><surname>Paşca</surname><given-names>S. P.</given-names></name>, <name><surname>Shcheglovitov</surname><given-names>A.</given-names></name>, <name><surname>Yazawa</surname><given-names>M.</given-names></name>, <name><surname>Schwemberger</surname><given-names>R.</given-names></name>, <name><surname>Rasmusson</surname><given-names>R.</given-names></name> and <name><surname>Dolmetsch</surname><given-names>R. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons</article-title>. <source/><italic>Nat. Neurosci.</italic>
<volume>16</volume>, <fpage>201</fpage>-<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3307</pub-id><pub-id pub-id-type="pmid">23313911</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>T.</given-names></name>, <name><surname>Endo</surname><given-names>M.</given-names></name>, <name><surname>Hata</surname><given-names>K.</given-names></name>, <name><surname>Taniguchi</surname><given-names>J.</given-names></name>, <name><surname>Kitajo</surname><given-names>K.</given-names></name>, <name><surname>Tomura</surname><given-names>S.</given-names></name>, <name><surname>Yamaguchi</surname><given-names>A.</given-names></name>, <name><surname>Mueller</surname><given-names>B. K.</given-names></name> and <name><surname>Yamashita</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Myosin IIA is required for neurite outgrowth inhibition produced by repulsive guidance molecule</article-title>. <source/><italic>J. Neurochem.</italic>
<volume>105</volume>, <fpage>113</fpage>-<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.05125.x</pub-id><pub-id pub-id-type="pmid">18005226</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landais</surname><given-names>S.</given-names></name>, <name><surname>Landry</surname><given-names>S.</given-names></name>, <name><surname>Legault</surname><given-names>P.</given-names></name> and <name><surname>Rassart</surname><given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia</article-title>. <source/><italic>Cancer Res.</italic>
<volume>67</volume>, <fpage>5699</fpage>-<lpage>5707</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-4478</pub-id><pub-id pub-id-type="pmid">17575136</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>C. L.</given-names></name>, <name><surname>O'Shea</surname><given-names>R. D.</given-names></name>, <name><surname>Broberg</surname><given-names>B. V.</given-names></name>, <name><surname>Bischof</surname><given-names>L.</given-names></name> and <name><surname>Beart</surname><given-names>P. M.</given-names></name></person-group> (<year>2011</year>). <article-title>The Rho kinase inhibitor Fasudil up-regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes</article-title>. <source/><italic>Br. J. Pharmacol.</italic>
<volume>163</volume>, <fpage>533</fpage>-<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01259.x</pub-id><pub-id pub-id-type="pmid">21309758</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>C. L.</given-names></name>, <name><surname>Perreau</surname><given-names>V. M.</given-names></name>, <name><surname>Chen</surname><given-names>M. J.</given-names></name>, <name><surname>Cate</surname><given-names>H. S.</given-names></name>, <name><surname>Merlo</surname><given-names>D.</given-names></name>, <name><surname>Cheung</surname><given-names>N. S.</given-names></name>, <name><surname>O'Shea</surname><given-names>R. D.</given-names></name> and <name><surname>Beart</surname><given-names>P. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor fasudil reveals cytoskeletal and pro-survival responses</article-title>. <source/><italic>J. Cell. Physiol.</italic>
<volume>227</volume>, <fpage>1199</fpage>-<lpage>1211</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.22838</pub-id><pub-id pub-id-type="pmid">21604263</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name>, <name><surname>Andreeva</surname><given-names>A.</given-names></name>, <name><surname>Sipe</surname><given-names>C. W.</given-names></name>, <name><surname>Liu</surname><given-names>L.</given-names></name>, <name><surname>Cheng</surname><given-names>A.</given-names></name> and <name><surname>Lu</surname><given-names>X.</given-names></name></person-group> (<year>2012</year>). <article-title>PTK7 regulates myosin II activity to orient planar polarity in the mammalian auditory epithelium</article-title>. <source/><italic>Curr. Biol.</italic>
<volume>22</volume>, <fpage>956</fpage>-<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2012.03.068</pub-id><pub-id pub-id-type="pmid">22560610</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>S.</given-names></name>, <name><surname>Czerwinska</surname><given-names>E.</given-names></name>, <name><surname>Czerwinski</surname><given-names>W.</given-names></name>, <name><surname>Walsh</surname><given-names>M. P.</given-names></name> and <name><surname>MacDonald</surname><given-names>J. F.</given-names></name></person-group> (<year>2001</year>). <article-title>Regulation of NMDA receptor activity by F-actin and myosin light chain kinase</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>21</volume>, <fpage>8464</fpage>-<lpage>8472</lpage>.<pub-id pub-id-type="pmid">11606635</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F.</given-names></name> and <name><surname>Zhu</surname><given-names>Y.-T.</given-names></name></person-group> (<year>2015</year>). <article-title>HGF-activated colonic fibroblasts mediates carcinogenesis of colonic epithelial cancer cells via PKC-cMET-ERK1/2-COX-2 signaling</article-title>. <source/><italic>Cell. Signal.</italic>
<volume>27</volume>, <fpage>860</fpage>-<lpage>866</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2015.01.014</pub-id><pub-id pub-id-type="pmid">25643632</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name>, <name><surname>Liu</surname><given-names>Y.-H.</given-names></name>, <name><surname>Liu</surname><given-names>X.-B.</given-names></name>, <name><surname>Xue</surname><given-names>Y.-X.</given-names></name>, <name><surname>Wang</surname><given-names>P.</given-names></name> and <name><surname>Liu</surname><given-names>L.-B.</given-names></name></person-group> (<year>2015a</year>). <article-title>Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood–tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism</article-title>. <source/><italic>Exp. Cell Res.</italic>
<volume>331</volume>, <fpage>257</fpage>-<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2014.12.021</pub-id><pub-id pub-id-type="pmid">25592443</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name>, <name><surname>Cai</surname><given-names>T.</given-names></name>, <name><surname>Jiang</surname><given-names>Y.</given-names></name>, <name><surname>Chen</surname><given-names>H.</given-names></name>, <name><surname>He</surname><given-names>X.</given-names></name>, <name><surname>Chen</surname><given-names>C.</given-names></name>, <name><surname>Li</surname><given-names>X.</given-names></name>, <name><surname>Shao</surname><given-names>Q.</given-names></name>, <name><surname>Ran</surname><given-names>X.</given-names></name>, <name><surname>Li</surname><given-names>Z.</given-names></name><etal>et al.</etal></person-group> (<year>2015b</year>). <article-title>Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database</article-title>. <source/><italic>Mol. Psychiatry</italic> [<comment>Epub ahead of print</comment>] <pub-id pub-id-type="doi">10.1038/mp.2015.40</pub-id>.</mixed-citation>
</ref>
<ref id="DMM022103C134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>M.-H.</given-names></name>, <name><surname>Shih</surname><given-names>C.-C.</given-names></name>, <name><surname>Tsao</surname><given-names>C.-M.</given-names></name>, <name><surname>Chen</surname><given-names>S.-J.</given-names></name> and <name><surname>Wu</surname><given-names>C.-C.</given-names></name></person-group> (<year>2013</year>). <article-title>RhoA/Rho-kinase and nitric oxide in vascular reactivity in rats with endotoxaemia</article-title>. <source/><italic>PLoS ONE</italic>
<volume>8</volume>, <fpage>e56331</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0056331</pub-id><pub-id pub-id-type="pmid">23457552</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lienkamp</surname><given-names>S. S.</given-names></name>, <name><surname>Liu</surname><given-names>K.</given-names></name>, <name><surname>Karner</surname><given-names>C. M.</given-names></name>, <name><surname>Carroll</surname><given-names>T. J.</given-names></name>, <name><surname>Ronneberger</surname><given-names>O.</given-names></name>, <name><surname>Wallingford</surname><given-names>J. B.</given-names></name> and <name><surname>Walz</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Vertebrate kidney tubules elongate using a planar cell polarity-dependent, rosette-based mechanism of convergent extension</article-title>. <source/><italic>Nat. Genet.</italic>
<volume>44</volume>, <fpage>1382</fpage>-<lpage>1387</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2452</pub-id><pub-id pub-id-type="pmid">23143599</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name>, <name><surname>Goldstein</surname><given-names>R. H.</given-names></name>, <name><surname>Scepansky</surname><given-names>E. M.</given-names></name> and <name><surname>Rosenblatt</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Inhibition of Rho-associated kinase signaling prevents breast cancer metastasis to human bone</article-title>. <source/><italic>Cancer Res.</italic>
<volume>69</volume>, <fpage>8742</fpage>-<lpage>8751</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-1541</pub-id><pub-id pub-id-type="pmid">19887617</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M.</given-names></name>, <name><surname>Lang</surname><given-names>N.</given-names></name>, <name><surname>Qiu</surname><given-names>M.</given-names></name>, <name><surname>Xu</surname><given-names>F.</given-names></name>, <name><surname>Li</surname><given-names>Q.</given-names></name>, <name><surname>Tang</surname><given-names>Q.</given-names></name>, <name><surname>Chen</surname><given-names>J.</given-names></name>, <name><surname>Chen</surname><given-names>X.</given-names></name>, <name><surname>Zhang</surname><given-names>S.</given-names></name>, <name><surname>Liu</surname><given-names>Z.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells</article-title>. <source/><italic>Int. J. Cancer</italic>
<volume>128</volume>, <fpage>1269</fpage>-<lpage>1279</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.25452</pub-id><pub-id pub-id-type="pmid">20473940</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name>, <name><surname>Gritz</surname><given-names>D.</given-names></name> and <name><surname>Parent</surname><given-names>C. A.</given-names></name></person-group> (<year>2014</year>). <article-title>PKCβII acts downstream of chemoattractant receptors and mTORC2 to regulate cAMP production and myosin II activity in neutrophils</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>25</volume>, <fpage>1446</fpage>-<lpage>1457</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E14-01-0037</pub-id><pub-id pub-id-type="pmid">24600048</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name>, <name><surname>Ji</surname><given-names>Q.</given-names></name>, <name><surname>Ye</surname><given-names>N.</given-names></name>, <name><surname>Sui</surname><given-names>H.</given-names></name>, <name><surname>Zhou</surname><given-names>L.</given-names></name>, <name><surname>Zhu</surname><given-names>H.</given-names></name>, <name><surname>Fan</surname><given-names>Z.</given-names></name>, <name><surname>Cai</surname><given-names>J.</given-names></name> and <name><surname>Li</surname><given-names>Q.</given-names></name></person-group> (<year>2015</year>). <article-title>Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway</article-title>. <source/><italic>PLoS ONE</italic>
<volume>10</volume>, <fpage>e0123478</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0123478</pub-id><pub-id pub-id-type="pmid">25954974</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>W.-Y.</given-names></name>, <name><surname>Tsai</surname><given-names>M.-H.</given-names></name>, <name><surname>Tsai</surname><given-names>Y.</given-names></name>, <name><surname>Hua</surname><given-names>C.-H.</given-names></name>, <name><surname>Tsai</surname><given-names>F.-J.</given-names></name>, <name><surname>Huang</surname><given-names>S.-Y.</given-names></name>, <name><surname>Tsai</surname><given-names>C.-H.</given-names></name> and <name><surname>Lai</surname><given-names>C.-C.</given-names></name></person-group> (<year>2007</year>). <article-title>Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis</article-title>. <source/><italic>Clin. Chim. Acta</italic>
<volume>376</volume>, <fpage>101</fpage>-<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2006.06.030</pub-id><pub-id pub-id-type="pmid">16889763</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzon</surname><given-names>P.</given-names></name>, <name><surname>Vecile</surname><given-names>E.</given-names></name>, <name><surname>Nardon</surname><given-names>E.</given-names></name>, <name><surname>Ferrero</surname><given-names>E.</given-names></name>, <name><surname>Harlan</surname><given-names>J. M.</given-names></name>, <name><surname>Tedesco</surname><given-names>F.</given-names></name> and <name><surname>Dobrina</surname><given-names>A.</given-names></name></person-group> (<year>1998</year>). <article-title>Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>142</volume>, <fpage>1381</fpage>-<lpage>1391</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.142.5.1381</pub-id><pub-id pub-id-type="pmid">9732297</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loudon</surname><given-names>R. P.</given-names></name>, <name><surname>Silver</surname><given-names>L. D.</given-names></name>, <name><surname>Yee</surname><given-names>H. F.</given-names></name> and <name><surname>Gallo</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>RhoA-kinase and myosin II are required for the maintenance of growth cone polarity and guidance by nerve growth factor</article-title>. <source/><italic>J. Neurobiol.</italic>
<volume>66</volume>, <fpage>847</fpage>-<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1002/neu.20258</pub-id><pub-id pub-id-type="pmid">16673385</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H.-E.</given-names></name>, <name><surname>Yang</surname><given-names>Y.-C.</given-names></name>, <name><surname>Chen</surname><given-names>S.-M.</given-names></name>, <name><surname>Su</surname><given-names>H.-L.</given-names></name>, <name><surname>Huang</surname><given-names>P.-C.</given-names></name>, <name><surname>Tsai</surname><given-names>M.-S.</given-names></name>, <name><surname>Wang</surname><given-names>T.-H.</given-names></name>, <name><surname>Tseng</surname><given-names>C.-P.</given-names></name> and <name><surname>Hwang</surname><given-names>S.-M.</given-names></name></person-group> (<year>2013</year>). <article-title>Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells</article-title>. <source/><italic>Exp. Cell Res.</italic>
<volume>319</volume>, <fpage>498</fpage>-<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2012.09.017</pub-id><pub-id pub-id-type="pmid">23041301</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>G.</given-names></name>, <name><surname>Rex</surname><given-names>C. S.</given-names></name> and <name><surname>Gall</surname><given-names>C. M.</given-names></name></person-group> (<year>2007</year>). <article-title>LTP consolidation: substrates, explanatory power, and functional significance</article-title>. <source/><italic>Neuropharmacology</italic>
<volume>52</volume>, <fpage>12</fpage>-<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2006.07.027</pub-id><pub-id pub-id-type="pmid">16949110</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>J.</given-names></name>, <name><surname>Fay</surname><given-names>J.</given-names></name>, <name><surname>Meehan</surname><given-names>M.</given-names></name>, <name><surname>Bryan</surname><given-names>K.</given-names></name>, <name><surname>Watters</surname><given-names>K. M.</given-names></name>, <name><surname>Murphy</surname><given-names>D. M.</given-names></name> and <name><surname>Stallings</surname><given-names>R. L.</given-names></name></person-group> (<year>2012</year>). <article-title>MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway</article-title>. <source/><italic>Carcinogenesis</italic>
<volume>33</volume>, <fpage>976</fpage>-<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgs114</pub-id><pub-id pub-id-type="pmid">22382496</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.</given-names></name> and <name><surname>Adelstein</surname><given-names>R. S.</given-names></name></person-group> (<year>2012</year>). <article-title>In vivo studies on nonmuscle myosin II expression and function in heart development</article-title>. <source/><italic>Front. Biosci.</italic>
<volume>17</volume>, <fpage>545</fpage>-<lpage>555</lpage>. <pub-id pub-id-type="doi">10.2741/3942</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.</given-names></name> and <name><surname>Adelstein</surname><given-names>R. S.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of vertebrate nonmuscle Myosin II in development and human disease</article-title>. <source/><italic>Bioarchitecture</italic>
<volume>4</volume>, <fpage>88</fpage>-<lpage>102</lpage>. <pub-id pub-id-type="doi">10.4161/bioa.29766</pub-id><pub-id pub-id-type="pmid">25098841</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>J.</given-names></name>, <name><surname>Hirano</surname><given-names>T.</given-names></name>, <name><surname>Ogiwara</surname><given-names>A.</given-names></name>, <name><surname>Akimoto</surname><given-names>S.</given-names></name>, <name><surname>Kawakami</surname><given-names>T.</given-names></name>, <name><surname>Fukui</surname><given-names>Y.</given-names></name>, <name><surname>Oka</surname><given-names>T.</given-names></name>, <name><surname>Gong</surname><given-names>Y.</given-names></name>, <name><surname>Guo</surname><given-names>R.</given-names></name>, <name><surname>Inada</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy</article-title>. <source/><italic>Br. J. Cancer</italic>
<volume>98</volume>, <fpage>596</fpage>-<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjc.6604197</pub-id><pub-id pub-id-type="pmid">18212748</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandruzzato</surname><given-names>S.</given-names></name>, <name><surname>Callegaro</surname><given-names>A.</given-names></name>, <name><surname>Turcatel</surname><given-names>G.</given-names></name>, <name><surname>Francescato</surname><given-names>S.</given-names></name>, <name><surname>Montesco</surname><given-names>M. C.</given-names></name>, <name><surname>Chiarion-Sileni</surname><given-names>V.</given-names></name>, <name><surname>Mocellin</surname><given-names>S.</given-names></name>, <name><surname>Rossi</surname><given-names>C. R.</given-names></name>, <name><surname>Bicciato</surname><given-names>S.</given-names></name>, <name><surname>Wang</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2006</year>). <article-title>A gene expression signature associated with survival in metastatic melanoma</article-title>. <source/><italic>J. Transl. Med.</italic>
<volume>4</volume>, <fpage>50</fpage>
<pub-id pub-id-type="doi">10.1186/1479-5876-4-50</pub-id><pub-id pub-id-type="pmid">17129373</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manes</surname><given-names>T. D.</given-names></name> and <name><surname>Pober</surname><given-names>J. S.</given-names></name></person-group> (<year>2013</year>). <article-title>TCR-driven transendothelial migration of human effector memory CD4T cells involves Vav, Rac, and myosin IIA</article-title>. <source/><italic>J. Immunol.</italic>
<volume>190</volume>, <fpage>3079</fpage>-<lpage>3088</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1201817</pub-id><pub-id pub-id-type="pmid">23420881</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marigo</surname><given-names>V.</given-names></name>, <name><surname>Nigro</surname><given-names>A.</given-names></name>, <name><surname>Pecci</surname><given-names>A.</given-names></name>, <name><surname>Montanaro</surname><given-names>D.</given-names></name>, <name><surname>Di Stazio</surname><given-names>M.</given-names></name>, <name><surname>Balduini</surname><given-names>C. L.</given-names></name> and <name><surname>Savoia</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains</article-title>. <source/><italic>Genomics</italic>
<volume>83</volume>, <fpage>1125</fpage>-<lpage>1133</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2003.12.012</pub-id><pub-id pub-id-type="pmid">15177565</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrs</surname><given-names>G. S.</given-names></name>, <name><surname>Green</surname><given-names>S. H.</given-names></name> and <name><surname>Dailey</surname><given-names>M. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Rapid formation and remodeling of postsynaptic densities in developing dendrites</article-title>. <source/><italic>Nat. Neurosci.</italic>
<volume>4</volume>, <fpage>1006</fpage>-<lpage>1013</lpage>. <pub-id pub-id-type="doi">10.1038/nn717</pub-id><pub-id pub-id-type="pmid">11574832</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathieu</surname><given-names>J.</given-names></name> and <name><surname>Ruohola-Baker</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Regulation of stem cell populations by microRNAs</article-title>. <source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>786</volume>, <fpage>329</fpage>-<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1007/978-94-007-6621-1_18</pub-id><pub-id pub-id-type="pmid">23696365</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>D.</given-names></name> and <name><surname>Malik</surname><given-names>A. B.</given-names></name></person-group> (<year>2006</year>). <article-title>Signaling mechanisms regulating endothelial permeability</article-title>. <source/><italic>Physiol. Rev.</italic>
<volume>86</volume>, <fpage>279</fpage>-<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00012.2005</pub-id><pub-id pub-id-type="pmid">16371600</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melendez-Vasquez</surname><given-names>C. V.</given-names></name>, <name><surname>Einheber</surname><given-names>S.</given-names></name> and <name><surname>Salzer</surname><given-names>J. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Rho kinase regulates schwann cell myelination and formation of associated axonal domains</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>24</volume>, <fpage>3953</fpage>-<lpage>3963</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4920-03.2004</pub-id><pub-id pub-id-type="pmid">15102911</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meshel</surname><given-names>A. S.</given-names></name>, <name><surname>Wei</surname><given-names>Q.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name> and <name><surname>Sheetz</surname><given-names>M. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Basic mechanism of three-dimensional collagen fibre transport by fibroblasts</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>7</volume>, <fpage>157</fpage>-<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1216</pub-id><pub-id pub-id-type="pmid">15654332</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikulich</surname><given-names>A.</given-names></name>, <name><surname>Kavaliauskiene</surname><given-names>S.</given-names></name> and <name><surname>Juzenas</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue light</article-title>. <source/><italic>Biochim. Biophys. Acta</italic>
<volume>1820</volume>, <fpage>870</fpage>-<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2012.04.003</pub-id><pub-id pub-id-type="pmid">22507270</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>J. C.</given-names></name></person-group> (<year>1998</year>). <article-title>Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>140</volume>, <fpage>627</fpage>-<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.140.3.627</pub-id><pub-id pub-id-type="pmid">9456322</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minamiya</surname><given-names>Y.</given-names></name>, <name><surname>Nakagawa</surname><given-names>T.</given-names></name>, <name><surname>Saito</surname><given-names>H.</given-names></name>, <name><surname>Matsuzaki</surname><given-names>I.</given-names></name>, <name><surname>Taguchi</surname><given-names>K.</given-names></name>, <name><surname>Ito</surname><given-names>M.</given-names></name> and <name><surname>Ogawa</surname><given-names>J.-I.</given-names></name></person-group> (<year>2005</year>). <article-title>Increased expression of myosin light chain kinase mRNA is related to metastasis in non-small cell lung cancer</article-title>. <source/><italic>Tumour Biol.</italic>
<volume>26</volume>, <fpage>153</fpage>-<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1159/000086487</pub-id><pub-id pub-id-type="pmid">15970650</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name>, <name><surname>Kohli</surname><given-names>S.</given-names></name>, <name><surname>Dua</surname><given-names>S.</given-names></name>, <name><surname>Thinlas</surname><given-names>T.</given-names></name>, <name><surname>Mohammad</surname><given-names>G.</given-names></name> and <name><surname>Pasha</surname><given-names>M. A. Q.</given-names></name></person-group> (<year>2015</year>). <article-title>Genetic differences and aberrant methylation in the apelin system predict the risk of high-altitude pulmonary edema</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>112</volume>, <fpage>6134</fpage>-<lpage>6139</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1422759112</pub-id><pub-id pub-id-type="pmid">25918383</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>K.</given-names></name>, <name><surname>Kurihara</surname><given-names>H.</given-names></name>, <name><surname>Horita</surname><given-names>S.</given-names></name>, <name><surname>Chikamoto</surname><given-names>H.</given-names></name>, <name><surname>Hattori</surname><given-names>M.</given-names></name>, <name><surname>Harita</surname><given-names>Y.</given-names></name>, <name><surname>Tsurumi</surname><given-names>H.</given-names></name>, <name><surname>Kajiho</surname><given-names>Y.</given-names></name>, <name><surname>Sawada</surname><given-names>Y.</given-names></name>, <name><surname>Sasaki</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis</article-title>. <source/><italic>Nephrol. Dial. Transplant</italic>
<volume>28</volume>, <fpage>2993</fpage>-<lpage>3003</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/gft350</pub-id><pub-id pub-id-type="pmid">24042022</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monnier</surname><given-names>P. P.</given-names></name>, <name><surname>Sierra</surname><given-names>A.</given-names></name>, <name><surname>Schwab</surname><given-names>J. M.</given-names></name>, <name><surname>Henke-Fahle</surname><given-names>S.</given-names></name> and <name><surname>Mueller</surname><given-names>B. K.</given-names></name></person-group> (<year>2003</year>). <article-title>The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar</article-title>. <source/><italic>Mol. Cell. Neurosci.</italic>
<volume>22</volume>, <fpage>319</fpage>-<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/S1044-7431(02)00035-0</pub-id><pub-id pub-id-type="pmid">12691734</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>C. S.</given-names></name>, <name><surname>Rao</surname><given-names>V. T. S.</given-names></name>, <name><surname>Durafourt</surname><given-names>B. A.</given-names></name>, <name><surname>Bedell</surname><given-names>B. J.</given-names></name>, <name><surname>Ludwin</surname><given-names>S. K.</given-names></name>, <name><surname>Bar-Or</surname><given-names>A.</given-names></name> and <name><surname>Antel</surname><given-names>J. P.</given-names></name></person-group> (<year>2013</year>). <article-title>miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization</article-title>. <source/><italic>Ann. Neurol.</italic>
<volume>74</volume>, <fpage>709</fpage>-<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1002/ana.23967</pub-id><pub-id pub-id-type="pmid">23818336</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>M.</given-names></name> and <name><surname>Fifková</surname><given-names>E.</given-names></name></person-group> (<year>1989</year>). <article-title>In situ localization of myosin and actin in dendritic spines with the immunogold technique</article-title>. <source/><italic>J. Comp. Neurol.</italic>
<volume>279</volume>, <fpage>666</fpage>-<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1002/cne.902790412</pub-id><pub-id pub-id-type="pmid">2918091</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>B. K.</given-names></name>, <name><surname>Mack</surname><given-names>H.</given-names></name> and <name><surname>Teusch</surname><given-names>N.</given-names></name></person-group> (<year>2005</year>). <article-title>Rho kinase, a promising drug target for neurological disorders</article-title>. <source/><italic>Nat. Rev. Drug Discov.</italic>
<volume>4</volume>, <fpage>387</fpage>-<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1038/nrd1719</pub-id><pub-id pub-id-type="pmid">15864268</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>W. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Mechanisms of leukocyte transendothelial migration</article-title>. <source/><italic>Annu. Rev. Pathol.</italic>
<volume>6</volume>, <fpage>323</fpage>-<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathol-011110-130224</pub-id><pub-id pub-id-type="pmid">21073340</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mundalil Vasu</surname><given-names>M.</given-names></name>, <name><surname>Anitha</surname><given-names>A.</given-names></name>, <name><surname>Thanseem</surname><given-names>I.</given-names></name>, <name><surname>Suzuki</surname><given-names>K.</given-names></name>, <name><surname>Yamada</surname><given-names>K.</given-names></name>, <name><surname>Takahashi</surname><given-names>T.</given-names></name>, <name><surname>Wakuda</surname><given-names>T.</given-names></name>, <name><surname>Iwata</surname><given-names>K.</given-names></name>, <name><surname>Tsujii</surname><given-names>M.</given-names></name>, <name><surname>Sugiyama</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Serum microRNA profiles in children with autism</article-title>. <source/><italic>Mol. Autism</italic>
<volume>5</volume>, <fpage>40</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-5-40</pub-id><pub-id pub-id-type="pmid">25126405</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murata-Hori</surname><given-names>M.</given-names></name>, <name><surname>Suizu</surname><given-names>F.</given-names></name>, <name><surname>Iwasaki</surname><given-names>T.</given-names></name>, <name><surname>Kikuchi</surname><given-names>A.</given-names></name> and <name><surname>Hosoya</surname><given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>ZIP kinase identified as a novel myosin regulatory light chain kinase in HeLa cells</article-title>. <source/><italic>FEBS Lett.</italic>
<volume>451</volume>, <fpage>81</fpage>-<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(99)00550-5</pub-id><pub-id pub-id-type="pmid">10356987</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murk</surname><given-names>K.</given-names></name>, <name><surname>Blanco Suarez</surname><given-names>E. M.</given-names></name>, <name><surname>Cockbill</surname><given-names>L. M. R.</given-names></name>, <name><surname>Banks</surname><given-names>P.</given-names></name> and <name><surname>Hanley</surname><given-names>J. G.</given-names></name></person-group> (<year>2013</year>). <article-title>The antagonistic modulation of Arp2/3 activity by N-WASP, WAVE2 and PICK1 defines dynamic changes in astrocyte morphology</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>126</volume>, <fpage>3873</fpage>-<lpage>3883</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.125146</pub-id><pub-id pub-id-type="pmid">23843614</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>W. L.</given-names></name>, <name><surname>McDevitt</surname><given-names>T. C.</given-names></name> and <name><surname>Engler</surname><given-names>A. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Materials as stem cell regulators</article-title>. <source/><italic>Nat. Mater.</italic>
<volume>13</volume>, <fpage>547</fpage>-<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1038/nmat3937</pub-id><pub-id pub-id-type="pmid">24845994</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>A.</given-names></name>, <name><surname>Naeem</surname><given-names>A.</given-names></name>, <name><surname>Barnes</surname><given-names>S. H.</given-names></name>, <name><surname>Drescher</surname><given-names>U.</given-names></name> and <name><surname>Guthrie</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Slit and Netrin-1 guide cranial motor axon pathfinding via Rho-kinase, myosin light chain kinase and myosin II</article-title>. <source/><italic>Neural Dev.</italic>
<volume>5</volume>, <fpage>16</fpage>
<pub-id pub-id-type="doi">10.1186/1749-8104-5-16</pub-id><pub-id pub-id-type="pmid">20569485</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musah</surname><given-names>S.</given-names></name>, <name><surname>Wrighton</surname><given-names>P. J.</given-names></name>, <name><surname>Zaltsman</surname><given-names>Y.</given-names></name>, <name><surname>Zhong</surname><given-names>X.</given-names></name>, <name><surname>Zorn</surname><given-names>S.</given-names></name>, <name><surname>Parlato</surname><given-names>M. B.</given-names></name>, <name><surname>Hsiao</surname><given-names>C.</given-names></name>, <name><surname>Palecek</surname><given-names>S. P.</given-names></name>, <name><surname>Chang</surname><given-names>Q.</given-names></name>, <name><surname>Murphy</surname><given-names>W. L.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>111</volume>, <fpage>13805</fpage>-<lpage>13810</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1415330111</pub-id><pub-id pub-id-type="pmid">25201954</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>K. A.</given-names></name>, <name><surname>Tint</surname><given-names>I.</given-names></name>, <name><surname>Nadar</surname><given-names>C. V.</given-names></name>, <name><surname>He</surname><given-names>Y.</given-names></name>, <name><surname>Black</surname><given-names>M. M.</given-names></name> and <name><surname>Baas</surname><given-names>P. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Antagonistic forces generated by cytoplasmic dynein and myosin-II during growth cone turning and axonal retraction</article-title>. <source/><italic>Traffic</italic>
<volume>7</volume>, <fpage>1333</fpage>-<lpage>1351</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0854.2006.00476.x</pub-id><pub-id pub-id-type="pmid">16911591</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadif Kasri</surname><given-names>N.</given-names></name> and <name><surname>Van Aelst</surname><given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Rho-linked genes and neurological disorders</article-title>. <source/><italic>Pflugers Arch.</italic>
<volume>455</volume>, <fpage>787</fpage>-<lpage>797</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-007-0385-1</pub-id><pub-id pub-id-type="pmid">18004590</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadif Kasri</surname><given-names>N.</given-names></name>, <name><surname>Nakano-Kobayashi</surname><given-names>A.</given-names></name>, <name><surname>Malinow</surname><given-names>R.</given-names></name>, <name><surname>Li</surname><given-names>B.</given-names></name> and <name><surname>Van Aelst</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors</article-title>. <source/><italic>Genes Dev.</italic>
<volume>23</volume>, <fpage>1289</fpage>-<lpage>1302</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1783809</pub-id><pub-id pub-id-type="pmid">19487570</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>T.</given-names></name> and <name><surname>Kaneko</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>SLC1 glutamate transporters and diseases: psychiatric diseases and pathological pain</article-title>. <source/><italic>Curr. Mol. Pharmacol.</italic>
<volume>6</volume>, <fpage>66</fpage>-<lpage>73</lpage>. <pub-id pub-id-type="doi">10.2174/18744672113069990033</pub-id><pub-id pub-id-type="pmid">23876150</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>M.</given-names></name>, <name><surname>Adachi</surname><given-names>S.</given-names></name>, <name><surname>Yasuda</surname><given-names>I.</given-names></name>, <name><surname>Yamauchi</surname><given-names>T.</given-names></name>, <name><surname>Kawaguchi</surname><given-names>J.</given-names></name>, <name><surname>Hanamatsu</surname><given-names>T.</given-names></name>, <name><surname>Yoshioka</surname><given-names>T.</given-names></name>, <name><surname>Okano</surname><given-names>Y.</given-names></name>, <name><surname>Hirose</surname><given-names>Y.</given-names></name>, <name><surname>Kozawa</surname><given-names>O.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells</article-title>. <source/><italic>Mol. Cancer</italic>
<volume>10</volume>, <fpage>79</fpage>
<pub-id pub-id-type="doi">10.1186/1476-4598-10-79</pub-id><pub-id pub-id-type="pmid">21722395</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>P.</given-names></name>, <name><surname>Zweifel</surname><given-names>M.</given-names></name>, <name><surname>Padhani</surname><given-names>A. R.</given-names></name>, <name><surname>Koh</surname><given-names>D.-M.</given-names></name>, <name><surname>Ng</surname><given-names>M.</given-names></name>, <name><surname>Collins</surname><given-names>D. J.</given-names></name>, <name><surname>Harris</surname><given-names>A.</given-names></name>, <name><surname>Carden</surname><given-names>C.</given-names></name>, <name><surname>Smythe</surname><given-names>J.</given-names></name>, <name><surname>Fisher</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer</article-title>. <source/><italic>Clin. Cancer Res.</italic>
<volume>18</volume>, <fpage>3428</fpage>-<lpage>3439</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-3376</pub-id><pub-id pub-id-type="pmid">22645052</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newell-Litwa</surname><given-names>K. A.</given-names></name>, <name><surname>Badoual</surname><given-names>M.</given-names></name>, <name><surname>Asmussen</surname><given-names>H.</given-names></name>, <name><surname>Patel</surname><given-names>H.</given-names></name>, <name><surname>Whitmore</surname><given-names>L.</given-names></name> and <name><surname>Horwitz</surname><given-names>A. R.</given-names></name></person-group> (<year>2015</year>). <article-title>ROCK1 and 2 differentially regulate actomyosin organization to drive cell and synaptic polarity</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>210</volume>, <fpage>225</fpage>-<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201504046</pub-id><pub-id pub-id-type="pmid">26169356</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>M. R.</given-names></name>, <name><surname>Besser</surname><given-names>A.</given-names></name>, <name><surname>Danuser</surname><given-names>G.</given-names></name> and <name><surname>Brugge</surname><given-names>J. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Substrate stiffness regulates cadherin-dependent collective migration through myosin-II contractility</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>199</volume>, <fpage>545</fpage>-<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201207148</pub-id><pub-id pub-id-type="pmid">23091067</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>T. O.</given-names></name>, <name><surname>West</surname><given-names>R. B.</given-names></name>, <name><surname>Linn</surname><given-names>S. C.</given-names></name>, <name><surname>Alter</surname><given-names>O.</given-names></name>, <name><surname>Knowling</surname><given-names>M. A.</given-names></name>, <name><surname>O'Connell</surname><given-names>J. X.</given-names></name>, <name><surname>Zhu</surname><given-names>S.</given-names></name>, <name><surname>Fero</surname><given-names>M.</given-names></name>, <name><surname>Sherlock</surname><given-names>G.</given-names></name>, <name><surname>Pollack</surname><given-names>J. R.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>). <article-title>Molecular characterisation of soft tissue tumours: a gene expression study</article-title>. <source/><italic>Lancet</italic>
<volume>359</volume>, <fpage>1301</fpage>-<lpage>1307</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(02)08270-3</pub-id><pub-id pub-id-type="pmid">11965276</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikol</surname><given-names>S.</given-names></name>, <name><surname>Murakami</surname><given-names>N.</given-names></name>, <name><surname>Pickering</surname><given-names>J. G.</given-names></name>, <name><surname>Kearney</surname><given-names>M.</given-names></name>, <name><surname>Leclerc</surname><given-names>G.</given-names></name>, <name><surname>Höfling</surname><given-names>B.</given-names></name>, <name><surname>Isner</surname><given-names>J. M.</given-names></name> and <name><surname>Weir</surname><given-names>L.</given-names></name></person-group> (<year>1997</year>). <article-title>Differential expression of nonmuscle myosin II isoforms in human atherosclerotic plaque</article-title>. <source/><italic>Atherosclerosis</italic>
<volume>130</volume>, <fpage>71</fpage>-<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9150(96)06047-9</pub-id><pub-id pub-id-type="pmid">9126650</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>K.</given-names></name>, <name><surname>Tanaka</surname><given-names>T.</given-names></name>, <name><surname>Tsunoda</surname><given-names>T.</given-names></name>, <name><surname>Kitahara</surname><given-names>O.</given-names></name>, <name><surname>Kihara</surname><given-names>C.</given-names></name>, <name><surname>Okamoto</surname><given-names>A.</given-names></name>, <name><surname>Ochiai</surname><given-names>K.</given-names></name>, <name><surname>Takagi</surname><given-names>T.</given-names></name> and <name><surname>Nakamura</surname><given-names>Y.</given-names></name></person-group> (<year>2000</year>). <article-title>Identification by cDNA microarray of genes involved in ovarian carcinogenesis</article-title>. <source/><italic>Cancer Res.</italic>
<volume>60</volume>, <fpage>5007</fpage>-<lpage>5011</lpage>.<pub-id pub-id-type="pmid">11016619</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>G.</given-names></name>, <name><surname>Stuurman</surname><given-names>N.</given-names></name>, <name><surname>D'Ambrosio</surname><given-names>M.</given-names></name> and <name><surname>Vale</surname><given-names>R. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Polarized myosin produces unequal-size daughters during asymmetric cell division</article-title>. <source/><italic>Science</italic>
<volume>330</volume>, <fpage>677</fpage>-<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1126/science.1196112</pub-id><pub-id pub-id-type="pmid">20929735</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>P.</given-names></name>, <name><surname>Shen</surname><given-names>M.</given-names></name>, <name><surname>Yu</surname><given-names>H.</given-names></name>, <name><surname>Li</surname><given-names>Y.</given-names></name>, <name><surname>Li</surname><given-names>D.</given-names></name> and <name><surname>Hou</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Advances in the development of Rho-associated protein kinase (ROCK) inhibitors</article-title>. <source/><italic>Drug Discov. Today</italic>
<volume>18</volume>, <fpage>1323</fpage>-<lpage>1333</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2013.09.010</pub-id><pub-id pub-id-type="pmid">24076262</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parisi</surname><given-names>C.</given-names></name>, <name><surname>Arisi</surname><given-names>I.</given-names></name>, <name><surname>D'Ambrosi</surname><given-names>N.</given-names></name>, <name><surname>Storti</surname><given-names>A. E.</given-names></name>, <name><surname>Brandi</surname><given-names>R.</given-names></name>, <name><surname>D'Onofrio</surname><given-names>M.</given-names></name> and <name><surname>Volonté</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation</article-title>. <source/><italic>Cell Death Dis.</italic>
<volume>4</volume>, <fpage>e959</fpage>
<pub-id pub-id-type="doi">10.1038/cddis.2013.491</pub-id><pub-id pub-id-type="pmid">24336079</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>R. A.</given-names></name>, <name><surname>Forinash</surname><given-names>K. D.</given-names></name>, <name><surname>Pireddu</surname><given-names>R.</given-names></name>, <name><surname>Sun</surname><given-names>Y.</given-names></name>, <name><surname>Sun</surname><given-names>N.</given-names></name>, <name><surname>Martin</surname><given-names>M. P.</given-names></name>, <name><surname>Schönbrunn</surname><given-names>E.</given-names></name>, <name><surname>Lawrence</surname><given-names>N. J.</given-names></name> and <name><surname>Sebti</surname><given-names>S. M.</given-names></name></person-group> (<year>2012</year>). <article-title>RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer</article-title>. <source/><italic>Cancer Res.</italic>
<volume>72</volume>, <fpage>5025</fpage>-<lpage>5034</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-0954</pub-id><pub-id pub-id-type="pmid">22846914</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>R. A.</given-names></name>, <name><surname>Liu</surname><given-names>Y.</given-names></name>, <name><surname>Wang</surname><given-names>B.</given-names></name>, <name><surname>Li</surname><given-names>R.</given-names></name> and <name><surname>Sebti</surname><given-names>S. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activities</article-title>. <source/><italic>Oncogene</italic>
<volume>33</volume>, <fpage>550</fpage>-<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2012.634</pub-id><pub-id pub-id-type="pmid">23396364</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>M. M.</given-names></name>, <name><surname>Nourse</surname><given-names>J. L.</given-names></name>, <name><surname>Tran</surname><given-names>T.</given-names></name>, <name><surname>Hwe</surname><given-names>J.</given-names></name>, <name><surname>Arulmoli</surname><given-names>J.</given-names></name>, <name><surname>Le</surname><given-names>D. T. T.</given-names></name>, <name><surname>Bernardis</surname><given-names>E.</given-names></name>, <name><surname>Flanagan</surname><given-names>L. A.</given-names></name> and <name><surname>Tombola</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>Stretch-activated ion channel Piezo1 directs lineage choice in human neural stem cells</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>111</volume>, <fpage>16148</fpage>-<lpage>16153</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1409802111</pub-id><pub-id pub-id-type="pmid">25349416</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pecci</surname><given-names>A.</given-names></name>, <name><surname>Malara</surname><given-names>A.</given-names></name>, <name><surname>Badalucco</surname><given-names>S.</given-names></name>, <name><surname>Bozzi</surname><given-names>V.</given-names></name>, <name><surname>Torti</surname><given-names>M.</given-names></name>, <name><surname>Balduini</surname><given-names>C. L.</given-names></name> and <name><surname>Balduini</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation</article-title>. <source/><italic>Thromb. Haemost.</italic>
<volume>102</volume>, <fpage>90</fpage>-<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1160/th09-01-0068</pub-id><pub-id pub-id-type="pmid">19572073</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peglion</surname><given-names>F.</given-names></name>, <name><surname>Llense</surname><given-names>F.</given-names></name> and <name><surname>Etienne-Manneville</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Adherens junction treadmilling during collective migration</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>16</volume>, <fpage>639</fpage>-<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2985</pub-id><pub-id pub-id-type="pmid">24929360</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrino</surname><given-names>L.</given-names></name>, <name><surname>Stebbing</surname><given-names>J.</given-names></name>, <name><surname>Braga</surname><given-names>V. M.</given-names></name>, <name><surname>Frampton</surname><given-names>A. E.</given-names></name>, <name><surname>Jacob</surname><given-names>J.</given-names></name>, <name><surname>Buluwela</surname><given-names>L.</given-names></name>, <name><surname>Jiao</surname><given-names>L. R.</given-names></name>, <name><surname>Periyasamy</surname><given-names>M.</given-names></name>, <name><surname>Madsen</surname><given-names>C. D.</given-names></name>, <name><surname>Caley</surname><given-names>M. P.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts</article-title>. <source/><italic>Nucleic Acids Res.</italic>
<volume>41</volume>, <fpage>5400</fpage>-<lpage>5412</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt245</pub-id><pub-id pub-id-type="pmid">23580553</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>H.</given-names></name>, <name><surname>Ong</surname><given-names>Y. M.</given-names></name>, <name><surname>Shah</surname><given-names>W. A.</given-names></name>, <name><surname>Holland</surname><given-names>P. C.</given-names></name> and <name><surname>Carbonetto</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Integrins regulate centrosome integrity and astrocyte polarization following a wound</article-title>. <source/><italic>Dev. Neurobiol.</italic>
<volume>73</volume>, <fpage>333</fpage>-<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22055</pub-id><pub-id pub-id-type="pmid">22949126</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penzes</surname><given-names>P.</given-names></name>, <name><surname>Cahill</surname><given-names>M. E.</given-names></name>, <name><surname>Jones</surname><given-names>K. A.</given-names></name>, <name><surname>VanLeeuwen</surname><given-names>J.-E.</given-names></name> and <name><surname>Woolfrey</surname><given-names>K. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Dendritic spine pathology in neuropsychiatric disorders</article-title>. <source/><italic>Nat. Neurosci.</italic>
<volume>14</volume>, <fpage>285</fpage>-<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2741</pub-id><pub-id pub-id-type="pmid">21346746</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perou</surname><given-names>C. M.</given-names></name>, <name><surname>Sørlie</surname><given-names>T.</given-names></name>, <name><surname>Eisen</surname><given-names>M. B.</given-names></name>, <name><surname>van de Rijn</surname><given-names>M.</given-names></name>, <name><surname>Jeffrey</surname><given-names>S. S.</given-names></name>, <name><surname>Rees</surname><given-names>C. A.</given-names></name>, <name><surname>Pollack</surname><given-names>J. R.</given-names></name>, <name><surname>Ross</surname><given-names>D. T.</given-names></name>, <name><surname>Johnsen</surname><given-names>H.</given-names></name>, <name><surname>Akslen</surname><given-names>L. A.</given-names></name><etal>et al.</etal></person-group> (<year>2000</year>). <article-title>Molecular portraits of human breast tumours</article-title>. <source/><italic>Nature</italic>
<volume>406</volume>, <fpage>747</fpage>-<lpage>752</lpage>. <pub-id pub-id-type="doi">10.1038/35021093</pub-id><pub-id pub-id-type="pmid">10963602</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrie</surname><given-names>R. J.</given-names></name>, <name><surname>Gavara</surname><given-names>N.</given-names></name>, <name><surname>Chadwick</surname><given-names>R. S.</given-names></name> and <name><surname>Yamada</surname><given-names>K. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Nonpolarized signaling reveals two distinct modes of 3D cell migration</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>197</volume>, <fpage>439</fpage>-<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201201124</pub-id><pub-id pub-id-type="pmid">22547408</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>H. M.</given-names></name>, <name><surname>Murdoch</surname><given-names>J. N.</given-names></name>, <name><surname>Chaudhry</surname><given-names>B.</given-names></name>, <name><surname>Copp</surname><given-names>A. J.</given-names></name> and <name><surname>Henderson</surname><given-names>D. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Vangl2 acts via RhoA signaling to regulate polarized cell movements during development of the proximal outflow tract</article-title>. <source/><italic>Circ. Res.</italic>
<volume>96</volume>, <fpage>292</fpage>-<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000154912.08695.88</pub-id><pub-id pub-id-type="pmid">15637299</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>D.</given-names></name>, <name><surname>Pagnamenta</surname><given-names>A. T.</given-names></name>, <name><surname>Klei</surname><given-names>L.</given-names></name>, <name><surname>Anney</surname><given-names>R.</given-names></name>, <name><surname>Merico</surname><given-names>D.</given-names></name>, <name><surname>Regan</surname><given-names>R.</given-names></name>, <name><surname>Conroy</surname><given-names>J.</given-names></name>, <name><surname>Magalhaes</surname><given-names>T. R.</given-names></name>, <name><surname>Correia</surname><given-names>C.</given-names></name>, <name><surname>Abrahams</surname><given-names>B. S.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>. <source/><italic>Nature</italic>
<volume>466</volume>, <fpage>368</fpage>-<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1038/nature09146</pub-id><pub-id pub-id-type="pmid">20531469</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollard</surname><given-names>T. D.</given-names></name></person-group> (<year>1982</year>). <article-title>Structure and polymerization of Acanthamoeba myosin-II filaments</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>95</volume>, <fpage>816</fpage>-<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.95.3.816</pub-id><pub-id pub-id-type="pmid">7153247</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollock</surname><given-names>J. K.</given-names></name>, <name><surname>Verma</surname><given-names>N. K.</given-names></name>, <name><surname>O'Boyle</surname><given-names>N. M.</given-names></name>, <name><surname>Carr</surname><given-names>M.</given-names></name>, <name><surname>Meegan</surname><given-names>M. J.</given-names></name> and <name><surname>Zisterer</surname><given-names>D. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Combretastatin (CA)-4 and its novel analogue CA-432 impair T-cell migration through the Rho/ROCK signalling pathway</article-title>. <source/><italic>Biochem. Pharmacol.</italic>
<volume>92</volume>, <fpage>544</fpage>-<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2014.10.002</pub-id><pub-id pub-id-type="pmid">25450669</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polo-Parada</surname><given-names>L.</given-names></name>, <name><surname>Plattner</surname><given-names>F.</given-names></name>, <name><surname>Bose</surname><given-names>C.</given-names></name> and <name><surname>Landmesser</surname><given-names>L. T.</given-names></name></person-group> (<year>2005</year>). <article-title>NCAM 180 acting via a conserved C-terminal domain and MLCK is essential for effective transmission with repetitive stimulation</article-title>. <source/><italic>Neuron</italic>
<volume>46</volume>, <fpage>917</fpage>-<lpage>931</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.05.018</pub-id><pub-id pub-id-type="pmid">15953420</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porazinski</surname><given-names>S.</given-names></name>, <name><surname>Wang</surname><given-names>H.</given-names></name>, <name><surname>Asaoka</surname><given-names>Y.</given-names></name>, <name><surname>Behrndt</surname><given-names>M.</given-names></name>, <name><surname>Miyamoto</surname><given-names>T.</given-names></name>, <name><surname>Morita</surname><given-names>H.</given-names></name>, <name><surname>Hata</surname><given-names>S.</given-names></name>, <name><surname>Sasaki</surname><given-names>T.</given-names></name>, <name><surname>Krens</surname><given-names>S. F. G.</given-names></name>, <name><surname>Osada</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>YAP is essential for tissue tension to ensure vertebrate 3D body shape</article-title>. <source/><italic>Nature</italic>
<volume>521</volume>, <fpage>217</fpage>-<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature14215</pub-id><pub-id pub-id-type="pmid">25778702</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portera-Cailliau</surname><given-names>C.</given-names></name>, <name><surname>Pan</surname><given-names>D. T.</given-names></name> and <name><surname>Yuste</surname><given-names>R.</given-names></name></person-group> (<year>2003</year>). <article-title>Activity-regulated dynamic behavior of early dendritic protrusions: evidence for different types of dendritic filopodia</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>23</volume>, <fpage>7129</fpage>-<lpage>7142</lpage>.<pub-id pub-id-type="pmid">12904473</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puszkin</surname><given-names>S.</given-names></name>, <name><surname>Berl</surname><given-names>S.</given-names></name>, <name><surname>Puszkin</surname><given-names>E.</given-names></name> and <name><surname>Clarke</surname><given-names>D. D.</given-names></name></person-group> (<year>1968</year>). <article-title>Actomyosin-like protein isolated from mammalian brain</article-title>. <source/><italic>Science</italic>
<volume>161</volume>, <fpage>170</fpage>-<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1126/science.161.3837.170</pub-id><pub-id pub-id-type="pmid">4231987</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rah</surname><given-names>S.-Y.</given-names></name>, <name><surname>Park</surname><given-names>K.-H.</given-names></name>, <name><surname>Nam</surname><given-names>T.-S.</given-names></name>, <name><surname>Kim</surname><given-names>S.-J.</given-names></name>, <name><surname>Kim</surname><given-names>H.</given-names></name>, <name><surname>Im</surname><given-names>M.-J.</given-names></name> and <name><surname>Kim</surname><given-names>U.-H.</given-names></name></person-group> (<year>2007</year>). <article-title>Association of CD38 with nonmuscle myosin heavy chain IIA and Lck is essential for the internalization and activation of CD38</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>282</volume>, <fpage>5653</fpage>-<lpage>5660</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M609478200</pub-id><pub-id pub-id-type="pmid">17182620</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakers</surname><given-names>G. J. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Rho proteins, mental retardation and the cellular basis of cognition</article-title>. <source/><italic>Trends Neurosci.</italic>
<volume>25</volume>, <fpage>191</fpage>-<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-2236(00)02118-4</pub-id><pub-id pub-id-type="pmid">11998687</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakers</surname><given-names>G. J. A.</given-names></name> and <name><surname>Moolenaar</surname><given-names>W. H.</given-names></name></person-group> (<year>1998</year>). <article-title>Regulation of astrocyte morphology by RhoA and lysophosphatidic acid</article-title>. <source/><italic>Exp. Cell Res.</italic>
<volume>245</volume>, <fpage>252</fpage>-<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1006/excr.1998.4224</pub-id><pub-id pub-id-type="pmid">9851865</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaswamy</surname><given-names>S.</given-names></name>, <name><surname>Ross</surname><given-names>K. N.</given-names></name>, <name><surname>Lander</surname><given-names>E. S.</given-names></name> and <name><surname>Golub</surname><given-names>T. R.</given-names></name></person-group> (<year>2003</year>). <article-title>A molecular signature of metastasis in primary solid tumors</article-title>. <source/><italic>Nat. Genet.</italic>
<volume>33</volume>, <fpage>49</fpage>-<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1038/ng1060</pub-id><pub-id pub-id-type="pmid">12469122</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayment</surname><given-names>I.</given-names></name>, <name><surname>Rypniewski</surname><given-names>W. R.</given-names></name>, <name><surname>Schmidt-Bäse</surname><given-names>K.</given-names></name>, <name><surname>Smith</surname><given-names>R.</given-names></name>, <name><surname>Tomchick</surname><given-names>D. R.</given-names></name>, <name><surname>Benning</surname><given-names>M. M.</given-names></name>, <name><surname>Winkelmann</surname><given-names>D. A.</given-names></name>, <name><surname>Wesenberg</surname><given-names>G.</given-names></name> and <name><surname>Holden</surname><given-names>H. M.</given-names></name></person-group> (<year>1993a</year>). <article-title>Three-dimensional structure of myosin subfragment-1: a molecular motor</article-title>. <source/><italic>Science</italic>
<volume>261</volume>, <fpage>50</fpage>-<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1126/science.8316857</pub-id><pub-id pub-id-type="pmid">8316857</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayment</surname><given-names>I.</given-names></name>, <name><surname>Holden</surname><given-names>H. M.</given-names></name>, <name><surname>Whittaker</surname><given-names>M.</given-names></name>, <name><surname>Yohn</surname><given-names>C. B.</given-names></name>, <name><surname>Lorenz</surname><given-names>M.</given-names></name>, <name><surname>Holmes</surname><given-names>K. C.</given-names></name> and <name><surname>Milligan</surname><given-names>R. A.</given-names></name></person-group> (<year>1993b</year>). <article-title>Structure of the actin-myosin complex and its implications for muscle contraction</article-title>. <source/><italic>Science</italic>
<volume>261</volume>, <fpage>58</fpage>-<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1126/science.8316858</pub-id><pub-id pub-id-type="pmid">8316858</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>M. D.</given-names></name>, <name><surname>Dang</surname><given-names>L.</given-names></name>, <name><surname>Thai</surname><given-names>T.</given-names></name>, <name><surname>Owen</surname><given-names>D. M.</given-names></name>, <name><surname>Malle</surname><given-names>E.</given-names></name> and <name><surname>Thomas</surname><given-names>S. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Targeted subendothelial matrix oxidation by myeloperoxidase triggers myosin II-dependent de-adhesion and alters signaling in endothelial cells</article-title>. <source/><italic>Free Radic. Biol. Med.</italic>
<volume>53</volume>, <fpage>2344</fpage>-<lpage>2356</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.10.002</pub-id><pub-id pub-id-type="pmid">23059132</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reffay</surname><given-names>M.</given-names></name>, <name><surname>Parrini</surname><given-names>M. C.</given-names></name>, <name><surname>Cochet-Escartin</surname><given-names>O.</given-names></name>, <name><surname>Ladoux</surname><given-names>B.</given-names></name>, <name><surname>Buguin</surname><given-names>A.</given-names></name>, <name><surname>Coscoy</surname><given-names>S.</given-names></name>, <name><surname>Amblard</surname><given-names>F.</given-names></name>, <name><surname>Camonis</surname><given-names>J.</given-names></name> and <name><surname>Silberzan</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Interplay of RhoA and mechanical forces in collective cell migration driven by leader cells</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>16</volume>, <fpage>217</fpage>-<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2917</pub-id><pub-id pub-id-type="pmid">24561621</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>C. S.</given-names></name>, <name><surname>Chen</surname><given-names>L. Y.</given-names></name>, <name><surname>Sharma</surname><given-names>A.</given-names></name>, <name><surname>Liu</surname><given-names>J.</given-names></name>, <name><surname>Babayan</surname><given-names>A. H.</given-names></name>, <name><surname>Gall</surname><given-names>C. M.</given-names></name> and <name><surname>Lynch</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>186</volume>, <fpage>85</fpage>-<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200901084</pub-id><pub-id pub-id-type="pmid">19596849</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>C. S.</given-names></name>, <name><surname>Gavin</surname><given-names>C. F.</given-names></name>, <name><surname>Rubio</surname><given-names>M. D.</given-names></name>, <name><surname>Kramar</surname><given-names>E. A.</given-names></name>, <name><surname>Chen</surname><given-names>L. Y.</given-names></name>, <name><surname>Jia</surname><given-names>Y.</given-names></name>, <name><surname>Huganir</surname><given-names>R. L.</given-names></name>, <name><surname>Muzyczka</surname><given-names>N.</given-names></name>, <name><surname>Gall</surname><given-names>C. M.</given-names></name>, <name><surname>Miller</surname><given-names>C. A.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Myosin IIb regulates actin dynamics during synaptic plasticity and memory formation</article-title>. <source/><italic>Neuron</italic>
<volume>67</volume>, <fpage>603</fpage>-<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.07.016</pub-id><pub-id pub-id-type="pmid">20797537</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricketson</surname><given-names>D.</given-names></name>, <name><surname>Johnston</surname><given-names>C. A.</given-names></name> and <name><surname>Prehoda</surname><given-names>K. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Multiple tail domain interactions stabilize nonmuscle myosin II bipolar filaments</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>107</volume>, <fpage>20964</fpage>-<lpage>20969</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1007025107</pub-id><pub-id pub-id-type="pmid">21078954</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ripke</surname><given-names>S.</given-names></name>, <name><surname>Sanders</surname><given-names>A. R.</given-names></name>, <name><surname>Kendler</surname><given-names>K. S.</given-names></name>, <name><surname>Levinson</surname><given-names>D. F.</given-names></name>, <name><surname>Sklar</surname><given-names>P.</given-names></name>, <name><surname>Holmans,</surname><given-names>P. A.</given-names></name>, <name><surname>Lin</surname><given-names>D.-Y.</given-names></name>, <name><surname>Duan</surname><given-names>J.</given-names></name>, <name><surname>Ophoff</surname><given-names>R. A.</given-names></name>, <name><surname>Andreassen</surname><given-names>O. A</given-names></name>. <etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Genome-wide association study identifies five new schizophrenia loci</article-title>. <source/><italic>Nat. Genet.</italic>
<volume>43</volume>, <fpage>969</fpage>-<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1038/ng.940</pub-id><pub-id pub-id-type="pmid">21926974</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochlin</surname><given-names>M. W.</given-names></name>, <name><surname>Itoh</surname><given-names>K.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name> and <name><surname>Bridgman</surname><given-names>P. C.</given-names></name></person-group> (<year>1995</year>). <article-title>Localization of myosin II A and B isoforms in cultured neurons</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>108</volume>, <fpage>3661</fpage>-<lpage>3670</lpage>.<pub-id pub-id-type="pmid">8719872</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roland</surname><given-names>A. B.</given-names></name>, <name><surname>Ricobaraza</surname><given-names>A.</given-names></name>, <name><surname>Carrel</surname><given-names>D.</given-names></name>, <name><surname>Jordan</surname><given-names>B. M.</given-names></name>, <name><surname>Rico</surname><given-names>F.</given-names></name>, <name><surname>Simon</surname><given-names>A.</given-names></name>, <name><surname>Humbert-Claude</surname><given-names>M.</given-names></name>, <name><surname>Ferrier</surname><given-names>J.</given-names></name>, <name><surname>McFadden</surname><given-names>M. H.</given-names></name>, <name><surname>Scheuring</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth</article-title>. <source/><italic>Elife</italic>
<volume>3</volume>, <fpage>e03159</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.03159</pub-id><pub-id pub-id-type="pmid">25225054</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronen</surname><given-names>D.</given-names></name> and <name><surname>Ravid</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Myosin II tailpiece determines its paracrystal structure, filament assembly properties, and cellular localization</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>284</volume>, <fpage>24948</fpage>-<lpage>24957</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.023754</pub-id><pub-id pub-id-type="pmid">19553683</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Astrocyte physiopathology: at the crossroads of intercellular networking, inflammation and cell death</article-title>. <source/><italic>Prog. Neurobiol.</italic>
<volume>130</volume>, <fpage>86</fpage>-<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.04.003</pub-id><pub-id pub-id-type="pmid">25930681</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubio</surname><given-names>M. D.</given-names></name>, <name><surname>Haroutunian</surname><given-names>V.</given-names></name> and <name><surname>Meador-Woodruff</surname><given-names>J. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Abnormalities of the Duo/Ras-related C3 botulinum toxin substrate 1/p21-activated kinase 1 pathway drive myosin light chain phosphorylation in frontal cortex in schizophrenia</article-title>. <source/><italic>Biol. Psychiatry</italic>
<volume>71</volume>, <fpage>906</fpage>-<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2012.02.006</pub-id><pub-id pub-id-type="pmid">22458949</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruprecht</surname><given-names>V.</given-names></name>, <name><surname>Wieser</surname><given-names>S.</given-names></name>, <name><surname>Callan-Jones</surname><given-names>A.</given-names></name>, <name><surname>Smutny</surname><given-names>M.</given-names></name>, <name><surname>Morita</surname><given-names>H.</given-names></name>, <name><surname>Sako</surname><given-names>K.</given-names></name>, <name><surname>Barone</surname><given-names>V.</given-names></name>, <name><surname>Ritsch-Marte</surname><given-names>M.</given-names></name>, <name><surname>Sixt</surname><given-names>M.</given-names></name>, <name><surname>Voituriez</surname><given-names>R.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Cortical contractility triggers a stochastic switch to fast amoeboid cell motility</article-title>. <source/><italic>Cell</italic>
<volume>160</volume>, <fpage>673</fpage>-<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.01.008</pub-id><pub-id pub-id-type="pmid">25679761</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusielewicz</surname><given-names>T.</given-names></name>, <name><surname>Nam</surname><given-names>J.</given-names></name>, <name><surname>Damanakis</surname><given-names>E.</given-names></name>, <name><surname>John</surname><given-names>G. R.</given-names></name>, <name><surname>Raine</surname><given-names>C. S.</given-names></name> and <name><surname>Melendez-Vasquez</surname><given-names>C. V.</given-names></name></person-group> (<year>2014</year>). <article-title>Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB</article-title>. <source/><italic>Glia</italic>
<volume>62</volume>, <fpage>580</fpage>-<lpage>591</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22627</pub-id><pub-id pub-id-type="pmid">24470341</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>J.</given-names></name>, <name><surname>Liu</surname><given-names>L.</given-names></name>, <name><surname>Wong</surname><given-names>T. P.</given-names></name>, <name><surname>Wu</surname><given-names>D. C.</given-names></name>, <name><surname>Burette</surname><given-names>A.</given-names></name>, <name><surname>Weinberg</surname><given-names>R.</given-names></name>, <name><surname>Wang</surname><given-names>Y. T.</given-names></name> and <name><surname>Sheng</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>A critical role for myosin IIb in dendritic spine morphology and synaptic function</article-title>. <source/><italic>Neuron</italic>
<volume>49</volume>, <fpage>175</fpage>-<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.12.017</pub-id><pub-id pub-id-type="pmid">16423692</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahai</surname><given-names>E.</given-names></name> and <name><surname>Marshall</surname><given-names>C. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>5</volume>, <fpage>711</fpage>-<lpage>719</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1019</pub-id><pub-id pub-id-type="pmid">12844144</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salhia</surname><given-names>B.</given-names></name>, <name><surname>Hwang</surname><given-names>J. H.</given-names></name>, <name><surname>Smith</surname><given-names>C. A.</given-names></name>, <name><surname>Nakada</surname><given-names>M.</given-names></name>, <name><surname>Rutka</surname><given-names>F.</given-names></name>, <name><surname>Symons</surname><given-names>M.</given-names></name> and <name><surname>Rutka</surname><given-names>J. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Role of myosin II activity and the regulation of myosin light chain phosphorylation in astrocytomas</article-title>. <source/><italic>Cell Motil. Cytoskeleton</italic>
<volume>65</volume>, <fpage>12</fpage>-<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/cm.20240</pub-id><pub-id pub-id-type="pmid">17896341</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandberg</surname><given-names>A.</given-names></name>, <name><surname>Lindell</surname><given-names>G.</given-names></name>, <name><surname>Kallstrom</surname><given-names>B. N.</given-names></name>, <name><surname>Branca</surname><given-names>R. M.</given-names></name>, <name><surname>Danielsson</surname><given-names>K. G.</given-names></name>, <name><surname>Dahlberg</surname><given-names>M.</given-names></name>, <name><surname>Larson</surname><given-names>B.</given-names></name>, <name><surname>Forshed</surname><given-names>J.</given-names></name> and <name><surname>Lehtio</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes</article-title>. <source/><italic>Mol. Cell. Proteomics</italic>
<volume>11</volume>, <fpage>M112.016998</fpage>
<pub-id pub-id-type="doi">10.1074/mcp.M112.016998</pub-id><pub-id pub-id-type="pmid">22499770</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandquist</surname><given-names>J. C.</given-names></name> and <name><surname>Means</surname><given-names>A. R.</given-names></name></person-group> (<year>2008</year>). <article-title>The C-terminal tail region of nonmuscle myosin II directs isoform-specific distribution in migrating cells</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>19</volume>, <fpage>5156</fpage>-<lpage>5167</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E08-05-0533</pub-id><pub-id pub-id-type="pmid">18843042</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schramek</surname><given-names>D.</given-names></name>, <name><surname>Sendoel</surname><given-names>A.</given-names></name>, <name><surname>Segal</surname><given-names>J. P.</given-names></name>, <name><surname>Beronja</surname><given-names>S.</given-names></name>, <name><surname>Heller</surname><given-names>E.</given-names></name>, <name><surname>Oristian</surname><given-names>D.</given-names></name>, <name><surname>Reva</surname><given-names>B.</given-names></name> and <name><surname>Fuchs</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas</article-title>. <source/><italic>Science</italic>
<volume>343</volume>, <fpage>309</fpage>-<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1126/science.1248627</pub-id><pub-id pub-id-type="pmid">24436421</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>M.</given-names></name>, <name><surname>Kipnis</surname><given-names>J.</given-names></name>, <name><surname>Rivest</surname><given-names>S.</given-names></name> and <name><surname>Prat</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>How do immune cells support and shape the brain in health, disease, and aging?</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>, <fpage>17587</fpage>-<lpage>17596</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3241-13.2013</pub-id><pub-id pub-id-type="pmid">24198349</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>C. H.</given-names></name>, <name><surname>Jeong</surname><given-names>H.</given-names></name>, <name><surname>Feng</surname><given-names>Y.</given-names></name>, <name><surname>Montagne</surname><given-names>K.</given-names></name>, <name><surname>Ushida</surname><given-names>T.</given-names></name>, <name><surname>Suzuki</surname><given-names>Y.</given-names></name> and <name><surname>Furukawa</surname><given-names>K. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Micropit surfaces designed for accelerating osteogenic differentiation of murine mesenchymal stem cells via enhancing focal adhesion and actin polymerization</article-title>. <source/><italic>Biomaterials</italic>
<volume>35</volume>, <fpage>2245</fpage>-<lpage>2252</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.11.089</pub-id><pub-id pub-id-type="pmid">24342724</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Q.</given-names></name>, <name><surname>Rigor</surname><given-names>R. R.</given-names></name>, <name><surname>Pivetti</surname><given-names>C. D.</given-names></name>, <name><surname>Wu</surname><given-names>M. H.</given-names></name> and <name><surname>Yuan</surname><given-names>S. Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Myosin light chain kinase in microvascular endothelial barrier function</article-title>. <source/><italic>Cardiovasc. Res.</italic>
<volume>87</volume>, <fpage>272</fpage>-<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvq144</pub-id><pub-id pub-id-type="pmid">20479130</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinto</surname><given-names>O.</given-names></name>, <name><surname>Yashiro</surname><given-names>M.</given-names></name>, <name><surname>Kawajiri</surname><given-names>H.</given-names></name>, <name><surname>Shimizu</surname><given-names>K.</given-names></name>, <name><surname>Shimizu</surname><given-names>T.</given-names></name>, <name><surname>Miwa</surname><given-names>A.</given-names></name> and <name><surname>Hirakawa</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells</article-title>. <source/><italic>Br. J. Cancer</italic>
<volume>102</volume>, <fpage>844</fpage>-<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjc.6605561</pub-id><pub-id pub-id-type="pmid">20145621</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Si</surname><given-names>J.</given-names></name>, <name><surname>Ge</surname><given-names>Y.</given-names></name>, <name><surname>Zhuang</surname><given-names>S.</given-names></name> and <name><surname>Gong</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Inhibiting nonmuscle myosin II impedes inflammatory infiltration and ameliorates progressive renal disease</article-title>. <source/><italic>Lab. Invest.</italic>
<volume>90</volume>, <fpage>448</fpage>-<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2009.142</pub-id><pub-id pub-id-type="pmid">20065948</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>M.</given-names></name>, <name><surname>Wang</surname><given-names>M.</given-names></name>, <name><surname>McBride</surname><given-names>O. W.</given-names></name>, <name><surname>Kawamoto</surname><given-names>S.</given-names></name>, <name><surname>Yamakawa</surname><given-names>K.</given-names></name>, <name><surname>Gdula</surname><given-names>D.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name> and <name><surname>Weir</surname><given-names>L.</given-names></name></person-group> (<year>1991</year>). <article-title>Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes</article-title>. <source/><italic>Circ. Res.</italic>
<volume>69</volume>, <fpage>530</fpage>-<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.69.2.530</pub-id><pub-id pub-id-type="pmid">1860190</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smutny</surname><given-names>M.</given-names></name>, <name><surname>Cox</surname><given-names>H. L.</given-names></name>, <name><surname>Leerberg</surname><given-names>J. M.</given-names></name>, <name><surname>Kovacs</surname><given-names>E. M.</given-names></name>, <name><surname>Conti</surname><given-names>M. A.</given-names></name>, <name><surname>Ferguson</surname><given-names>C.</given-names></name>, <name><surname>Hamilton</surname><given-names>N. A.</given-names></name>, <name><surname>Parton</surname><given-names>R. G.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name> and <name><surname>Yap</surname><given-names>A. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Myosin II isoforms identify distinct functional modules that support integrity of the epithelial zonula adherens</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>12</volume>, <fpage>696</fpage>-<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2072</pub-id><pub-id pub-id-type="pmid">20543839</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somlyo</surname><given-names>A. P.</given-names></name> and <name><surname>Somlyo</surname><given-names>A. V.</given-names></name></person-group> (<year>2003</year>). <article-title>Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase</article-title>. <source/><italic>Physiol. Rev.</italic>
<volume>83</volume>, <fpage>1325</fpage>-<lpage>1358</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00023.2003</pub-id><pub-id pub-id-type="pmid">14506307</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y.</given-names></name>, <name><surname>Chen</surname><given-names>X.</given-names></name>, <name><surname>Wang</surname><given-names>L.-Y.</given-names></name>, <name><surname>Gao</surname><given-names>W.</given-names></name> and <name><surname>Zhu</surname><given-names>M.-J.</given-names></name></person-group> (<year>2013</year>). <article-title>Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats</article-title>. <source/><italic>CNS Neurosci. Ther.</italic>
<volume>19</volume>, <fpage>603</fpage>-<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12116</pub-id><pub-id pub-id-type="pmid">23638992</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinler</surname><given-names>K. R.</given-names></name>, <name><surname>Shin</surname><given-names>J.-W.</given-names></name>, <name><surname>Lambert</surname><given-names>M. P.</given-names></name> and <name><surname>Discher</surname><given-names>D. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia</article-title>. <source/><italic>Blood</italic>
<volume>125</volume>, <fpage>525</fpage>-<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2014-05-576462</pub-id><pub-id pub-id-type="pmid">25395423</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>K.</given-names></name>, <name><surname>Shao</surname><given-names>B.</given-names></name> and <name><surname>Bayraktutan</surname><given-names>U.</given-names></name></person-group> (<year>2013</year>). <article-title>PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway</article-title>. <source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>33</volume>, <fpage>1928</fpage>-<lpage>1936</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2013.151</pub-id><pub-id pub-id-type="pmid">23963366</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>M.</given-names></name>, <name><surname>Franks-Skiba</surname><given-names>K.</given-names></name> and <name><surname>Cooke</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Myosin regulatory light chain phosphorylation inhibits shortening velocities of skeletal muscle fibers in the presence of the myosin inhibitor blebbistatin</article-title>. <source/><italic>J. Muscle Res. Cell Motil.</italic>
<volume>30</volume>, <fpage>17</fpage>-<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1007/s10974-008-9162-9</pub-id><pub-id pub-id-type="pmid">19125340</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straussman</surname><given-names>R.</given-names></name>, <name><surname>Even</surname><given-names>L.</given-names></name> and <name><surname>Ravid</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>Myosin II heavy chain isoforms are phosphorylated in an EGF-dependent manner: involvement of protein kinase C</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>114</volume>, <fpage>3047</fpage>-<lpage>3057</lpage>.<pub-id pub-id-type="pmid">11686307</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strilić</surname><given-names>B.</given-names></name>, <name><surname>Kučera</surname><given-names>T.</given-names></name>, <name><surname>Eglinger</surname><given-names>J.</given-names></name>, <name><surname>Hughes</surname><given-names>M. R.</given-names></name>, <name><surname>McNagny</surname><given-names>K. M.</given-names></name>, <name><surname>Tsukita</surname><given-names>S.</given-names></name>, <name><surname>Dejana</surname><given-names>E.</given-names></name>, <name><surname>Ferrara</surname><given-names>N.</given-names></name> and <name><surname>Lammert</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>The molecular basis of vascular lumen formation in the developing mouse aorta</article-title>. <source/><italic>Dev. Cell</italic>
<volume>17</volume>, <fpage>505</fpage>-<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2009.08.011</pub-id><pub-id pub-id-type="pmid">19853564</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroka</surname><given-names>K. M.</given-names></name>, <name><surname>Hayenga</surname><given-names>H. N.</given-names></name> and <name><surname>Aranda-Espinoza</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Human neutrophil cytoskeletal dynamics and contractility actively contribute to trans-endothelial migration</article-title>. <source/><italic>PLoS ONE</italic>
<volume>8</volume>, <fpage>e61377</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0061377</pub-id><pub-id pub-id-type="pmid">23626676</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name>, <name><surname>Zhang</surname><given-names>D.</given-names></name>, <name><surname>Zheng</surname><given-names>Y.</given-names></name>, <name><surname>Zhao</surname><given-names>Q.</given-names></name>, <name><surname>Zheng</surname><given-names>M.</given-names></name>, <name><surname>Kovacevic</surname><given-names>Z.</given-names></name> and <name><surname>Richardson</surname><given-names>D. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway</article-title>. <source/><italic>Mol. Pharmacol.</italic>
<volume>83</volume>, <fpage>454</fpage>-<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1124/mol.112.083097</pub-id><pub-id pub-id-type="pmid">23188716</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name>, <name><surname>Yong</surname><given-names>K. M. A.</given-names></name>, <name><surname>Villa-Diaz</surname><given-names>L. G.</given-names></name>, <name><surname>Zhang</surname><given-names>X.</given-names></name>, <name><surname>Chen</surname><given-names>W.</given-names></name>, <name><surname>Philson</surname><given-names>R.</given-names></name>, <name><surname>Weng</surname><given-names>S.</given-names></name>, <name><surname>Xu</surname><given-names>H.</given-names></name>, <name><surname>Krebsbach</surname><given-names>P. H.</given-names></name> and <name><surname>Fu</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells</article-title>. <source/><italic>Nat. Mater.</italic>
<volume>13</volume>, <fpage>599</fpage>-<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1038/nmat3945</pub-id><pub-id pub-id-type="pmid">24728461</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swiech</surname><given-names>L.</given-names></name>, <name><surname>Heidenreich</surname><given-names>M.</given-names></name>, <name><surname>Banerjee</surname><given-names>A.</given-names></name>, <name><surname>Habib</surname><given-names>N.</given-names></name>, <name><surname>Li</surname><given-names>Y.</given-names></name>, <name><surname>Trombetta</surname><given-names>J.</given-names></name>, <name><surname>Sur</surname><given-names>M.</given-names></name> and <name><surname>Zhang</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9</article-title>. <source/><italic>Nat. Biotechnol.</italic>
<volume>33</volume>, <fpage>102</fpage>-<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3055</pub-id><pub-id pub-id-type="pmid">25326897</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaoka</surname><given-names>M.</given-names></name>, <name><surname>Saito</surname><given-names>H.</given-names></name>, <name><surname>Takenaka</surname><given-names>K.</given-names></name>, <name><surname>Miki</surname><given-names>Y.</given-names></name> and <name><surname>Nakanishi</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>BRCA2 phosphorylated by PLK1 moves to the midbody to regulate cytokinesis mediated by nonmuscle myosin IIC</article-title>. <source/><italic>Cancer Res.</italic>
<volume>74</volume>, <fpage>1518</fpage>-<lpage>1528</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-0504</pub-id><pub-id pub-id-type="pmid">24448238</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y.</given-names></name>, <name><surname>Rowe</surname><given-names>R. G.</given-names></name>, <name><surname>Botvinick</surname><given-names>E. L.</given-names></name>, <name><surname>Kurup</surname><given-names>A.</given-names></name>, <name><surname>Putnam</surname><given-names>A. J.</given-names></name>, <name><surname>Seiki</surname><given-names>M.</given-names></name>, <name><surname>Weaver</surname><given-names>V. M.</given-names></name>, <name><surname>Keller</surname><given-names>E. T.</given-names></name>, <name><surname>Goldstein</surname><given-names>S.</given-names></name>, <name><surname>Dai</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>MT1-MMP-dependent control of skeletal stem cell commitment via a β1-integrin/YAP/TAZ signaling axis</article-title>. <source/><italic>Dev. Cell</italic>
<volume>25</volume>, <fpage>402</fpage>-<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2013.04.011</pub-id><pub-id pub-id-type="pmid">23685250</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatenhorst</surname><given-names>L.</given-names></name>, <name><surname>Tönges</surname><given-names>L.</given-names></name>, <name><surname>Saal</surname><given-names>K.-A.</given-names></name>, <name><surname>Koch</surname><given-names>J. C.</given-names></name>, <name><surname>Szegõ</surname><given-names>É. M.</given-names></name>, <name><surname>Bähr</surname><given-names>M.</given-names></name> and <name><surname>Lingor</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease</article-title>. <source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>73</volume>, <fpage>770</fpage>-<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0000000000000095</pub-id><pub-id pub-id-type="pmid">25003236</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thon</surname><given-names>J. N.</given-names></name> and <name><surname>Italiano</surname><given-names>J. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Does size matter in platelet production?</article-title>
<source/><italic>Blood</italic>
<volume>120</volume>, <fpage>1552</fpage>-<lpage>1561</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2012-04-408724</pub-id><pub-id pub-id-type="pmid">22665937</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokuoka</surname><given-names>H.</given-names></name> and <name><surname>Goda</surname><given-names>Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Myosin light chain kinase is not a regulator of synaptic vesicle trafficking during repetitive exocytosis in cultured hippocampal neurons</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>26</volume>, <fpage>11606</fpage>-<lpage>11614</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3400-06.2006</pub-id><pub-id pub-id-type="pmid">17093082</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tönges</surname><given-names>L.</given-names></name>, <name><surname>Frank</surname><given-names>T.</given-names></name>, <name><surname>Tatenhorst</surname><given-names>L.</given-names></name>, <name><surname>Saal</surname><given-names>K. A.</given-names></name>, <name><surname>Koch</surname><given-names>J. C.</given-names></name>, <name><surname>Szego</surname><given-names>É. M.</given-names></name>, <name><surname>Bähr</surname><given-names>M.</given-names></name>, <name><surname>Weishaupt</surname><given-names>J. H.</given-names></name> and <name><surname>Lingor</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease</article-title>. <source/><italic>Brain</italic>
<volume>135</volume>, <fpage>3355</fpage>-<lpage>3370</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aws254</pub-id><pub-id pub-id-type="pmid">23087045</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tönges</surname><given-names>L.</given-names></name>, <name><surname>Günther</surname><given-names>R.</given-names></name>, <name><surname>Suhr</surname><given-names>M.</given-names></name>, <name><surname>Jansen</surname><given-names>J.</given-names></name>, <name><surname>Balck</surname><given-names>A.</given-names></name>, <name><surname>Saal</surname><given-names>K.-A.</given-names></name>, <name><surname>Barski</surname><given-names>E.</given-names></name>, <name><surname>Nientied</surname><given-names>T.</given-names></name>, <name><surname>Götz</surname><given-names>A. A.</given-names></name>, <name><surname>Koch</surname><given-names>J.-C.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis</article-title>. <source/><italic>Glia</italic>
<volume>62</volume>, <fpage>217</fpage>-<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22601</pub-id><pub-id pub-id-type="pmid">24311453</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tornavaca</surname><given-names>O.</given-names></name>, <name><surname>Chia</surname><given-names>M.</given-names></name>, <name><surname>Dufton</surname><given-names>N.</given-names></name>, <name><surname>Almagro</surname><given-names>L. O.</given-names></name>, <name><surname>Conway</surname><given-names>D. E.</given-names></name>, <name><surname>Randi</surname><given-names>A. M.</given-names></name>, <name><surname>Schwartz</surname><given-names>M. A.</given-names></name>, <name><surname>Matter</surname><given-names>K.</given-names></name> and <name><surname>Balda</surname><given-names>M. S.</given-names></name></person-group> (<year>2015</year>). <article-title>ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>208</volume>, <fpage>821</fpage>-<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201404140</pub-id><pub-id pub-id-type="pmid">25753039</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Totsukawa</surname><given-names>G.</given-names></name>, <name><surname>Yamakita</surname><given-names>Y.</given-names></name>, <name><surname>Yamashiro</surname><given-names>S.</given-names></name>, <name><surname>Hartshorne</surname><given-names>D. J.</given-names></name>, <name><surname>Sasaki</surname><given-names>Y.</given-names></name> and <name><surname>Matsumura</surname><given-names>F.</given-names></name></person-group> (<year>2000</year>). <article-title>Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>150</volume>, <fpage>797</fpage>-<lpage>806</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.150.4.797</pub-id><pub-id pub-id-type="pmid">10953004</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>J.-W.</given-names></name>, <name><surname>Bremner</surname><given-names>K. H.</given-names></name> and <name><surname>Vallee</surname><given-names>R. B.</given-names></name></person-group> (<year>2007</year>). <article-title>Dual subcellular roles for LIS1 and dynein in radial neuronal migration in live brain tissue</article-title>. <source/><italic>Nat. Neurosci.</italic>
<volume>10</volume>, <fpage>970</fpage>-<lpage>979</lpage>. <pub-id pub-id-type="doi">10.1038/nn1934</pub-id><pub-id pub-id-type="pmid">17618279</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turbedsky</surname><given-names>K.</given-names></name>, <name><surname>Pollard</surname><given-names>T. D.</given-names></name> and <name><surname>Yeager</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Assembly of Acanthamoeba myosin-II minifilaments. Model of anti-parallel dimers based on EM and X-ray diffraction of 2D and 3D crystals</article-title>. <source/><italic>J. Mol. Biol.</italic>
<volume>345</volume>, <fpage>363</fpage>-<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2004.10.048</pub-id><pub-id pub-id-type="pmid">15571728</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrich</surname><given-names>T. A.</given-names></name>, <name><surname>De Juan Pardo</surname><given-names>E. M.</given-names></name> and <name><surname>Kumar</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells</article-title>. <source/><italic>Cancer Res.</italic>
<volume>69</volume>, <fpage>4167</fpage>-<lpage>4174</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-4859</pub-id><pub-id pub-id-type="pmid">19435897</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umemoto</surname><given-names>S.</given-names></name>, <name><surname>Bengur</surname><given-names>A. R.</given-names></name> and <name><surname>Sellers</surname><given-names>J. R.</given-names></name></person-group> (<year>1989</year>). <article-title>Effect of multiple phosphorylations of smooth muscle and cytoplasmic myosins on movement in an in vitro motility assay</article-title>. <source/><italic>J. Biol. Chem.</italic>
<volume>264</volume>, <fpage>1431</fpage>-<lpage>1436</lpage>.<pub-id pub-id-type="pmid">2521481</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unbekandt</surname><given-names>M.</given-names></name>, <name><surname>Croft</surname><given-names>D. R.</given-names></name>, <name><surname>Crighton</surname><given-names>D.</given-names></name>, <name><surname>Mezna</surname><given-names>M.</given-names></name>, <name><surname>McArthur</surname><given-names>D.</given-names></name>, <name><surname>McConnell</surname><given-names>P.</given-names></name>, <name><surname>Schüttelkopf</surname><given-names>A. W.</given-names></name>, <name><surname>Belshaw</surname><given-names>S.</given-names></name>, <name><surname>Pannifer</surname><given-names>A.</given-names></name>, <name><surname>Sime</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>A novel small-molecule MRCK inhibitor blocks cancer cell invasion</article-title>. <source/><italic>Cell Commun. Signal.</italic>
<volume>12</volume>, <fpage>54</fpage>
<pub-id pub-id-type="doi">10.1186/s12964-014-0054-x</pub-id><pub-id pub-id-type="pmid">25288205</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Buul</surname><given-names>J. D.</given-names></name>, <name><surname>Allingham</surname><given-names>M. J.</given-names></name>, <name><surname>Samson</surname><given-names>T.</given-names></name>, <name><surname>Meller</surname><given-names>J.</given-names></name>, <name><surname>Boulter</surname><given-names>E.</given-names></name>, <name><surname>García-Mata</surname><given-names>R.</given-names></name> and <name><surname>Burridge</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>RhoG regulates endothelial apical cup assembly downstream from ICAM1 engagement and is involved in leukocyte trans-endothelial migration</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>178</volume>, <fpage>1279</fpage>-<lpage>1293</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200612053</pub-id><pub-id pub-id-type="pmid">17875742</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Buul</surname><given-names>J. D.</given-names></name>, <name><surname>van Rijssel</surname><given-names>J.</given-names></name>, <name><surname>van Alphen</surname><given-names>F. P. J.</given-names></name>, <name><surname>Hoogenboezem</surname><given-names>M.</given-names></name>, <name><surname>Tol</surname><given-names>S.</given-names></name>, <name><surname>Hoeben</surname><given-names>K. A.</given-names></name>, <name><surname>van Marle</surname><given-names>J.</given-names></name>, <name><surname>Mul</surname><given-names>E. P. J.</given-names></name> and <name><surname>Hordijk</surname><given-names>P. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Inside-out regulation of ICAM-1 dynamics in TNF-alpha-activated endothelium</article-title>. <source/><italic>PLoS ONE</italic>
<volume>5</volume>, <fpage>e11336</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0011336</pub-id><pub-id pub-id-type="pmid">20596527</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasiliev</surname><given-names>J. M.</given-names></name>, <name><surname>Omelchenko</surname><given-names>T.</given-names></name>, <name><surname>Gelfand</surname><given-names>I. M.</given-names></name>, <name><surname>Feder</surname><given-names>H. H.</given-names></name> and <name><surname>Bonder</surname><given-names>E. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Rho overexpression leads to mitosis-associated detachment of cells from epithelial sheets: a link to the mechanism of cancer dissemination</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>101</volume>, <fpage>12526</fpage>-<lpage>12530</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0404723101</pub-id><pub-id pub-id-type="pmid">15304643</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente-Manzanares</surname><given-names>M.</given-names></name> and <name><surname>Horwitz</surname><given-names>A. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Myosin light chain mono- and di-phosphorylation differentially regulate adhesion and polarity in migrating cells</article-title>. <source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>402</volume>, <fpage>537</fpage>-<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2010.10.071</pub-id><pub-id pub-id-type="pmid">20971064</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente-Manzanares</surname><given-names>M.</given-names></name>, <name><surname>Zareno</surname><given-names>J.</given-names></name>, <name><surname>Whitmore</surname><given-names>L.</given-names></name>, <name><surname>Choi</surname><given-names>C. K.</given-names></name> and <name><surname>Horwitz</surname><given-names>A. F.</given-names></name></person-group> (<year>2007</year>). <article-title>Regulation of protrusion, adhesion dynamics, and polarity by myosins IIA and IIB in migrating cells</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>176</volume>, <fpage>573</fpage>-<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200612043</pub-id><pub-id pub-id-type="pmid">17312025</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente-Manzanares</surname><given-names>M.</given-names></name>, <name><surname>Koach</surname><given-names>M. A.</given-names></name>, <name><surname>Whitmore</surname><given-names>L.</given-names></name>, <name><surname>Lamers</surname><given-names>M. L.</given-names></name> and <name><surname>Horwitz</surname><given-names>A. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Segregation and activation of myosin IIB creates a rear in migrating cells</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>183</volume>, <fpage>543</fpage>-<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200806030</pub-id><pub-id pub-id-type="pmid">18955554</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente-Manzanares</surname><given-names>M.</given-names></name>, <name><surname>Hodges</surname><given-names>J.</given-names></name> and <name><surname>Horwitz</surname><given-names>A. R.</given-names></name></person-group> (<year>2009a</year>). <article-title>Dendritic spines: similarities with protrusions and adhesions in migrating cells</article-title>. <source/><italic>Open Neurosci. J.</italic>
<volume>3</volume>, <fpage>87</fpage>-<lpage>96</lpage>. <pub-id pub-id-type="doi">10.2174/1874082000903020087</pub-id><pub-id pub-id-type="pmid">20559447</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente-Manzanares</surname><given-names>M.</given-names></name>, <name><surname>Ma</surname><given-names>X.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name> and <name><surname>Horwitz</surname><given-names>A. R.</given-names></name></person-group> (<year>2009b</year>). <article-title>Non-muscle myosin II takes centre stage in cell adhesion and migration</article-title>. <source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>10</volume>, <fpage>778</fpage>-<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2786</pub-id><pub-id pub-id-type="pmid">19851336</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente-Manzanares</surname><given-names>M.</given-names></name>, <name><surname>Newell-Litwa</surname><given-names>K.</given-names></name>, <name><surname>Bachir</surname><given-names>A. I.</given-names></name>, <name><surname>Whitmore</surname><given-names>L. A.</given-names></name> and <name><surname>Horwitz</surname><given-names>A. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Myosin IIA/IIB restrict adhesive and protrusive signaling to generate front-back polarity in migrating cells</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>193</volume>, <fpage>381</fpage>-<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201012159</pub-id><pub-id pub-id-type="pmid">21482721</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wälchli</surname><given-names>T.</given-names></name>, <name><surname>Pernet</surname><given-names>V.</given-names></name>, <name><surname>Weinmann</surname><given-names>O.</given-names></name>, <name><surname>Shiu</surname><given-names>J.-Y.</given-names></name>, <name><surname>Guzik-Kornacka</surname><given-names>A.</given-names></name>, <name><surname>Decrey</surname><given-names>G.</given-names></name>, <name><surname>Yüksel</surname><given-names>D.</given-names></name>, <name><surname>Schneider</surname><given-names>H.</given-names></name>, <name><surname>Vogel</surname><given-names>J.</given-names></name>, <name><surname>Ingber</surname><given-names>D. E.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Nogo-A is a negative regulator of CNS angiogenesis</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>110</volume>, <fpage>E1943</fpage>-<lpage>E1952</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1216203110</pub-id><pub-id pub-id-type="pmid">23625008</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>A.</given-names></name>, <name><surname>Su</surname><given-names>H.</given-names></name>, <name><surname>Conti</surname><given-names>M. A.</given-names></name>, <name><surname>Harb</surname><given-names>N.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name> and <name><surname>Sato</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>Non-muscle myosin II regulates survival threshold of pluripotent stem cells</article-title>. <source/><italic>Nat. Commun.</italic>
<volume>1</volume>, <fpage>71</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms1074</pub-id><pub-id pub-id-type="pmid">20842192</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name>, <name><surname>Tewari</surname><given-names>A.</given-names></name>, <name><surname>Einheber</surname><given-names>S.</given-names></name>, <name><surname>Salzer</surname><given-names>J. L.</given-names></name> and <name><surname>Melendez-Vasquez</surname><given-names>C. V.</given-names></name></person-group> (<year>2008</year>). <article-title>Myosin II has distinct functions in PNS and CNS myelin sheath formation</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>182</volume>, <fpage>1171</fpage>-<lpage>1184</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200802091</pub-id><pub-id pub-id-type="pmid">18794332</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name>, <name><surname>Cadwallader</surname><given-names>A. B.</given-names></name>, <name><surname>Jang</surname><given-names>D. S.</given-names></name>, <name><surname>Tsang</surname><given-names>M.</given-names></name>, <name><surname>Yost</surname><given-names>H. J.</given-names></name> and <name><surname>Amack</surname><given-names>J. D.</given-names></name></person-group> (<year>2011</year>). <article-title>The Rho kinase Rock2b establishes anteroposterior asymmetry of the ciliated Kupffer's vesicle in zebrafish</article-title>. <source/><italic>Development</italic>
<volume>138</volume>, <fpage>45</fpage>-<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1242/dev.052985</pub-id><pub-id pub-id-type="pmid">21098560</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name>, <name><surname>Rusielewicz</surname><given-names>T.</given-names></name>, <name><surname>Tewari</surname><given-names>A.</given-names></name>, <name><surname>Leitman</surname><given-names>E. M.</given-names></name>, <name><surname>Einheber</surname><given-names>S.</given-names></name> and <name><surname>Melendez-Vasquez</surname><given-names>C. V.</given-names></name></person-group> (<year>2012a</year>). <article-title>Myosin II is a negative regulator of oligodendrocyte morphological differentiation</article-title>. <source/><italic>J. Neurosci. Res.</italic>
<volume>90</volume>, <fpage>1547</fpage>-<lpage>1556</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23036</pub-id><pub-id pub-id-type="pmid">22437915</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name>, <name><surname>Manning</surname><given-names>M. L.</given-names></name> and <name><surname>Amack</surname><given-names>J. D.</given-names></name></person-group> (<year>2012b</year>). <article-title>Regional cell shape changes control form and function of Kupffer's vesicle in the zebrafish embryo</article-title>. <source/><italic>Dev. Biol.</italic>
<volume>370</volume>, <fpage>52</fpage>-<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2012.07.019</pub-id><pub-id pub-id-type="pmid">22841644</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name>, <name><surname>Zhao</surname><given-names>Y.</given-names></name>, <name><surname>Zhang</surname><given-names>X.</given-names></name>, <name><surname>Badie</surname><given-names>H.</given-names></name>, <name><surname>Zhou</surname><given-names>Y.</given-names></name>, <name><surname>Mu</surname><given-names>Y.</given-names></name>, <name><surname>Loo</surname><given-names>L. S.</given-names></name>, <name><surname>Cai</surname><given-names>L.</given-names></name>, <name><surname>Thompson</surname><given-names>R. C.</given-names></name>, <name><surname>Yang</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2013a</year>). <article-title>Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome</article-title>. <source/><italic>Nat. Med.</italic>
<volume>19</volume>, <fpage>473</fpage>-<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3117</pub-id><pub-id pub-id-type="pmid">23524343</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.-H.</given-names></name>, <name><surname>Wu</surname><given-names>C.-C.</given-names></name>, <name><surname>Hsu</surname><given-names>S.-H.</given-names></name>, <name><surname>Liou</surname><given-names>J.-Y.</given-names></name>, <name><surname>Li</surname><given-names>Y.-W.</given-names></name>, <name><surname>Wu</surname><given-names>K. K.</given-names></name>, <name><surname>Lai</surname><given-names>Y.-K.</given-names></name> and <name><surname>Yen</surname><given-names>B. L.</given-names></name></person-group> (<year>2013b</year>). <article-title>The role of RhoA kinase inhibition in human placenta-derived multipotent cells on neural phenotype and cell survival</article-title>. <source/><italic>Biomaterials</italic>
<volume>34</volume>, <fpage>3223</fpage>-<lpage>3230</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.12.034</pub-id><pub-id pub-id-type="pmid">23410680</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watabe</surname><given-names>T.</given-names></name> and <name><surname>Miyazono</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Roles of TGF-beta family signaling in stem cell renewal and differentiation</article-title>. <source/><italic>Cell Res.</italic>
<volume>19</volume>, <fpage>103</fpage>-<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2008.323</pub-id><pub-id pub-id-type="pmid">19114993</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C281">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K.</given-names></name>, <name><surname>Ueno</surname><given-names>M.</given-names></name>, <name><surname>Kamiya</surname><given-names>D.</given-names></name>, <name><surname>Nishiyama</surname><given-names>A.</given-names></name>, <name><surname>Matsumura</surname><given-names>M.</given-names></name>, <name><surname>Wataya</surname><given-names>T.</given-names></name>, <name><surname>Takahashi</surname><given-names>J. B.</given-names></name>, <name><surname>Nishikawa</surname><given-names>S.</given-names></name>, <name><surname>Nishikawa</surname><given-names>S.-I.</given-names></name>, <name><surname>Muguruma</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>2007</year>). <article-title>A ROCK inhibitor permits survival of dissociated human embryonic stem cells</article-title>. <source/><italic>Nat. Biotechnol.</italic>
<volume>25</volume>, <fpage>681</fpage>-<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1038/nbt1310</pub-id><pub-id pub-id-type="pmid">17529971</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C282">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>M.</given-names></name>, <name><surname>Kim</surname><given-names>S.</given-names></name>, <name><surname>Patterson</surname><given-names>N.</given-names></name>, <name><surname>Rooney</surname><given-names>K.</given-names></name> and <name><surname>Searles</surname><given-names>C. D.</given-names></name></person-group> (<year>2014</year>). <article-title>MiRNA-155 targets myosin light chain kinase and modulates actin cytoskeleton organization in endothelial cells</article-title>. <source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>306</volume>, <fpage>H1192</fpage>-<lpage>H1203</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00521.2013</pub-id><pub-id pub-id-type="pmid">24486510</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C283">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidert</surname><given-names>E.</given-names></name>, <name><surname>Pohler</surname><given-names>S. E.</given-names></name>, <name><surname>Gomez</surname><given-names>E. W.</given-names></name> and <name><surname>Dong</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Actinomyosin contraction, phosphorylation of VE-cadherin, and actin remodeling enable melanoma-induced endothelial cell-cell junction disassembly</article-title>. <source/><italic>PLoS ONE</italic>
<volume>9</volume>, <fpage>e108092</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0108092</pub-id><pub-id pub-id-type="pmid">25225982</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C284">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickman</surname><given-names>G. R.</given-names></name>, <name><surname>Julian</surname><given-names>L.</given-names></name>, <name><surname>Mardilovich</surname><given-names>K.</given-names></name>, <name><surname>Schumacher</surname><given-names>S.</given-names></name>, <name><surname>Munro</surname><given-names>J.</given-names></name>, <name><surname>Rath</surname><given-names>N.</given-names></name>, <name><surname>Zander</surname><given-names>S. A.</given-names></name>, <name><surname>Mleczak</surname><given-names>A.</given-names></name>, <name><surname>Sumpton</surname><given-names>D.</given-names></name>, <name><surname>Morrice</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs</article-title>. <source/><italic>Cell Death Differ.</italic>
<volume>20</volume>, <fpage>1293</fpage>-<lpage>1305</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2013.69</pub-id><pub-id pub-id-type="pmid">23787996</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C285">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>S.</given-names></name>, <name><surname>Paterson</surname><given-names>H. F.</given-names></name> and <name><surname>Marshall</surname><given-names>C. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>7</volume>, <fpage>255</fpage>-<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1230</pub-id><pub-id pub-id-type="pmid">15723050</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C286">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkelmann</surname><given-names>D. A.</given-names></name>, <name><surname>Almeda</surname><given-names>S.</given-names></name>, <name><surname>Vibert</surname><given-names>P.</given-names></name> and <name><surname>Cohen</surname><given-names>C.</given-names></name></person-group> (<year>1984</year>). <article-title>A new myosin fragment: visualization of the regulatory domain</article-title>. <source/><italic>Nature</italic>
<volume>307</volume>, <fpage>758</fpage>-<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1038/307758a0</pub-id><pub-id pub-id-type="pmid">6422307</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C287">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wootla</surname><given-names>B.</given-names></name>, <name><surname>Denic</surname><given-names>A.</given-names></name>, <name><surname>Warrington</surname><given-names>A. E.</given-names></name> and <name><surname>Rodriguez</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Need for a paradigm shift in therapeutic approaches to CNS injury</article-title>. <source/><italic>Expert Rev. Neurother.</italic>
<volume>12</volume>, <fpage>409</fpage>-<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1586/ern.12.24</pub-id><pub-id pub-id-type="pmid">22449213</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C288">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D.-J.</given-names></name>, <name><surname>Xu</surname><given-names>J.-Z.</given-names></name>, <name><surname>Wu</surname><given-names>Y.-J.</given-names></name>, <name><surname>Jean-Charles</surname><given-names>L.</given-names></name>, <name><surname>Xiao</surname><given-names>B.</given-names></name>, <name><surname>Gao</surname><given-names>P.-J.</given-names></name> and <name><surname>Zhu</surname><given-names>D.-L.</given-names></name></person-group> (<year>2009</year>). <article-title>Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice</article-title>. <source/><italic>Atherosclerosis</italic>
<volume>207</volume>, <fpage>68</fpage>-<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2009.04.025</pub-id><pub-id pub-id-type="pmid">19473657</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C289">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q.</given-names></name>, <name><surname>Sahasrabudhe</surname><given-names>R. M.</given-names></name>, <name><surname>Luo</surname><given-names>L. Z.</given-names></name>, <name><surname>Lewis</surname><given-names>D. W.</given-names></name>, <name><surname>Gollin</surname><given-names>S. M.</given-names></name> and <name><surname>Saunders</surname><given-names>W. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Deficiency in myosin light-chain phosphorylation causes cytokinesis failure and multipolarity in cancer cells</article-title>. <source/><italic>Oncogene</italic>
<volume>29</volume>, <fpage>4183</fpage>-<lpage>4193</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2010.165</pub-id><pub-id pub-id-type="pmid">20498637</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C290">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wylie</surname><given-names>S. R.</given-names></name> and <name><surname>Chantler</surname><given-names>P. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Separate but linked functions of conventional myosins modulate adhesion and neurite outgrowth</article-title>. <source/><italic>Nat. Cell Biol.</italic>
<volume>3</volume>, <fpage>88</fpage>-<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1038/35050613</pub-id><pub-id pub-id-type="pmid">11146631</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C291">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wylie</surname><given-names>S. R.</given-names></name> and <name><surname>Chantler</surname><given-names>P. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Myosin IIC: a third molecular motor driving neuronal dynamics</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>19</volume>, <fpage>3956</fpage>-<lpage>3968</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E07-08-0744</pub-id><pub-id pub-id-type="pmid">18614800</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C292">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wylie</surname><given-names>S. R.</given-names></name>, <name><surname>Wu</surname><given-names>P.-J.</given-names></name>, <name><surname>Patel</surname><given-names>H.</given-names></name> and <name><surname>Chantler</surname><given-names>P. D.</given-names></name></person-group> (<year>1998</year>). <article-title>A conventional myosin motor drives neurite outgrowth</article-title>. <source/><italic>Proc. Natl. Acad. Sci. USA</italic>
<volume>95</volume>, <fpage>12967</fpage>-<lpage>12972</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.22.12967</pub-id><pub-id pub-id-type="pmid">9789024</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C293">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>M.</given-names></name> and <name><surname>Land</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility</article-title>. <source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>14</volume>, <fpage>215</fpage>-<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb1208</pub-id><pub-id pub-id-type="pmid">17310253</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C294">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Z.-K.</given-names></name>, <name><surname>Yuan</surname><given-names>Y.-C.</given-names></name>, <name><surname>Yin</surname><given-names>N.</given-names></name>, <name><surname>Yin</surname><given-names>B.-L.</given-names></name>, <name><surname>Tan</surname><given-names>Z.-P.</given-names></name> and <name><surname>Hu</surname><given-names>Y.-R.</given-names></name></person-group> (<year>2012</year>). <article-title>Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancer</article-title>. <source/><italic>Dis. Esophagus</italic>
<volume>25</volume>, <fpage>427</fpage>-<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1111/j.1442-2050.2011.01261.x</pub-id><pub-id pub-id-type="pmid">21951916</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C295">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>D.</given-names></name>, <name><surname>Ye</surname><given-names>Y.-L.</given-names></name>, <name><surname>Chen</surname><given-names>M.-K.</given-names></name>, <name><surname>Qin</surname><given-names>Z.-K.</given-names></name>, <name><surname>Li</surname><given-names>M.-Z.</given-names></name>, <name><surname>Zhang</surname><given-names>H.</given-names></name>, <name><surname>Xu</surname><given-names>L.-H.</given-names></name>, <name><surname>Xu</surname><given-names>Z.-Z.</given-names></name> and <name><surname>Zeng</surname><given-names>M.-S.</given-names></name></person-group> (<year>2012</year>). <article-title>Non-muscle myosin II is an independent predictor of overall survival for cystectomy candidates with early-stage bladder cancer</article-title>. <source/><italic>Oncol. Rep.</italic>
<volume>28</volume>, <fpage>1625</fpage>-<lpage>1632</lpage>. <pub-id pub-id-type="doi">10.3892/or.2012.1965</pub-id><pub-id pub-id-type="pmid">22895805</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C296">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name>, <name><surname>Lamouille</surname><given-names>S.</given-names></name> and <name><surname>Derynck</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>TGF-beta-induced epithelial to mesenchymal transition</article-title>. <source/><italic>Cell Res.</italic>
<volume>19</volume>, <fpage>156</fpage>-<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2009.5</pub-id><pub-id pub-id-type="pmid">19153598</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C297">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yam</surname><given-names>J. W. P.</given-names></name>, <name><surname>Chan</surname><given-names>K. W.</given-names></name> and <name><surname>Hsiao</surname><given-names>W.-L. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B</article-title>. <source/><italic>Oncogene</italic>
<volume>20</volume>, <fpage>58</fpage>-<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1203982</pub-id><pub-id pub-id-type="pmid">11244504</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C298">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H.</given-names></name>, <name><surname>Yoshida</surname><given-names>N.</given-names></name>, <name><surname>Takanashi</surname><given-names>M.</given-names></name>, <name><surname>Ito</surname><given-names>Y.</given-names></name>, <name><surname>Fukami</surname><given-names>K.</given-names></name>, <name><surname>Yanagihara</surname><given-names>K.</given-names></name>, <name><surname>Yashiro</surname><given-names>M.</given-names></name> and <name><surname>Sakai</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells</article-title>. <source/><italic>PLoS ONE</italic>
<volume>9</volume>, <fpage>e85485</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0085485</pub-id><pub-id pub-id-type="pmid">24427313</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C299">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>N.</given-names></name>, <name><surname>Okano</surname><given-names>T.</given-names></name>, <name><surname>Ma</surname><given-names>X.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name> and <name><surname>Kelley</surname><given-names>M. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Myosin II regulates extension, growth and patterning in the mammalian cochlear duct</article-title>. <source/><italic>Development</italic>
<volume>136</volume>, <fpage>1977</fpage>-<lpage>1986</lpage>. <pub-id pub-id-type="doi">10.1242/dev.030718</pub-id><pub-id pub-id-type="pmid">19439495</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C300">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F.</given-names></name>, <name><surname>Wei</surname><given-names>Q.</given-names></name>, <name><surname>Adelstein</surname><given-names>R. S.</given-names></name> and <name><surname>Wang</surname><given-names>P. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Non-muscle myosin IIB is essential for cytokinesis during male meiotic cell divisions</article-title>. <source/><italic>Dev. Biol.</italic>
<volume>369</volume>, <fpage>356</fpage>-<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2012.07.011</pub-id><pub-id pub-id-type="pmid">22820068</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C301">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C.</given-names></name>, <name><surname>Tibbitt</surname><given-names>M. W.</given-names></name>, <name><surname>Basta</surname><given-names>L.</given-names></name> and <name><surname>Anseth</surname><given-names>K. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Mechanical memory and dosing influence stem cell fate</article-title>. <source/><italic>Nat. Mater.</italic>
<volume>13</volume>, <fpage>645</fpage>-<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1038/nmat3889</pub-id><pub-id pub-id-type="pmid">24633344</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C302">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonemura</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Cadherin-actin interactions at adherens junctions</article-title>. <source/><italic>Curr. Opin. Cell Biol.</italic>
<volume>23</volume>, <fpage>515</fpage>-<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceb.2011.07.001</pub-id><pub-id pub-id-type="pmid">21807490</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C303">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>P.</given-names></name>, <name><surname>Santiago</surname><given-names>L. Y.</given-names></name>, <name><surname>Katagiri</surname><given-names>Y.</given-names></name> and <name><surname>Geller</surname><given-names>H. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Myosin II activity regulates neurite outgrowth and guidance in response to chondroitin sulfate proteoglycans</article-title>. <source/><italic>J. Neurochem.</italic>
<volume>120</volume>, <fpage>1117</fpage>-<lpage>1128</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07638.x</pub-id><pub-id pub-id-type="pmid">22191382</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C304">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>H.-Y.</given-names></name> and <name><surname>Xu</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Myosin light chain kinase accelerates vesicle endocytosis at the calyx of Held synapse</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>34</volume>, <fpage>295</fpage>-<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3744-13.2014</pub-id><pub-id pub-id-type="pmid">24381290</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C305">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>S. L.</given-names></name>, <name><surname>Ogut</surname><given-names>O.</given-names></name> and <name><surname>Brozovich</surname><given-names>F. V.</given-names></name></person-group> (<year>2009</year>). <article-title>Nonmuscle myosin is regulated during smooth muscle contraction</article-title>. <source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>297</volume>, <fpage>H191</fpage>-<lpage>H199</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00132.2009</pub-id><pub-id pub-id-type="pmid">19429828</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C306">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuste</surname><given-names>R.</given-names></name> and <name><surname>Bonhoeffer</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Genesis of dendritic spines: insights from ultrastructural and imaging studies</article-title>. <source/><italic>Nat. Rev. Neurosci.</italic>
<volume>5</volume>, <fpage>24</fpage>-<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1300</pub-id><pub-id pub-id-type="pmid">14708001</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C306a">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Q.</given-names></name>, <name><surname>Lagunoff</surname><given-names>D.</given-names></name>, <name><surname>Masaracchia</surname><given-names>R.</given-names></name>, <name><surname>Goeckeler</surname><given-names>Z.</given-names></name>, <name><surname>Côté</surname><given-names>G.</given-names></name> and <name><surname>Wysolmerski</surname><given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Endothelial cell retraction is induced by PAK2 monophosphorylation of myosin II</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>113</volume>, <fpage>471</fpage>-<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1300</pub-id><pub-id pub-id-type="pmid">10639334</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C307">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D.</given-names></name> and <name><surname>Kilian</surname><given-names>K. A.</given-names></name></person-group> (<year>2013</year>). <article-title>The effect of mesenchymal stem cell shape on the maintenance of multipotency</article-title>. <source/><italic>Biomaterials</italic>
<volume>34</volume>, <fpage>3962</fpage>-<lpage>3969</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.02.029</pub-id><pub-id pub-id-type="pmid">23473964</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C308">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name>, <name><surname>Webb</surname><given-names>D. J.</given-names></name>, <name><surname>Asmussen</surname><given-names>H.</given-names></name>, <name><surname>Niu</surname><given-names>S.</given-names></name> and <name><surname>Horwitz</surname><given-names>A. F.</given-names></name></person-group> (<year>2005</year>). <article-title>A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC</article-title>. <source/><italic>J. Neurosci.</italic>
<volume>25</volume>, <fpage>3379</fpage>-<lpage>3388</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3553-04.2005</pub-id><pub-id pub-id-type="pmid">15800193</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C309">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name>, <name><surname>Li</surname><given-names>X.</given-names></name>, <name><surname>Qi</surname><given-names>J.</given-names></name>, <name><surname>Wang</surname><given-names>J.</given-names></name>, <name><surname>Liu</surname><given-names>X.</given-names></name>, <name><surname>Zhang</surname><given-names>H.</given-names></name>, <name><surname>Lin</surname><given-names>S.-C.</given-names></name> and <name><surname>Meng</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Rock2 controls TGFbeta signaling and inhibits mesoderm induction in zebrafish embryos</article-title>. <source/><italic>J. Cell Sci.</italic>
<volume>122</volume>, <fpage>2197</fpage>-<lpage>2207</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.040659</pub-id><pub-id pub-id-type="pmid">19509062</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C311">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Z.</given-names></name>, <name><surname>Xu</surname><given-names>J.</given-names></name>, <name><surname>Chen</surname><given-names>J.</given-names></name>, <name><surname>Kim</surname><given-names>S.</given-names></name>, <name><surname>Reimers</surname><given-names>M.</given-names></name>, <name><surname>Bacanu</surname><given-names>S.-A.</given-names></name>, <name><surname>Yu</surname><given-names>H.</given-names></name>, <name><surname>Liu</surname><given-names>C.</given-names></name>, <name><surname>Sun</surname><given-names>J.</given-names></name>, <name><surname>Wang</surname><given-names>Q.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder</article-title>. <source/><italic>Mol. Psychiatry</italic> [<comment>Epub ahead of print</comment>] <pub-id pub-id-type="doi">10.1038/mp.2014.82</pub-id>.</mixed-citation>
</ref>
<ref id="DMM022103C312">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.-F.</given-names></name>, <name><surname>Zhang</surname><given-names>Q.</given-names></name>, <name><surname>Xi</surname><given-names>J.-Y.</given-names></name>, <name><surname>Li</surname><given-names>Y.-H.</given-names></name>, <name><surname>Ma</surname><given-names>C.-G.</given-names></name> and <name><surname>Xiao</surname><given-names>B.-G.</given-names></name></person-group> (<year>2015</year>). <article-title>Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease</article-title>. <source/><italic>J. Neurol. Sci.</italic>
<volume>353</volume>, <fpage>28</fpage>-<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2015.03.022</pub-id><pub-id pub-id-type="pmid">25908255</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C313">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>C.</given-names></name>, <name><surname>Kinch</surname><given-names>M. S.</given-names></name> and <name><surname>Burridge</surname><given-names>K.</given-names></name></person-group> (<year>1997</year>). <article-title>Rho-stimulated contractility contributes to the fibroblastic phenotype of Ras-transformed epithelial cells</article-title>. <source/><italic>Mol. Biol. Cell</italic>
<volume>8</volume>, <fpage>2329</fpage>-<lpage>2344</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.8.11.2329</pub-id><pub-id pub-id-type="pmid">9362072</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C314">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>C.</given-names></name>, <name><surname>Chrzanowska-Wodnicka</surname><given-names>M.</given-names></name>, <name><surname>Brown</surname><given-names>J.</given-names></name>, <name><surname>Shaub</surname><given-names>A.</given-names></name>, <name><surname>Belkin</surname><given-names>A. M.</given-names></name> and <name><surname>Burridge</surname><given-names>K.</given-names></name></person-group> (<year>1998</year>). <article-title>Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly</article-title>. <source/><italic>J. Cell Biol.</italic>
<volume>141</volume>, <fpage>539</fpage>-<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.141.2.539</pub-id><pub-id pub-id-type="pmid">9548730</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C315">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name>, <name><surname>Liu</surname><given-names>Y.</given-names></name>, <name><surname>You</surname><given-names>J.</given-names></name>, <name><surname>Zhang</surname><given-names>H.</given-names></name>, <name><surname>Zhang</surname><given-names>X.</given-names></name> and <name><surname>Ye</surname><given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2</article-title>. <source/><italic>Cancer Lett.</italic>
<volume>270</volume>, <fpage>312</fpage>-<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2008.05.028</pub-id><pub-id pub-id-type="pmid">18710790</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C316">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimman</surname><given-names>A.</given-names></name>, <name><surname>Chen</surname><given-names>S. S.</given-names></name>, <name><surname>Komisopoulou</surname><given-names>E.</given-names></name>, <name><surname>Titz</surname><given-names>B.</given-names></name>, <name><surname>Martínez-Pinna</surname><given-names>R.</given-names></name>, <name><surname>Kafi</surname><given-names>A.</given-names></name>, <name><surname>Berliner</surname><given-names>J. A.</given-names></name> and <name><surname>Graeber</surname><given-names>T. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Activation of aortic endothelial cells by oxidized phospholipids: a phosphoproteomic analysis</article-title>. <source/><italic>J. Proteome Res.</italic>
<volume>9</volume>, <fpage>2812</fpage>-<lpage>2824</lpage>. <pub-id pub-id-type="doi">10.1021/pr901194x</pub-id><pub-id pub-id-type="pmid">20307106</pub-id></mixed-citation>
</ref>
<ref id="DMM022103C317">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziv</surname><given-names>N. E.</given-names></name> and <name><surname>Smith</surname><given-names>S. J.</given-names></name></person-group> (<year>1996</year>). <article-title>Evidence for a role of dendritic filopodia in synaptogenesis and spine formation</article-title>. <source/><italic>Neuron</italic>
<volume>17</volume>, <fpage>91</fpage>-<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80283-4</pub-id><pub-id pub-id-type="pmid">8755481</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>